Prof. H.R. Buller PhD publications

2021

• Hamulyák Eva N., Wiegers Hanke M. G., Scheres Luuk J. J., Hutten Barbara A., de Lange Maria E., Timmermans Anne, Westerweel Peter E., Nijziel Marten R., Kruip Marieke J. H. A., ten Wolde Marije, Ypma Paula F., Klok Frederikus A., Nieuwenhuizen Laurens, van Wissen Sanne, Hovens Marcel M. C., Faber Laura M., Kamphuisen Pieter W., Büller Harry R., Middeldorp Saskia Heavy menstrual bleeding on direct factor Xa inhibitors: Rationale and design of the MEDEA study Research and practice in thrombosis and haemostasis 2021;5 (1):223-230
• de Winter Maria A., van Es Nick, Büller Harry R., Visseren Frank L. J., Nijkeuter Mathilde Prediction models for recurrence and bleeding in patients with venous thromboembolism: A systematic review and critical appraisal Thrombosis research 2021;199:85-96 [PubMed]

2020

• Kraaijpoel Noémie Cancer-associated thrombosis: Advances in diagnosis and treatmen 2020. 309p. ISBN 9789463757744. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Middeldorp Saskia; Co-supervisors: Buller Harry R., van Es Nick)
• Mulder Frits I., di Nisio Marcello, Ay Cihan, Carrier Marc, Bosch Floris T. M., Segers Annelise, Kraaijpoel Noémie, Grosso Michael A., Zhang George, Verhamme Peter, Wang Tzu-Fei, Weitz Jeffrey I., Middeldorp Saskia, Raskob Gary, Beenen Ludo F. M., Büller Harry R., van Es Nick Clinical implications of incidental venous thromboembolism in cancer patients European respiratory journal 2020;55 (2) [PubMed]
• Mulder F. I., van Es N., Kraaijpoel N., di Nisio M., Carrier M., Duggal A., Gaddh M., Garcia D., Grosso M. A., Kakkar A. K., Mercuri M. F., Middeldorp S., Royle G., Segers A., Shivakumar S., Verhamme P., Wang T., Weitz J. I., Zhang G., Büller H. R., Raskob G. Corrigendum to “Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study” [Thromb. Res. vol. 185, January 2020, pages 13–19] (Thrombosis Research (2020) 185 (13–19), (S0049384819304931), (10.1016/j.thromres.2019.11.007)) Thrombosis research 2020;191:156-159 [PubMed]
• Oudkerk Matthijs, Büller Harry R., Kuijpers Dirkjan, Oudkerk Sytse F., van Beek Edwin J. R. D-dimer and COVID-19 Radiology 2020;297 (3):E343 [PubMed]
• Tritschler Tobias, Kraaijpoel Noémie, Girard Philippe, Büller Harry R., Langlois Nicole, Righini Marc, Schulman Sam, Segers Annelise, le Gal Grégoire Definition of pulmonary embolism-related death and classification of the cause of death in venous thromboembolism studies: Communication from the SSC of the ISTH Journal of thrombosis and haemostasis 2020;18 (6):1495-1500 [PubMed]
• Tritschler Tobias, Kraaijpoel Noémie, Langlois Nicole, Girard Philippe, Schulman Sam, Büller Harry R., Segers Annelise, Righini Marc, le Gal Grégoire Development of a standardized definition of pulmonary embolism-related death: A cross-sectional survey of international thrombosis experts Journal of thrombosis and haemostasis 2020;18 (6):1415-1420 [PubMed]
• Oudkerk Matthijs, Büller Harry R., Kuijpers Dirkjan, van Es Nick, Oudkerk Sytse F., McLoud Theresa, Gommers Diederik, van Dissel Jaap, ten Cate Hugo, van Beek Edwin J. R. Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands Radiology 2020;297 (1):E216-E222 [PubMed]
• Kraaijpoel Noémie, Carrier Marc, le Gal Grégoire, McInnes Matthew D. F., Salameh Jean-Paul, McGrath Trevor A., van Es Nick, Moher David, Büller Harry R., Bossuyt Patrick M., Leeflang Mariska M. G. Diagnostic accuracy of three ultrasonography strategies for deep vein thrombosis of the lower extremity: A systematic review and meta-analysis PLoS ONE 2020;15 (2) [PubMed]
• Mulder Frits I., Bosch Floris T.M., Young Annie M., Marshall Andrea, McBane Robert D., Zemla Tyler J., Carrier Marc, Kamphuisen Pieter Willem, Bossuyt Patrick M.M., Büller Harry R., Weitz Jeffrey I., Middeldorp Saskia, van Es Nick Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis Blood 2020;136 (12):1433-1441 [PubMed]
• Mulder F. I., van Es N., Kraaijpoel N., di Nisio M., Carrier M., Duggal A., Gaddh M., Garcia D., Grosso M. A., Kakkar A. K., Mercuri M. F., Middeldorp S., Royle G., Segers A., Shivakumar S., Verhamme P., Wang T., Weitz J. I., Zhang G., Büller H. R., Raskob G. Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study Thrombosis research 2020;185:13-19 [PubMed]
• den Exter Paul L, Kroft Lucia J M, Gonsalves Carol, Le Gal Gregoire, Schaefer-Prokop Cornelia M, Carrier Marc, Huisman Menno V, Klok Frederikus A, Meijboom L, Beenen L F, de Roos A, Hartmann Ijc, Dennie C, Revel M P, Haramati L, van Beek E, Screaton N, Ferretti G, Ghaye B, Das M, White C, Pena Fernandez E, Paul N, Vlahos I, Renapurkar R D, Ravenel J, Kanne J, Abbara S, Rémy-Jardin M, Geurts B, Frauenfelder T, Sverzellati N, Prosch H, Goo J M, Vogel-Claussen J, MacMahon P J, Bhalla S, Kahn S, Shivakumar S, Wells P, Rodger M, Castellucci L, Duffett L, Delluc A, Siegal D, Wu C, Barco S, Kamphuisen P W, Büller H R, van Es N Establishing diagnostic criteria and treatment of subsegmental pulmonary embolism: A Delphi analysis of experts Research and practice in thrombosis and haemostasis 2020;4 (8):1251-1261 [PubMed]
• Schünemann Holger J., Ventresca Matthew, Crowther Mark, Briel Matthias, Zhou Qi, Noble Simon, Macbeth Fergus, Griffiths Gareth, Garcia David, Lyman Gary H., di Nisio Marcello, Iorio Alfonso, Mbuagbaw Lawrence, Neumann Ignacio, van Es Nick, Brouwers Melissa, Guyatt Gordon, Streiff Michael B., Marcucci Maura, Baldeh Tejan, Florez Ivan D., Alma Ozlem Gurunlu, Solh Ziad, Bossuyt Patrick M., Kahale Lara A., Ageno Walter, Bozas George, Büller Harry R., Lebeau Bernard, Lecumberri Ramon, Loprinzi Charles, McBane Robert, Sideras Kostandinos, Maraveyas Anthony, Pelzer Uwe, Perry James, Klerk Clara, Agnelli Giancarlo, Akl Elie A. Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis Lancet. Haematology 2020;7 (10):e746-e755
• Leader Avi, Hamulyák Eva N., Carney Brian J., Avrahami Maya, Knip Jelijn J., Rozenblatt Shira, Beenen Ludo F. M., Yust-Katz Shlomit, Icht Oded, Coppens Michiel, Raanani Pia, Middeldorp Saskia, Büller Harry R., Zwicker Jeffrey I., Spectre Galia Intracranial hemorrhage with direct oral anticoagulants in patients with brain metastases Blood advances 2020;4 (24):6291-6297 [PubMed]
• Bosch Floris T. M., Mulder Frits I., Willem Kamphuisen Pieter, Middeldorp Saskia, Bossuyt Patrick M., Büller Harry R., van Es Nick Primary thromboprophylaxis in ambulatory cancer patients with a high Khorana score: a systematic review and meta-analysis Blood advances 2020;4 (20):5215-5225 [PubMed]
• Mulder Frits I., Carrier Marc, van Doormaal Frederiek, Robin Philippe, Otten Hans-Martin, Salaun Pierre-Yves, Büller Harry R., le Gal Grégoire, van Es Nick Risk scores for occult cancer in patients with unprovoked venous thromboembolism: Results from an individual patient data meta-analysis Journal of thrombosis and haemostasis 2020;18 (10):2622-2628 [PubMed]
• van Es Nick, Ventresca Matthew, di Nisio Marcello, Zhou Qi, Noble Simon, Crowther Mark, Briel Matthias, Garcia David, Lyman Gary H., Macbeth Fergus, Griffiths Gareth, Iorio Alfonso, Mbuagbaw Lawrence, Neumann Ignacio, Brozek Jan, Guyatt Gordon, Streiff Michael B., Baldeh Tejan, Florez Ivan D., Gurunlu Alma Ozlem, Agnelli Giancarlo, Ageno Walter, Marcucci Maura, Bozas George, Zulian Gilbert, Maraveyas Anthony, Lebeau Bernard, Lecumberri Ramon, Sideras Kostandinos, Loprinzi Charles, McBane Robert, Pelzer Uwe, Riess Hanno, Solh Ziad, Perry James, Kahale Lara A., Bossuyt Patrick M., Klerk Clara, Büller Harry R., Akl Elie A., Schünemann Holger J. The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysis Journal of thrombosis and haemostasis 2020;18 (8):1940-1951 [PubMed]
• Mulder F. I., Hovenkamp A., van Laarhoven H. W. M., Büller H. R., Kamphuisen P. W., Hulshof M. C. C. M., van Berge Henegouwen M. I., Middeldorp S., van Es N. Thromboembolic and bleeding complications in patients with oesophageal cancer British journal of surgery 2020;107 (10):1324-1333 [PubMed]
• D'Alessandro Elisa, Becker Christian, Bergmeier Wolfgang, Bode Christoph, Bourne Joshua H., Brown Helena, Buller Harry R., ten Cate-Hoek Arina J., ten Cate Vincent, van Cauteren Yvonne J. M., Cheung Yam F. H., Cleuren Audrey, Coenen Danielle, Crijns Harry J. G. M., de Simone Ilaria, Dolleman Sophie C., Klein Christine Espinola, Fernandez Delia I., Granneman Lianne, van t Hof Arnoud, Henke Peter, Henskens Yvonne M. C., Huang Jingnan, Jennings Lisa K., Jooss Natalie, Karel Mieke, van den Kerkhof Danique, Klok Frederik A., Kremers Bram, Lämmle Bernhard, Leader Avi, Lundstrom Annika, Mackman Nigel, Mannucci Pier M., Maqsood Zahra, van der Meijden Paola E. J., van Moorsel Marc, Moran Luis A., Morser John, van Mourik Manouk, Navarro Stefano, Neagoe Raluca A. I., Olie Renske H., van Paridon Pauline, Posma Jens, Provenzale Isabella, Reitsma Pieter H., Scaf Billy, Schurgers Leon, Seelig Jaap, Siegbahn Agneta, Siegerink Bob, Soehnlein Oliver, Soriano Eva Maria, Sowa Marcin A., Spronk Henri M. H., Storey Robert F., Tantiwong Chukiat, Veninga Alicia, Wang Xueqing, Watson Steve P., Weitz Jeff, Zeerleder Sacha S., ten Cate Hugo, Lina Badimon, Christoph Binder, Marc Hoylaerts, Peter Karlheinz, Rory Koenen, Gregory Lip, Steffen Massberg, Philipp Von Hundelshausen, Christian Weber, Johann Wojta Thrombo-Inflammation in Cardiovascular Disease: An Expert Consensus Document from the Third Maastricht Consensus Conference on Thrombosis Thrombosis and haemostasis 2020;120 (4):538-564 [PubMed]
• Mulder Frits I, Horvàth-Puhó Erzsébet, van Es Nick, van Laarhoven Hanneke, Pedersen Lars, Moik Florian, Ay Cihan, Buller Harry R, Toft Sørensen Henrik Venous thromboembolism in cancer patients: a population-based cohort study Blood 2020 [PubMed]

2019

• Cohen Alexander T., Agnelli Giancarlo, Buller Harry R., Gallus Alexander, Raskob Gary E., Sanders Paul, Thompson John, Weitz Jeffrey I. Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial Thrombosis and haemostasis 2019;119 (3):461-466 [PubMed]
• Elsebaie Maha A. T., van Es Nick, Langston Amelia, Büller Harry R., Gaddh Manila Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis Journal of thrombosis and haemostasis 2019;17 (4):645-656 [PubMed]
• Wang Kang-Ling, Lopes Renato D., Patel Manesh R., Büller Harry R., Tan Doreen Su-Yin, Chiang Chern-En, Giugliano Robert P. Efficacy and safety of reduced-dose non-vitamin k antagonist oral anticoagulants in patients with atrial fibrillation: A meta-analysis of randomized controlled trials European heart journal 2019;40 (19):1492-1500 [PubMed]
• Wang Kang-Ling, van Es Nick, Cameron Chris, Castellucci Lana A., Büller Harry R., Carrier Marc Extended treatment of venous thromboembolism: A systematic review and network meta-analysis Heart (British Cardiac Society) 2019;105 (7):545-552 [PubMed]
• di Nisio Marcello, van Es Nick, Carrier Marc, Wang Tzu-Fei, Garcia David, Segers Annelise, Weitz Jeffrey, Buller Harry, Raskob Gary Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study Journal of thrombosis and haemostasis 2019;17 (11):1866-1874 [PubMed]
• Elsebaie Maha A. T., van Es Nick, Langston Amelia, Büller Harry R., Gaddh Manila Follow-up to comment on “Direct Oral Anticoagulants in Patients with Venous Thromboembolism and Thrombophilia: Systematic Review and Meta-Analysis” Journal of thrombosis and haemostasis 2019;17 (6):1007-1009 [PubMed]
• Khan Faizan, Rahman Alvi, Carrier Marc, Kearon Clive, Weitz Jeffrey I., Schulman Sam, Couturaud Francis, Eichinger Sabine, Kyrle Paul A., Becattini Cecilia, Agnelli Giancarlo, Brighton Timothy A., Lensing Anthonie W. A., Prins Martin H., Sabri Elham, Hutton Brian, Pinede Laurent, Cushman Mary, Palareti Gualtiero, Wells George A., Prandoni Paolo, Büller Harry R., Rodger Marc A. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: Systematic review and meta-analysis BMJ (Clinical research ed.) 2019;366 [PubMed]
• Mol G. C. M., Büller H. R., Sinnige H. A. M., Péquériaux N. C. V., Coppens M. Perioperative bridging of anticoagulation: Towards a more reserved approach Netherlands journal of medicine 2019;77 (8):280-286
• Jara-Palomares L., van Es N., Praena-Fernandez J. M., le Gal G., Otten H. M., Robin P., Piccioli A., Lecumberri R., Religa P., Rieu V., Rondina M., Beckers M., Prandoni P., Salaun P. Y., di Nisio M., Bossuyt P. M., Kraaijpoel N., Büller H. R., Carrier M. Relationship between type of unprovoked venous thromboembolism and cancer location: An individual patient data meta-analysis Thrombosis research 2019;176:79-84 [PubMed]
• van Mens T. E., Büller H. R., Nieuwdorp M. Targeted inhibition of gut microbiota proteins involved in TMAO production to reduce platelet aggregation and arterial thrombosis: a blueprint for drugging the microbiota in the treatment of cardiometabolic disease? Journal of thrombosis and haemostasis 2019;17 (1):3-5 [PubMed]
• Mohammed Yassene, Kootte Ruud S., Kopatz Wil F., Borchers Christoph H., Büller Harry R., Versteeg Henri H., Nieuwdorp Max, van Mens Thijs E. The intestinal microbiome potentially affects thrombin generation in human subjects Journal of thrombosis and haemostasis 2019 [PubMed]
• Mulder Frits I., Candeloro Matteo, Kamphuisen Pieter W., di Nisio Marcello, Bossuyt Patrick M., Guman Noori, Smit Kirsten, Buller Harry R., van Es Nick The khorana score for prediction of venous thromboembolism in cancer patients: A systematic review and meta-analysis Haematologica 2019;104 (6):1277-1287 [PubMed]
• Mulder Frits I., Kraaijpoel Noémie, di Nisio Marcello, Meyer Guy, Mahé Isabelle, Muñoz Andrés, Bertoletti Laurent, Biosca Mercedes, Maraveyas Anthony, Büller Harry R., van Es Nick The Ottawa score performs poorly in cancer patients with incidental pulmonary embolism Thrombosis research 2019;181:59-63 [PubMed]
• Kraaijpoel Noémie, Bleker Suzanne M., Meyer Guy, Mahé Isabelle, Muñoz Andrés, Bertoletti Laurent, Bartels-Rutten Annemarieke, Beyer-Westendorf Jan, Porreca Ettore, Boulon Carine, van Es Nick, Iosub Diana I., Couturaud Francis, Biosca Mercedes, Lerede Teresa, Lacroix Philippe, Maraveyas Anthony, Aggarwal Anita, Girard Philippe, Büller Harry R., di Nisio Marcello, Accassat S., Aquilant S., Assaf J. D., Baars J., Beenen L. M., Bergmann J. F., Bozas G., Caliandro R., Carrier M., Confrere E., Constans J., Désormais I., Dublanchet N., Endig S., Falanga A., Falvo N., Ferrer Pérez Al, García Escobar I., Gonzàlez Santiago S., Grange C., Helfer H., Kleinjan A., Lalezari F., de Magalhaes E., Marten S., Martinez del Prado P., Otten H. M., Paleiron N., Pérez Ramírez S. Treatment and long-term clinical outcomes of incidental pulmonary embolism in patients with cancer: An international prospective cohort study Journal of clinical oncology 2019;37 (20):1713-1720 [PubMed]

2018

• Scheres L. J. J., Brekelmans M. P. A., Ageno W., Ay C., Büller H. R., Eichinger S., Hutten B. A., Klok F. A., Middeldorp S., Schreiber K., Stach K., Blondon M., Delluc A. Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai-VTE study BJOG 2018;125 (12):1581-1589 [PubMed]
• Pabinger Ingrid, van Es Nick, Heinze Georg, Posch Florian, Riedl Julia, Reitter Eva-Maria, di Nisio Marcello, Cesarman-Maus Gabriela, Kraaijpoel Noémie, Zielinski Christoph Carl, Büller Harry Roger, Ay Cihan A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts Lancet. Haematology 2018;5 (7):e289-e298 [PubMed]
• Spronk H. M. H., Padro T., Siland J. E., Prochaska J. H., Winters J., van der Wal A. C., Posthuma J. J., Lowe G., d'Alessandro E., Wenzel P., Coenen D. M., Reitsma P. H., Ruf W., van Gorp R. H., Koenen R. R., Vajen T., Alshaikh N. A., Wolberg A. S., Macrae F. L., Asquith N., Heemskerk J., Heinzmann A., Moorlag M., Mackman N., van der Meijden P., Meijers J. C. M., Heestermans M., Renné T., Dólleman S., Chayouâ W., Ariëns R. A. S., Baaten C. C., Nagy M., Kuliopulos A., Posma J. J., Harrison P., Vries M. J., Crijns H. J. G. M., Dudink E. A. M. P., Buller H. R., Henskens Y. M. C., Själander A., Zwaveling S., Erküner O., Eikelboom J. W., Gulpen A., Peeters F. E. C. M., Douxfils J., Olie R. H., Baglin T., Leader A., Schotten U., Scaf B., van Beusekom H. M. M., Mosnier L. O., van der Vorm L., Declerck P., Visser M., Dippel D. W. J., Strijbis V. J., Pertiwi K., ten Cate-Hoek A. J., ten Cate H. Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis Thrombosis and haemostasis 2018;118 (2):229-250 [PubMed]
• Kraaijpoel Noémie, van Es Nick, Bleker Suzanne M., Brekelmans Marjolein P. A., Eerenberg Elise S., Middeldorp Saskia, Cohen Alexander T., Raskob Gary E., Büller Harry R. Clinical Impact and Course of Anticoagulant-Related Major Bleeding in Cancer Patients Thrombosis and haemostasis 2018;118 (1):174-181 [PubMed]
• Kraaijpoel Noémie, di Nisio Marcello, Mulder Frits I., van Es Nick, Beyer-Westendorf Jan, Carrier Marc, Garcia David, Grosso Michael, Kakkar Ajay K., Mercuri Michele F., Middeldorp Saskia, Hernandez Cristhiam Rojas, Santamaria Amparo, Schwocho Lee, Segers Annelise, Verhamme Peter, Wang Tzu-Fei, Weitz Jeffrey I., Zhang George, Zwicker Jeffrey I., Büller Harry R., Raskob Gary E. Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study Thrombosis and haemostasis 2018;118 (8):1439-1449 [PubMed]
• Mazzolai Lucia, Aboyans Victor, Ageno Walter, Agnelli Giancarlo, Alatri Adriano, Bauersachs Rupert, Brekelmans Marjolein P. A., Büller Harry R., Elias Antoine, Farge Dominique, Konstantinides Stavros, Palareti Gualtiero, Prandoni Paolo, Righini Marc, Torbicki Adam, Vlachopoulos Charalambos, Brodmann Marianne Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European society of cardiology working groups of aorta and peripheral circulation and pulmonary circulation and right ventricular function European heart journal 2018;39 (47):4208-4218 [PubMed]
• Hoolwerf Evert Willian, Kraaijpoel Noémie, Büller Harry Roger, van Es Nick Direct oral anticoagulants in patients with liver cirrhosis: A systematic review Thrombosis research 2018;170:102-108 [PubMed]
• Raskob Gary E., van Es Nick, Verhamme Peter, Carrier Marc, Di Nisio Marcello, Garcia David, Grosso Michael A., Kakkar Ajay K., Kovacs Michael J., Mercuri Michele F., Meyer Guy, Segers Annelise, Shi Minggao, Wang Tzu-Fei, Yeo Erik, Zhang George, Zwicker Jeffrey I., Weitz Jeffrey I., Büller Harry R., Beyer-Westendorf Jan, Boda Zoltan, Chlumsky Yaromir, Gibbs Harry, Kamphuizen P. W., Monreal Manuel, Ockleford Paul, Pabinger-Fasching Ingrid, Sinnaeve Peter, Beenen Ludo, Gerdes Victor, Laleman Wim, Larrey Dominiqe, van Mechelen Rob, Roos Yvo, Scheerder Maeke, Slagboom Ton, Thijs Vincent, Eikelboom John W., Crowther Mark, Roberts Robin S., Vanassche Thomas, Vandenbriele Christophe, Debaveye Barbara, Dani Vidhi, Schwocho Lee, Duggal Anil, Baker R., Carroll P., Kuijer P., Middeldorp S. Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism New England journal of medicine 2018;378 (7):615-624 [PubMed]
• van Es Nick, Hisada Yohei, di Nisio Marcello, Cesarman Gabriela, Kleinjan Ankie, Mahé Isabelle, Otten Hans-Martin, Kamphuisen Pieter W., Berckmans René J., Büller Harry R., Mackman Nigel, Nieuwland Rienk Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study Thrombosis research 2018;166:54-59 [PubMed]
• van den Heuvel J. M., Hövels A. M., Büller H. R., Mantel-Teeuwisse A. K., de Boer A., Maitland-van der Zee A. H. NOACs replace VKA as preferred oral anticoagulant among new patients: A drug utilization study in 560 pharmacies in The Netherlands Thrombosis journal 2018;16 (1) [PubMed]
• Kraaijpoel N., Toorop M. M. A., Bossuyt P. M., Klok F. A., Büller H. R., van Es N. Questioning the use of an age-adjusted D-dimer threshold to exclude venous thromboembolism: comment Journal of thrombosis and haemostasis 2018;16 (7):1445-1448 [PubMed]
• Schapkaitz Elise, de Jong P. R., Jacobson B. F., Büller H. R. Recommendations for thromboprophylaxis in obstetrics and gynaecology South African Journal of Obstetrics and Gynaecology 2018;24 (1):27-31
• Kraaijpoel Noémie, van Es Nick, Raskob Gary E., Büller Harry R., Carrier Marc, Zhang George, Lin Min, Grosso Michael A., di Nisio Marcello Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study Thrombosis and haemostasis 2018;118 (7):1270-1278 [PubMed]

2017

• Brekelmans Marjolein P. A., Scheres Luuk J. J., Bleker Suzanne M., Hutten Barbara A., Timmermans Anne, Büller Harry R., Middeldorp Saskia Abnormal vaginal bleeding in women with venous thromboembolism treated with apixaban or warfarin Thrombosis and haemostasis 2017;117 (4):809-815 [PubMed]
• Robert-Ebadi H., Mostaguir K., Hovens M. M., Kare M., Verschuren F., Girard P., Huisman M. V., Moustafa F., Kamphuisen P. W., Buller H. R., Righini M., Le Gal G. Assessing clinical probability of pulmonary embolism: prospective validation of the simplified Geneva score Journal of thrombosis and haemostasis 2017;15 (9):1764-1769 [PubMed]
• Wilts I. T., Hutten B. A., Meijers J. C. M., Spek C. A., Büller H. R., Kamphuisen P. W. Association between protein C levels and mortality in patients with advanced prostate, lung and pancreatic cancer Thrombosis research 2017;154:1-6 [PubMed]
• van Es Nick Cancer and thrombosis: Improvements in strategies for prediction, diagnosis, and treatment 2017. 297p. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Middeldorp S., Bossuyt P. M. M.; Co-supervisors: Büller H. R., Di Nisio M.)
• Bleker Suzanne M. Clinical aspects of venous thromboembolism in special patient populations 2017. 297p. ISBN 9789462996632. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Middeldorp S.; Co-supervisors: Büller H. R., Di Nisio M.)
• Bleker Suzanne M., Brekelmans Marjolein P. A., Eerenberg Elise S., Cohen Alexander T., Middeldorp Saskia, Raskob Gary, Büller Harry R. Clinical impact of major bleeding in patients with venous thrombo-embolism treated with factor Xa inhibitors or vitamin K antagonists Thrombosis and haemostasis 2017;117 (10):1944-1951 [PubMed]
• van Es Nick, Di Nisio Marcello, Cesarman Gabriela, Kleinjan Ankie, Otten Hans-Martin, Mahé Isabelle, Wilts Ineke T., Twint Desirée C., Porreca Ettore, Arrieta Oscar, Stépanian Alain, Smit Kirsten, de Tursi Michele, Bleker Suzanne M., Bossuyt Patrick M., Nieuwland Rienk, Kamphuisen Pieter W., Büller Harry R. Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study Haematologica 2017;102 (9):1494-1501 [PubMed]
• Di Minno Matteo Nicola Dario, Ageno Walter, Lupoli Roberta, Conte Giulia, van Es Nick, Buller Harry R., Dentali Francesco Direct oral anticoagulants for the treatment of acute venous thromboembolism in patients with cancer: a meta-analysis of randomised controlled trials European respiratory journal 2017;50 (3):1701097 [PubMed]
• Wang Kang-Ling, Büller Harry R., Goto Shinya, Lin Chun-Yi, Lai En-Yu, Chiu Chun-Chih, Chiang Chern-En, Giugliano Robert P. Extracranial arterial and venous thromboembolism in patients with atrial fibrillation: A meta-analysis of randomized controlled trials Heart rhythm 2017;14 (4):599-605 [PubMed]
• Vanassche Thomas, Verhamme Peter, Wells Philip S., Segers Annelise, Ageno Walter, Brekelmans Marjolein P. A., Chen Cathy Z., Cohen Alexander T., Grosso Michael A., Medina Andria P., Mercuri Michele F., Winters Shannon M., Zhang George, Weitz Jeffrey I., Raskob Gary E., Büller Harry R. Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial Thrombosis research 2017;162:7-14 [PubMed]
• van Es N., Bleker S. M., Di Nisio M., Kleinjan A., Beyer-Westendorf J., Camporese G., Aggarwal A., Verhamme P., Righini M., Büller H. R., Bossuyt P. M. Improving the diagnostic management of upper extremity deep vein thrombosis Journal of thrombosis and haemostasis 2017;15 (1):66-73 [PubMed]
• van der Hulle Tom, van Es Nick, den Exter Paul L., van Es Josien, Mos Inge C. M., Douma Renée A., Kruip Marieke J. H. A., Hovens Marcel M. C., ten Wolde Marije, Nijkeuter Mathilde, ten Cate Hugo, Kamphuisen Pieter W., Büller Harry R., Huisman Menno V., Klok Frederikus A. Is a normal computed tomography pulmonary angiography safe to rule out acute pulmonary embolism in patients with a likely clinical probability? Thrombosis and haemostasis 2017;117 (8):1622-1629 [PubMed]
• van Es N., van der Hulle T., Büller H. R., Klok F. A., Huisman M. V., Galipienzo J., Di Nisio M. Is stand-alone D-dimer testing safe to rule out acute pulmonary embolism? Journal of thrombosis and haemostasis 2017;15 (2):323-328 [PubMed]
• Khan Faizan, Rahman Alvi, Carrier Marc, Kearon Clive, Schulman Sam, Couturaud Francis, Prandoni Paolo, Eichinger Sabine, Becattini Cecilia, Agnelli Giancarlo, Büller Harry R., Brighton Timothy A., Palareti Gualtiero, Pinede Laurent, Sabri Elham, Hutton Brian, Wells George A., Rodger Marc A. Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis BMJ open 2017;7 (9) [PubMed]
• Medina Andria, Raskob Gary, Ageno Walter, Cohen Alexander T., Brekelmans Marjolein P. A., Chen Cathy Z., Grosso Michael A., Mercuri Michele F., Segers Annelise, Verhamme Peter, Vanassche Thomas, Wells Philip S., Lin Min, Winters Shannon M., Weitz Jeffrey I., Büller Harry R. Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study Thrombosis and haemostasis 2017;117 (12):2406-2414 [PubMed]
• Wilts I. T., Le Gal G., den Exter P. L., van Es J., Carrier M., Planquette B., Büller H. R., Righini M., Huisman M. V., Kamphuisen P. W. Performance of the age-adjusted cut-off for D-dimer in patients with cancer and suspected pulmonary embolism Thrombosis research 2017;152:49-51 [PubMed]
• Ramspek Chava L., Nacak Hakan, van Diepen Merel, van Buren Marjolijn, Krediet Raymond T., Rotmans Joris I., Dekker Friedo W., Apperloo A. J., Bijlsma J. A., Boekhout M., Boer W. H., van der Boog P. J. M., Büller H. R., van Buren M., de Charro F. Th, Doorenbos C. J., van den Dorpel M. A., van Es A., Fagel W. J., Feith G. W., de Fijter C. W. H., Frenken L. A. M., van Geelen J. A. C. A., Gerlag P. G. G., Grave W., Gorgels J. P. M. C., Huisman R. M., Jager K. J., Jie K., Koning-Mulder W. A. H., Koolen M. I., Kremer Hovinga T. K., Lavrijssen A. T. J., Luik A. J., van der Meulen J., Parlevliet K. J., Raasveld M. H. M., van der Sande F. M., Schonck M. J. M., Schuurmans M. M. J., Siegert C. E. H., Stegeman C. A., Stevens P., Thijssen J. G. P., Valentijn R. M., Vastenburg G. H., Verburgh C. A., Vincent H. H., Vos P. F. Pre-dialysis decline of measured glomerular filtration rate but not serum creatinine-based estimated glomerular filtration rate is a risk factor for mortality on dialysis Nephrology, dialysis, transplantation 2017;32 (1):89-96 [PubMed]
• Di Nisio Marcello, Raskob Gary, Büller Harry R., Grosso Michael A., Zhang George, Winters Shannon M., Cohen Alexander Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists Thrombosis and haemostasis 2017;117 (4):784-793 [PubMed]
• Brekelmans M. P. A., Kappelhof M., Nieuwkerk P. T., Nierman M., Buller H. R., Coppens M. Preference for direct oral anticoagulants in patients treated with vitamin K antagonists for venous thromboembolism Netherlands journal of medicine 2017;75 (2):50-55 [PubMed]
• van Es Nick, Le Gal Grégoire, Otten Hans-Martin, Robin Philippe, Piccioli Andrea, Lécumberri Ramon, Palomares Luis Jara, Religa Piotr, Rieu Viriginie, Rondina Matthew T., Beckers Mariëlle M., Prandoni Paolo, Salaun Pierre-Yves, Di Nisio Marcello, Bossuyt Patrick M., Büller Harry R., Carrier Marc Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis BMJ open 2017;7 (6) [PubMed]
• van Es Nick, Le Gal Grégoire, Otten Hans-Martin, Robin Philippe, Piccioli Andrea, Lecumberri Ramón, Jara-Palomares Luis, Religa Piotr, Rieu Virginie, Rondina Matthew, Beckers Mariëlle M., Prandoni Paolo, Salaun Pierre-Yves, Di Nisio Marcello, Bossuyt Patrick M., Büller Harry R., Carrier Marc Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism A Systematic Review and Meta-analysis of Individual Patient Data Annals of internal medicine 2017;167 (6):410-417 [PubMed]
• Scheres L. J. J., Brekelmans M. P. A., Beenen L. F. M., Büller H. R., Cannegieter S. C., Middeldorp S. Sex-specific differences in the presenting location of a first venous thromboembolism Journal of thrombosis and haemostasis 2017;15 (7):1344-1350 [PubMed]
• Kraaijpoel Noémie, van Es Nick, Porreca Ettore, Büller Harry R., Di Nisio Marcello The diagnostic management of upper extremity deep vein thrombosis: A review of the literature Thrombosis research 2017;156:54-59 [PubMed]
• van Es N., Franke V. F., Middeldorp S., Wilmink J. W., Büller H. R. The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer Thrombosis research 2017;150:30-32 [PubMed]
• van Es N., Kraaijpoel N., Klok F. A., Huisman M. V., den Exter P. L., Mos I. C. M., Galipienzo J., Büller H. R., Bossuyt P. M. The original and simplified Wells rules and age-adjusted D-dimer testing to rule out pulmonary embolism: an individual patient data meta-analysis Journal of thrombosis and haemostasis 2017;15 (4):678-684 [PubMed]

2016

• van Es Nick, Bleker Suzanne M., Di Nisio Marcello, Kleinjan Ankie, Beyer-Westendorf Jan, Camporese Giuseppe, Kamphuisen Pieter W., Büller Harry R., Bossuyt Patrick M. A clinical decision rule and D-dimer testing to rule out upper extremity deep vein thrombosis in high-risk patients Thrombosis research 2016;148:59-62 [PubMed]
• Pépin M., Kleinjan A., Hajage D., Büller H. R., Di Nisio M., Kamphuisen P. W., Salomon L., Veyradier A., Stepanian A., Mahé I. ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer Journal of thrombosis and haemostasis 2016;14 (2):306-315 [PubMed]
• Connolly Stuart J., Milling Truman J., Eikelboom John W., Gibson C. Michael, Curnutte John T., Gold Alex, Bronson Michele D., Lu Genmin, Conley Pamela B., Verhamme Peter, Schmidt Jeannot, Middeldorp Saskia, Cohen Alexander T., Beyer-Westendorf Jan, Albaladejo Pierre, Lopez-Sendon Jose, Goodman Shelly, Leeds Janet, Wiens Brian L., Siegal Deborah M., Zotova Elena, Meeks Brandi, Nakamya Juliet, Lim W. Ting, Crowther Mark, Connolly S. C., Crowther M., Eikelboom J., Gibson M., Milling T. J., Albaladejo P., Cohen A., Lopez-Sendon J., Schmidt J., Verhamme P., Beyer-Westendorf J., Wyse D. G., Garcia D., Prins M. [=Martin H.], Nakamya J., Büller H. R., Mahaffey K., Alexander J., Demchuk A., Raskob G., Schulman S., Meeks B., Zotova E., Holadyk-Gris I., Coppens M. Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors New England journal of medicine 2016;375 (12):1131-1141 [PubMed]
• Bleker Suzanne M., van Es Nick, van Gils Luuk, Daams Joost G., Kleinjan Ankie, Büller Harry R., Di Nisio Marcello Clinical course of upper extremity deep vein thrombosis in patients with or without cancer: a systematic review Thrombosis research 2016;140 (Suppl. 1):S81-S88 [PubMed]
• Brekelmans Marjolein P. A., Bleker Suzanne M., Bauersachs Rupert, Boda Zoltan, Büller Harry R., Choi Youngsook, Gallus Alex, Grosso Michael A., Middeldorp Saskia, Oh Doyeun, Raskob Gary, Schwocho Lee, Cohen Alexander T. Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists Thrombosis and haemostasis 2016;116 (1):155-161 [PubMed]
• Bleker Suzanne M., Cohen Alexander T., Büller Harry R., Agnelli Giancarlo, Gallus Alexander S., Raskob Gary E., Weitz Jeffrey I., Curto Madelyn, Sisson Melanie, Middeldorp Saskia Clinical presentation and course of bleeding events in patients with venous thromboembolism, treated with apixaban or enoxaparin and warfarin. Results from the AMPLIFY trial Thrombosis and haemostasis 2016;116 (6):1159-1164 [PubMed]
• Bleker S. M., van Es N., Kleinjan A., Büller H. R., Kamphuisen P. W., Aggarwal A., Beyer-Westendorf J., Camporese G., Cosmi B., Gary T., Ghirarduzzi A., Kaasjager K., Lerede T., Marschang P., Meijer K., Otten H.-M., Porreca E., Righini M., Verhamme P., van Wissen S., Di Nisio M. Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis Journal of thrombosis and haemostasis 2016;14 (5):973-981 [PubMed]
• Di Nisio Marcello, van Es Nick, Büller Harry R. Deep vein thrombosis and pulmonary embolism Lancet 2016;388 (10063):3060-3073
• Verhamme Peter, Wells Philip S., Segers Annelise, Ageno Walter, Brekelmans Marjolein P. A., Cohen Alexander T., Meyer Guy, Grosso Michael A., Raskob Gary, Weitz Jeffrey I., Zhang George, Buller Harry Dose reduction of edoxaban preserves efficacy and safety for the treatment of venous thromboembolism. An analysis of the randomised, double-blind HOKUSAI VTE trial Thrombosis and haemostasis 2016;116 (4):747-753 [PubMed]
• Raskob Gary E., Gallus Alex S., Sanders Paul, Thompson John R., Agnelli Giancarlo, Buller Harry R., Cohen Alexander T., Ramacciotti Eduardo, Weitz Jeffrey I. Early time courses of recurrent thromboembolism and bleeding during apixaban or enoxaparin/warfarin therapy. A sub-analysis of the AMPLIFY trial Thrombosis and haemostasis 2016;115 (4):809-816 [PubMed]
• Raskob Gary E., van Es Nick, Segers Annelise, Angchaisuksiri Pantep, Oh Doyeun, Boda Zoltan, Lyons Roger M., Meijer Karina, Gudz Ivan, Weitz Jeffrey I., Zhang George, Lanz Hans, Mercuri Michele F., Büller Harry R. Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial Lancet. Haematology 2016;3 (8):e379-e387 [PubMed]
• Hendriksen Janneke, Geersing Geert-Jan, Lucassen Wim, Erkens Petra, Stoffers Jelle, van Weert Henk, Büller Harry, Hoes Arno, Moons Karel Een bruikbare klinische beslisregel voor longembolie Huisarts en wetenschap 2016;59 (5):200-203
• Raskob Gary, Ageno Walter, Cohen Alexander T., Brekelmans Marjolein P. A., Grosso Michael A., Segers Annelise, Meyer Guy, Verhamme Peter, Wells Philip S., Lin Min, Winters Shannon M., Weitz Jeffrey I., Büller Harry R. Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study Lancet. Haematology 2016;3 (5):e228-e236 [PubMed]
• Bleker S. M., Beenen L. F. M., Di Nisio M., van Es N., Büller H. R., Kraaijpoel N., Rutten A. Incidental pulmonary embolism in cancer patients: Interobserver agreement on the diagnosis and extent with a focus on distal clots Thrombosis research 2016;147:46-51 [PubMed]
• Ageno Walter, Büller Harry R., Falanga Anna, Hacke Werner, Hendriks Jeroen, Lobban Trudie, Merino Jose, Milojevic Ivan S., Moya Francisco, van der Worp H. Bart, Randall Gary, Tsioufis Konstantinos, Verhamme Peter, Camm A. John Managing reversal of direct oral anticoagulants in emergency situations Anticoagulation Education Task Force White Paper Thrombosis and haemostasis 2016;116 (6):1003-1010 [PubMed]
• Elbers Laura P. B., Boon Hjalmar A., Moes Maaike I., van Zaane Bregje, Brandjes Dees P. M., Fliers Eric, Büller Harry R., Cannegieter Suzanne, Gerdes Victor E. A. Plasma Levels of Free Thyroxine and Risk of Major Bleeding in Bariatric Surgery European thyroid journal 2016;5 (2):139-144 [PubMed]
• Wilts I T, Hutten B A, Meijers J C, Spek C A, Büller H R, Kamphuisen P W PO-28 - Protein C levels are associated with mortality in patients with advanced cancer Thrombosis research 2016;140 Suppl 1:S186-7 [PubMed]
• Brekelmans Marjolein P. A., Ageno Walter, Beenen Ludo F., Brenner Benjamin, Buller Harry R., Chen Cathy Z., Cohen Alexander T., Grosso Michael A., Meyer Guy, Raskob Gary, Segers Annelise, Vanassche Thomas, Verhamme Peter, Wells Philip S., Zhang George, Weitz Jeffrey I. Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study Lancet. Haematology 2016;3 (9):e437-e445 [PubMed]
• Di Nisio Marcello, Ageno Walter, Rutjes Anne W. S., Pap Akos F., Büller Harry R. Risk of major bleeding in patients with venous thromboembolism treated with rivaroxaban or with heparin and vitamin K antagonists Thrombosis and haemostasis 2016;115 (2):424-432 [PubMed]
• Hendriksen Janneke M. T., Lucassen Wim A. M., Erkens Petra M. G., Stoffers Henri E. J. H., van Weert Henk C. P. M., Büller Harry R., Hoes Arno W., Moons Karel G. M., Geersing Geert-Jan Ruling Out Pulmonary Embolism in Primary Care: Comparison of the Diagnostic Performance of "Gestalt" and the Wells Rule Annals of family medicine 2016;14 (3):227-234 [PubMed]
• Schünemann Holger J., Ventresca Matthew, Crowther Mark, Briel Matthias, Zhou Qi, Garcia David, Lyman Gary, Noble Simon, Macbeth Fergus, Griffiths Gareth, DiNisio Marcello, Iorio Alfonso, Beyene Joseph, Mbuagbaw Lawrance, Neumann Ignacio, van Es Nick, Brouwers Melissa, Brozek Jan, Guyatt Gordon, Levine Mark, Moll Stephan, Santesso Nancy, Streiff Michael, Baldeh Tejan, Florez Ivan, Gurunlu Alma Ozlem, Solh Ziad, Ageno Walter, Marcucci Maura, Bozas George, Zulian Gilbert, Maraveyas Anthony, Lebeau Bernard, Buller Harry, Evans Jessica, McBane Robert, Bleker Suzanne, Pelzer Uwe, Akl Elie A. Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol BMJ open 2016;6 (4):e010569 [PubMed]
• van Es Nick, van der Hulle Tom, van Es Josien, den Exter Paul L., Douma Renée A., Goekoop Robbert J., Mos Inge C. M., Galipienzo Javier, Kamphuisen Pieter W., Huisman Menno V., Klok Frederikus A., Büller Harry R., Bossuyt Patrick M. Wells Rule and d-Dimer Testing to Rule Out Pulmonary Embolism: A Systematic Review and Individual-Patient Data Meta-analysis Annals of internal medicine 2016;165 (4):253-261 [PubMed]

2015

• Piccioli Andrea Cancer, thrombosis and low-molecular-weight heparins 2015. 148p. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Büller H R.; Co-supervisor: Prandoni P.)
• Eerenberg E. S., Middeldorp S., Levi M., Lensing A. W., Büller H. R. Clinical impact and course of major bleeding with rivaroxaban and vitamin K antagonists Journal of thrombosis and haemostasis 2015;13 (9):1590-1596 [PubMed]
• Hendriksen Janneke M. T., Geersing Geert-Jan, Lucassen Wim A. M., Erkens Petra M. G., Stoffers Henri E. J. H., van Weert Henk C. P. M., Büller Harry R., Hoes Arno W., Moons Karel G. M. Diagnostic prediction models for suspected pulmonary embolism: systematic review and independent external validation in primary care BMJ (Clinical research ed.) 2015;351:h4438 [PubMed]
• van Es Nick, Di Nisio Marcello, Bleker Suzanne M., Segers Annelise, Mercuri Michele F., Schwocho Lee, Kakkar Ajay, Weitz Jeffrey I., Beyer-Westendorf Jan, Boda Zoltan, Carrier Marc, Chlumsky Jaromir, Décousus Hervé, Garcia David, Gibbs Harry, Kamphuisen Pieter W., Monreal Manuel, Ockelford Paul, Pabinger Ingrid, Verhamme Peter, Grosso Michael A., Büller Harry R., Raskob Gary E. Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer study Thrombosis and haemostasis 2015;114 (6):1268-1276 [PubMed]
• Nakamura M., Wang Y. Q., Wang C., Oh D., Yin W.-H., Kimura T., Miyazaki K., Abe K., Mercuri M., Lee L. H., Segers A., Büller H. Efficacy and safety of edoxaban for treatment of venous thromboembolism: a subanalysis of East Asian patients in the Hokusai-VTE trial Journal of thrombosis and haemostasis 2015;13 (9):1606-1614 [PubMed]
• Büller Harry R., Bethune Claudette, Bhanot Sanjay, Gailani David, Monia Brett P., Raskob Gary E., Segers Annelise, Verhamme Peter, Weitz Jeffrey I., Weitz Jeffrey, Prins Martin, Beenen Ludo, Otten Hans-Martin, Roos Yvo, Slagboom Ton, Vandenbriele Christophe, Vanassche Thomas, Dani Vidhi, Schulz Dan, Shapiro Cara, Kwoh Katherine, Jung Bill, Gawinek-Samelczak Agata, Kaemmer Christina, Angelov S., Stavrev V., Kinov P., Dessouki E., Abuzgaya F., Baurovskis A., Peredistijs A., Petronis S., Danilyak V., Driagin V., Kuropatkin G., Parfeev S., Safronov A., Ankin M., Korzh M., Olinichenko G., Polivoda A., Shevchenko V., Sulyma V. Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis New England journal of medicine 2015;372 (3):232-240 [PubMed]
• Büller Harry R., Gailani David, Weitz Jeffrey I. Factor XI Antisense Oligonucleotide for Venous Thrombosis REPLY New England journal of medicine 2015;372 (17):1672 [PubMed]
• Wendelboe A. M., McCumber M., Hylek E. M., Buller H., Weitz J. I., Raskob G., Angchaisuksiri P., Blanco A. N., Hunt B. J., Kakkar A., Konstantinides S. V., McLintock C., Ozaki Y. Global public awareness of venous thromboembolism Journal of thrombosis and haemostasis 2015;13 (8):1365-1371 [PubMed]
• Agnelli G., Buller H. R., Cohen A., Gallus A. S., Lee T. C., Pak R., Raskob G. E., Weitz J. I., Yamabe T. Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial Journal of thrombosis and haemostasis 2015;13 (12):2187-2191 [PubMed]
• Lucassen W. A. M., Erkens P. M. G., Geersing G. J., Büller H. R., Moons K. G. M., Stoffers H. E. J. H., van Weert H. C. P. M. Qualitative point-of-care D-dimer testing compared with quantitative D-dimer testing in excluding pulmonary embolism in primary care Journal of thrombosis and haemostasis 2015;13 (6):1004-1009 [PubMed]
• Schapkaitz Elise, Jacobson Barry Frank, Manga Pravin, Chitsike Rufaro Saeed, Benade Estee, Haas Sylvia, Buller Harry R. Recommendations for the anticoagulation of pregnant patients with mechanical heart valves South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2015;105 (9):733-738 [PubMed]
• Senoo Keitaro, Lip Gregory Y. H., Lane Deirdre A., Büller Harry R., Kotecha Dipak Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation: AMADEUS Trial Stroke; a journal of cerebral circulation 2015;46 (9):2523-2528 [PubMed]
• Wilts Ineke Theodora, Bleker Suzanne Mariëlla, van Es Nick, Büller Harry Roger, Di Nisio Marcello, Kamphuisen Pieter Willem Safety of anticoagulant treatment in cancer patients Expert opinion on drug safety 2015;14 (8):1227-1236 [PubMed]
• Bossuyt Patrick M., Reitsma Johannes B., Bruns David E., Gatsonis Constantine A., Glasziou Paul P., Irwig Les, Lijmer Jeroen G., Moher David, Rennie Drummond, de Vet Henrica C. W., Kressel Herbert Y., Rifai Nader, Golub Robert M., Altman Douglas G., Hooft Lotty, Korevaar Daniël A., Cohen Jérémie F., Alonzo Todd, Azuara-Blanco Augusto, Bachmann Lucas, Blume Jeffrey, Boutron Isabelle, Bruns David, Büller Harry, Buntinx Frank, Byron Sarah, Chang Stephanie, Cooper Richelle, de Groot Joris, Deeks Jon, Dendukuri Nandini, Dinnes Jac, Fleming Kenneth, Guyatt Gordon, Heneghan Carl, Hilden Jørgen, Horvath Rita, Hunink Myriam, Hyde Chris, Ioannidis John, Janes Holly, Kleijnen Jos, Knottnerus André, Korevaar A., Lange Stefan, Leeflang Mariska, Lord Sally, Lumbreras Blanca, Macaskill Petra, Magid Erik STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies BMJ (Clinical research ed.) 2015;351:h5527 [PubMed]
• Bossuyt Patrick M., Reitsma Johannes B., Bruns David E., Gatsonis Constantine A., Glasziou Paul P., Irwig Les, Lijmer Jeroen G., Moher David, Rennie Drummond, de Vet Henrica C. W., Kressel Herbert Y., Rifai Nader, Golub Robert M., Altman Douglas G., Hooft Lotty, Korevaar Daniël A., Cohen Jérémie F., Alonzo Todd, Azuara-Blanco Augusto, Bachmann Lucas, Blume Jeffrey, Boutron Isabelle, Bruns David, Büller Harry, Buntinx Frank, Byron Sarah, Chang Stephanie, de Groot Richelle Cooper Joris, Deeks Jon, Dendukuri Nandini, Dinnes Jac, Fleming Kenneth, Guyatt Gordon, Heneghan Carl, Hilden Jørgen, Horvath Rita, Hunink Myriam, Hyde Chris, Ioannidis John, Janes Holly, Kleijnen Jos, Knottnerus André, Lange Stefan, Leeflang Mariska, Lord Sally, Lumbreras Blanca, Macaskill Petra, Magid Erik, Mallett Susan, McInnes Matthew STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies Radiology 2015;277 (3):826-832 [PubMed]
• Bossuyt Patrick M., Reitsma Johannes B., Bruns David E., Gatsonis Constantine A., Glasziou Paul P., Irwig Les, Lijmer Jeroen G., Moher David, Rennie Drummond, de Vet Henrica C. W., Kressel Herbert Y., Rifai Nader, Golub Robert M., Altman Douglas G., Hooft Lotty, Korevaar Daniël A., Cohen Jérémie F., Alonzo Todd, Azuara-Blanco Augusto, Bachmann Lucas, Blume Jeffrey, Boutron Isabelle, Bruns David, Büller Harry, Buntinx Frank, Byron Sarah, Chang Stephanie, Cooper Richelle, de Groot Joris, Deeks Jon, Dendukuri Nandini, Dinnes Jac, Fleming Kenneth, Guyatt Gordon, Heneghan Carl, Hilden Jørgen, Horvath Rita, Hunink Myriam, Hyde Chris, Ioannidis John, Janes Holly, Kleijnen Jos, Knottnerus André, Lange Stefan, Leeflang Mariska, Lord Sally, Lumbreras Blanca, Macaskill Petra, Magid Erik, Mallett Susan STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies Clinical chemistry 2015;61 (12):1446-1452 [PubMed]
• Barreto Deirisa Lopes, Hoekstra Tiny, Halbesma Nynke, Leegte Martijn, Boeschoten Elisabeth W., Dekker Friedo W., Krediet Raymond T., Apperloo A. J., Bijlsma J. A., Boekhout M., Boer W. H., van der Boog P. J. M., Büller H. R., van Buren M., de Charro F. Th, Doorenbos C. J., van den Dorpel M. A., van Es A., Fagel W. J., Feith G. W., deFijter C. W. H., Frenken L. A. M., van Geelen J. A. C. A., Gorgels J. P. M. C., Grave W., Huisman R. M., Jager K. J., Jie K., Koning-Mulder W. A. H., Koolen M. I., Kremer Hovinga T. K., Lavrijssen A. T. J., Luik A. J., van der Meulen J., Parlevliet K. J., Raasveld M. H. M., van der Sande F. M., Schonck M. J. M., Schuurmans M. M. J., Siegert C. E. H., Stegeman C. A., Stevens P., Thijssen J. G. P., Valentijn R. M., Vastenburg G. H., Verburgh C. A., Vincent H. H., Vos P. F. The Association of Effluent Ca125 with Peritoneal Dialysis Technique Failure Peritoneal dialysis international 2015;35 (7):683-690 [PubMed]
• ten Cate-Hoek Arina J., Weitz Jeffrey I., Gailani David, Meijer Karina, Philippou Helen, Bouman Annemieke C., Whitney Cheung Y., van Mens Thijs E., Govers-Riemslag Jose W., Vries Minka, Bleker Suzanne, Biedermann Jossi S., Stoof S. Carina M., Buller Harry R. Theme 3: Non-invasive management of (recurrent) venous thromboembolism (VTE) and post thrombotic syndrome (PTS) Thrombosis research 2015;136 (Suppl. 1):S13-S18 [PubMed]
• Stuijver Danka J. F., Romualdi Erica, van Zaane Bregje, Bax Leon, Büller Harry R., Gerdes Victor E. A., Squizzato Alessandro Under-reporting of venous and arterial thrombotic events in randomized clinical trials: a meta-analysis Internal and emergency medicine 2015;10 (2):219-246 [PubMed]
• van Es Nick, Büller Harry R. Using direct oral anticoagulants (DOACs) in cancer and other high-risk populations Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2015;2015 (1):125-131 [PubMed]
• Boom M. S., Berghuis E. M., Nieuwkerk P. T., Pinedo S., Büller H. R. When do patients prefer a direct oral anticoagulant over a vitamin K antagonist? Netherlands journal of medicine 2015;73 (8):368-372 [PubMed]
• Di Nisio Marcello, van Es Nick, Büller Harry R. Whole-Arm Ultrasound for Suspected Upper-Extremity Deep Venous Thrombosis in Outpatients JAMA internal medicine 2015;175 (11):1871 [PubMed]

2014

• Konstantinides Stavros V., Torbicki Adam, Agnelli Giancarlo, Danchin Nicolas, Fitzmaurice David, Galiè Nazzareno, Gibbs J. Simon R., Huisman Menno V., Humbert Marc, Kucher Nils, Lang Irene, Lankeit Mareike, Lekakis John, Maack Christoph, Mayer Eckhard, Meneveau Nicolas, Perrier Arnaud, Pruszczyk Piotr, Rasmussen Lars H., Schindler Thomas H., Svitil Pavel, Vonk Noordegraaf Anton, Zamorano Jose Luis, Zompatori Maurizio, Achenbach Stephan, Baumgartner Helmut, Bax Jeroen J., Bueno Hector, Dean Veronica, Deaton Christi, Erol Cetin, Fagard Robert, Ferrari Roberto, Hasdai David, Hoes Arno, Kirchhof Paulus, Knuuti Juhani, Kolh Philippe, Lancellotti Patrizio, Linhart Ales, Nihoyannopoulos Petros, Piepoli Massimo F., Ponikowski Piotr, Sirnes Per Anton, Tamargo Juan Luis, Tendera Michal, Wijns William, Windecker Stephan, Jimenez David, Büller Harry R. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) European heart journal 2014;35 (43):3033-3080 [PubMed]
• Stuijver D. J. F., Piantanida E., van Zaane B., Galli L., Romualdi E., Tanda M. L., Meijers J. C. M., Büller H. R., Gerdes V. E. A., Squizzato A. Acquired von Willebrand syndrome in patients with overt hypothyroidism: a prospective cohort study Haemophilia 2014;20 (3):326-332 [PubMed]
• Erkens Petra M. G., Lucassen Wim A. M., Geersing Geert-Jan, van Weert Henk C. P. M., Kuijs-Augustijn Marlous, van Heugten Marloes, Rietjens Lonneke, ten Cate Hugo, Prins Martin H., Büller Harry R., Hoes Arno W., Moons Karel G. M., Oudega Ruud, Stoffers Henri E. J. H. Alternative diagnoses in patients in whom the GP considered the diagnosis of pulmonary embolism Family practice 2014;31 (6):670-677 [PubMed]
• Kleinjan A., Hutten B. A., Di Nisio M., Büller H. R., Kamphuisen P. W. Anticoagulant treatment of cancer patients with pulmonary embolism in the real world. Actual use of low-molecular-weight heparin in cancer Netherlands journal of medicine 2014;72 (9):467-472 [PubMed]
• Buller H. R., Halperin J., Hankey G. J., Pillion G., Prins M. H., Raskob G. E. Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study Journal of thrombosis and haemostasis 2014;12 (6):824-830 [PubMed]
• Cohen A. T., Spiro T. E., Spyropoulos A. C., Desanctis Y. H., Homering M., Büller H. R., Haskell L., Hu D., Hull R., Mebazaa A., Merli G., Schellong S., Tapson V. F., Burton P. D-dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial Journal of thrombosis and haemostasis 2014;12 (4):479-487 [PubMed]
• Mos Inge C. M., Douma Renée A., Erkens Petra M. G., Kruip Marieke J. H. A., Hovens Marcel M., van Houten Anja A., Hofstee Herman M. A., Kooiman Judith, Klok Frederikus A., Büller Harry R., Kamphuisen Pieter W., Huisman Menno V. Diagnostic outcome management study in patients with clinically suspected recurrent acute pulmonary embolism with a structured algorithm Thrombosis research 2014;133 (6):1039-1044 [PubMed]
• van Es Nick, Coppens Michiel, Schulman Sam, Middeldorp Saskia, Büller Harry R. Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials Blood 2014;124 (12):1968-1975 [PubMed]
• Büller Harry R. Edoxaban versus warfarin for venous thromboembolism New England journal of medicine 2014;370 (1):80-81 [PubMed]
• Debeij J., van Zaane B., Dekkers O. M., Doggen C. J. M., Smit J. W. A., van Zanten A. P., Brandjes D. P. M., Büller H. R., Gerdes V. E. A., Rosendaal F. R., Cannegieter S. C. High levels of procoagulant factors mediate the association between free thyroxine and the risk of venous thrombosis: the MEGA study Journal of thrombosis and haemostasis 2014;12 (6):839-846 [PubMed]
• Farge-Bancel Dominique, Bounameaux Henri, Brenner Benjamin, Büller Harry R., Kakkar Ajay, Pabinger Ingrid, Streiff Michael, Debourdeau Philippe Implementing thrombosis guidelines in cancer patients: a review Rambam Maimonides medical journal 2014;5 (4):e0041 [PubMed]
• Mebazaa Alexandre, Spiro Theodore E., Büller Harry R., Haskell Lloyd, Hu Dayi, Hull Russell, Merli Geno, Schellong Sebastian W., Spyropoulos Alex C., Tapson Victor F., de Sanctis Yoriko, Cohen Alexander T. Predicting the risk of venous thromboembolism in patients hospitalized with heart failure Circulation 2014;130 (5):410-418 [PubMed]
• Kleinjan Ankie, Di Nisio Marcello, Beyer-Westendorf Jan, Camporese Giuseppe, Cosmi Benilde, Ghirarduzzi Angelo, Kamphuisen Pieter W., Otten Hans-Martin, Porreca Ettore, Aggarwal Anita, Brodmann Marianne, Guglielmi Maria Domenica, Iotti Matteo, Kaasjager Karin, Kamvissi Virginia, Lerede Teresa, Marschang Peter, Meijer Karina, Palareti Gualtiero, Rickles Frederick R., Righini Marc, Rutjes Anne W. S., Tonello Chiara, Verhamme Peter, Werth Sebastian, van Wissen Sanne, Büller Harry R. Safety and feasibility of a diagnostic algorithm combining clinical probability, d-dimer testing, and ultrasonography for suspected upper extremity deep venous thrombosis: a prospective management study Annals of internal medicine 2014;160 (7):451-457 [PubMed]
• Kuipers S., Venemans-Jellema A., Cannegieter S. C., van Haften M., Middeldorp S., Büller H. R., Rosendaal F. R. The incidence of venous thromboembolism in commercial airline pilots: a cohort study of 2630 pilots Journal of thrombosis and haemostasis 2014;12 (8):1260-1265 [PubMed]
• Kuipers Saskia, Venemans Annemarie, Middeldorp Saskia, Büller Harry R., Cannegieter Suzanne C., Rosendaal Frits R. The risk of venous thrombosis after air travel: contribution of clinical risk factors British journal of haematology 2014;165 (3):412-413 [PubMed]
• Struijk-Mulder Marieke C. Thromboprophylaxis in orthopaedic surgery 2014. 140p. ISBN 9789461669490. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Büller H. R.; Co-supervisors: Verheyen C. C. P. M., Ettema H. B.)
• Raskob Gary E., Angchaisuksiri Pantep, Blanco Alicia N., Büller Harry, Gallus Alexander, Hunt Beverley J., Hylek Elaine M., Kakkar The Lord, Konstantinides Stavros V., McCumber Micah, Ozaki Yukio, Wendelboe Aaron, Weitz Jeffrey I. Thrombosis: a major contributor to global disease burden Seminars in thrombosis and hemostasis 2014;40 (7):724-735 [PubMed]
• Raskob G. E., Angchaisuksiri P., Blanco A. N., Buller H., Gallus A., Hunt B. J., Hylek E. M., Kakkar A., Konstantinides S. V., McCumber M., Ozaki Y., Wendelboe A., Weitz J. I. Thrombosis: a major contributor to global disease burden Arteriosclerosis, thrombosis, and vascular biology 2014;34 (11):2363-2371 [PubMed]
• Raskob G. E., Angchaisuksiri P., Blanco A. N., Buller H., Gallus A., Hunt B. J., Hylek E. M., Kakkar A., Konstantinides S. V., McCumber M., Ozaki Y., Wendelboe A., Weitz J. I. Thrombosis: A major contributor to global disease burden Thrombosis research 2014;134 (5):931-938 [PubMed]
• Raskob G. E., Angchaisuksiri P., Blanco A. N., Buller H., Gallus A., Hunt B. J., Hylek E. M., Kakkar A., Konstantinides S. V., McCumber M., Ozaki Y., Wendelboe A., Weitz J. I. Thrombosis: A major contributor to global disease burden Thrombosis and haemostasis 2014;112 (5):843-852 [PubMed]
• Raskob G. E., Angchaisuksiri P., Blanco A. N., Buller H., Gallus A., Hunt B. J., Hylek E. M., Kakkar A., Konstantinides S. V., McCumber M., Ozaki Y., Wendelboe A., Weitz J. I. Thrombosis: a major contributor to the global disease burden Journal of thrombosis and haemostasis 2014;12 (10):1580-1590 [PubMed]
• Schulman Sam, Kakkar Ajay K., Goldhaber Samuel Z., Schellong Sebastian, Eriksson Henry, Mismetti Patrick, Christiansen Anita Vedel, Friedman Jeffrey, Le Maulf Florence, Peter Nuala, Kearon Clive, Schulman S., Eriksson H., Goldhaber S., Kakkar A., Kearon C., Mismetti P., Schellong S., Bergqvist D., Tijssen J., Prins M. [=Martin H.], Robben S., Büller H., Otten H. M., Brandjes D., Peters R., Mac Gillavry M. R., Gan E., Salem H., Baker R., Blomberry P., Curnow J., Annichino-Bizzacch J. M., Brandao Panico M. D., Timi Ribas J. R., Fernandes Manenti E. R., Miranda F., Moraes J., Raev D., Mollov M., Peneva M., Milanov S., Anderson D., Crowther M., Dolan S., Eikelboom J., Game M., Kahn S., Kassis J., Ritchie B. Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis Circulation 2014;129 (7):764-772 [PubMed]
• Crobach Monique J. T., Büller Harry R., Cannegieter Suzanne C. Tromboseprofylaxe bij ambulante patiënten met kanker? Nederlands tijdschrift voor geneeskunde 2014;158:A7419 [PubMed]
• Struijk-Mulder M. C., Ettema H. B., Heyne R. A. J., Rondhuis J. J., Büller H. R., Verheyen C. C. P. M. Venous thromboembolism during hip plaster cast immobilisation: review of the literature Netherlands journal of medicine 2014;72 (1):17-19 [PubMed]

2013

• Agnelli Giancarlo, Buller Harry R., Cohen Alexander, Curto Madelyn, Gallus Alexander S., Johnson Margot, Porcari Anthony, Raskob Gary E., Weitz Jeffrey I., Gallus Alexander, Raskob Gary, Weitz Jeffrey, Prins Martin, Brandjes Dees, Kolbach Dinanda, Limburg Martinus, Mac Gillavry Melvin, Otten Johannes Martinus, Peters Ron, Roos Yvo, Segers Annelise, Slagboom Ton, Bounameaux Henry, Hirsh Jack, Samama Meyer Michel, Wedel Hans, Masiukiewicz Urszula, Pak Raphael, Sanders Paul, Sisson Melanie, Sullivan Beth, Thompson John, Auerbach Jennifer, Cesario Lynne, Gamero Miguel, Gordon Margot, Griffiths Angela, Noble Melanie, Ott Jana, Pennington Ann, Peffer Allison, Reinhold Peggy, Simmons Melanie, Urwin Keri, Ceresetto Jose, McRae Simon, Pabinger Ingrid, Pereira Adamastor Humberto, Spencer Fred, Gorican Karel Apixaban for Extended Treatment of Venous Thromboembolism New England journal of medicine 2013;368 (8):699-708 [PubMed]
• Kleinjan A., Aggarwal A., van de Geer A., Faselis C., Büller H. R., Di Nisio M., Rickles F. R., Kamphuisen P. W. A worldwide survey to assess the current approach to the treatment of patients with cancer and venous thromboembolism Thrombosis and haemostasis 2013;110 (5):959-965 [PubMed]
• Lauw Mandy N., van Doormaal Frederiek F., Middeldorp Saskia, Buller Harry R. Cancer and venous thrombosis: current comprehensions and future perspectives Seminars in thrombosis and hemostasis 2013;39 (5):507-514 [PubMed]
• van Es J., Douma R. A., Kamphuisen P. W., Gerdes V. E. A., Verhamme P., Wells P. S., Bounameaux H., Lensing A. W. A., Büller H. R. Clot resolution after 3 weeks of anticoagulant treatment for pulmonary embolism: comparison of computed tomography and perfusion scintigraphy Journal of thrombosis and haemostasis 2013;11 (4):679-685 [PubMed]
• Apostolakis Stavros, Lane Deirdre A., Büller Harry, Lip Gregory Y. H. Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: The AMADEUS trial Thrombosis and haemostasis 2013;110 (5):1074-1079 [PubMed]
• Lucassen Wim A. M., Beenen Ludo F. M., Büller Harry R., Erkens Petra M. G., Schaefer-Prokop Cornelia M., van den Berk Inge A. H., van Weert Henk C. Concerns in using multi-detector computed tomography for diagnosing pulmonary embolism in daily practice. A cross-sectional analysis using expert opinion as reference standard Thrombosis research 2013;131 (2):145-149 [PubMed]
• Oudman Inge Creatine kinase and blood pressure. Clinical and therapeutic implications 2013. 216p. ISBN 9789461916563. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Büller H R.; Co-supervisor: Brewster L. M.)
• Struijk-Mulder Marieke C., Ettema Harmen B., Verheyen Cees C. P. M., Büller Harry R. Deep vein thrombosis after arthroscopic anterior cruciate ligament reconstruction: a prospective cohort study of 100 patients Arthroscopy : the journal of arthroscopic & related surgery 2013;29 (7):1211-1216 [PubMed]
• Lip Gregory Y. H., Lane Deirdre A., Buller Harry, Apostolakis Stavros Development of a Novel Composite Stroke and Bleeding Risk Score in Patients With Atrial Fibrillation: The AMADEUS Study Chest 2013;144 (6):1839-1847 [PubMed]
• Di Nisio M., Squizzato A., Rutjes A. W. S., Buller H. R., Zwinderman A. H., Bossuyt P. M. M. Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review (vol 5, pg 296, 2007) Journal of thrombosis and haemostasis 2013;11 (10):1942
• Lucassen Wim A. M. Diagnostic strategy for excluding pulmonary embolism in primary care 2013. 190p. ISBN 9789053356661. [UvA Dissertations Online] University of Amsterdam. (Supervisors: van Weert Henk H. C. P. M., Büller H. R.)
• Raskob G., Büller H., Prins M. [=Martin H.], Segers A., Shi M., Schwocho L., van Kranen R., Mercuri M. Edoxaban for the long-term treatment of venous thromboembolism: rationale and design of the Hokusai-venous thromboembolism study--methodological implications for clinical trials Journal of thrombosis and haemostasis 2013;11 (7):1287-1294 [PubMed]
• Büller Harry R., Décousus Hervé, Grosso Michael A., Mercuri Michele, Middeldorp Saskia, Prins Martin H., Raskob Gary E., Schellong Sebastian M., Schwocho Lee, Segers Annelise, Shi Minggao, Verhamme Peter, Wells Phil, Agnelli Giancarlo, Angchaisuksiri Pantep, Banyai Martin, Bauersachs Rupert, van Bellen Bonno, Blüguermann Julio, Boda Zoltán, Bounameaux Henri, Brenner Benjamin, Brighton Tim, Castañon Javier Diaz, Chechulov Pavel, Chlumský Yaromir, Cohen Alexander, Davidson Bruce, Decousus Hervé, Eriksson Henry, Gallus Alexander, Gudz Ivan, Jacobson Barry, Heng Lee Lai, Lyons Roger, Meijer Karina, Minar Erich, Monreal Manuel, Nakamura Mashio, Oh Doyeun, Öngen Gül, Parakh Rajiv, Piovella Franco, Beenen Ludo, Peters Ron, Roos Yvo, Zhao J., Gerdes V. E. A., Kamphuisen P. W., Eerenberg E. S. Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism New England journal of medicine 2013;369 (15):1406-1415 [PubMed]
• Schulman Sam, Kearon Clive, Kakkar Ajay K., Schellong Sebastian, Eriksson Henry, Baanstra David, Kvamme Anne Mathilde, Friedman Jeffrey, Mismetti Patrick, Goldhaber Samuel Z., Schulman S., Eriksson H., Goldhaber S., Kakkar A., Kearon C., Mismetti P., Schellong S., Minar E., Bergqvist D., Tijssen J., Prins M. [=Martin H.], Büller H., Otten J., Mac Gillavry M., Brandjes D., Otten H., Peters R., Pol S., Burroughs A., Gilmore I., Bluguermann J., Bustos B., Carlevaro O., Cartasegna L., Cuello J., Gabito A., Gitelman P., Gutierrez Carrillo N., Hrabar A., Mackinon I., Santos D., Schygiel P., Sosa Liprandi M., Baker R., Blombery P., Gallus A., Gan E., McCann A., Salem H., Kamphuisen P. Extended use of dabigatran, warfarin, or placebo in venous thromboembolism New England journal of medicine 2013;368 (8):709-718 [PubMed]
• van Dijk Sandra, van den Beukel Tessa O., Kaptein Adrian A., Honig Adriaan, le Cessie Saskia, Siegert Carl E., Boeschoten Els W., Krediet Ray T., Dekker Friedo W., Apperloo A. J., Bijlsma J. A., Boekhout M., Boer W. H., van der Boog P. J. M., Büller H. R., van Buren M., de Charro F. T., Doorenbos C. J., van den Dorpel M. A., van Es A., Fagel W. J., Feith G. W., de Fijter C. W. H., Frenken L. A. M., Grave W., van Geelen J. A. C. A., Gerlag P. G. G., Gorgels J. P. M. C., Huisman R. M., Jager K. J., Jie K., Koning-Mulder W. A. H., Koolen M. I., Hovinga T. K. Kremer, Lavrijssen A. T. J., Luik A. J., van der Meulen J., Parlevliet K. J., Raasveld M. H. M., van der Sande F. M., Schonck M. J. M., Schuurmans M. M. J., Siegert C. E. H., Stegeman C. A., Stevens P., Thijssen J. G. P., Valentijn R. M., Vastenburg G. H., Verburgh C. A., Vincent H. H. How baseline, new-onset, and persistent depressive symptoms are associated with cardiovascular and non-cardiovascular mortality in incident patients on chronic dialysis Journal of psychosomatic research 2013;74 (6):511-517 [PubMed]
• Arts Derk L., Abu-Hanna Ameen, Büller Harry R., Peters Ron J. G., Eslami Saeid, van Weert Henk C. P. M. Improving stroke prevention in patients with atrial fibrillation Trials 2013;14 (1):193 [PubMed]
• Debourdeau P., Farge D., Beckers M., Baglin C., Bauersachs R. M., Brenner B., Brilhante D., Falanga A., Gerotzafias G. T., Haim N., Kakkar A. K., Khorana A. A., Lecumberri R., Mandala M., Marty M., Monreal M., Mousa S. A., Noble S., Pabinger I., Prandoni P., Prins M. H., Qari M. H., Streiff M. B., Syrigos K., Büller H. R., Bounameaux H. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer Journal of thrombosis and haemostasis 2013;11 (1):71-80 [PubMed]
• Farge D., Debourdeau P., Beckers M., Baglin C., Bauersachs R. M., Brenner B., Brilhante D., Falanga A., Gerotzafias G. T., Haim N., Kakkar A. K., Khorana A. A., Lecumberri R., Mandala M., Marty M., Monreal M., Mousa S. A., Noble S., Pabinger I., Prandoni P., Prins M. H., Qari M. H., Streiff M. B., Syrigos K., Bounameaux H., Büller H. R. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer Journal of thrombosis and haemostasis 2013;11 (1):56-70 [PubMed]
• de Jager Dinanda J., Halbesma Nynke, Krediet Raymond T., Boeschoten Elisabeth W., le Cessie Saskia, Dekker Friedo W., Grootendorst Diana C., Apperloo A. J., Bijlsma J. A., Boekhout M., Boer W. H., van der Boog P. J. M., Büller H. R., van Buren M., de Charro F. Th, Doorenbos C. J., van den Dorpel M. A., van Es A., Fagel W. J., Feith G. W., de Fijter C. W. H., Frenken L. A. M., van Geelen J. A. C. A., Gerlag P. G. G., Grave W., Gorgels J. P. M. C., Huisman R. M., Jager K. J., Jie K., Koning-Mulder W. A. H., Koolen M. I., Hovinga T. K. Kremer, Lavrijssen A. T. J., Luik A. J., van der Meulen J., Parlevliet K. J., Raasveld M. H. M., van der Sande F. M., Schonck M. J. M., Schuurmans M. M. J., Siegert C. E. H., Stegeman C. A., Stevens P., Thijssen J. G. P., Valentijn R. M., Vastenburg G. H., Verburgh C. A., Vincent H. H., Vos P. F. Is the decline of renal function different before and after the start of dialysis? Nephrology, dialysis, transplantation 2013;28 (3):698-705 [PubMed]
• van Es Nick, Bleker Suzanne M., Büller Harry R., Coppens Michiel New developments in parenteral anticoagulation for arterial and venous thromboembolism Best practice & research. Clinical haematology 2013;26 (2):203-213 [PubMed]
• Agnelli Giancarlo, Buller Harry R., Cohen Alexander, Curto Madelyn, Gallus Alexander S., Johnson Margot, Masiukiewicz Urszula, Pak Raphael, Thompson John, Raskob Gary E., Weitz Jeffrey I., Gallus Alexander, Raskob Gary, Weitz Jeffrey, Prins Martin, Brandjes Dees, Kolbach Dinanda, Limburg Martinus, Mac Gillavry Melvin, Otten Johannes Martinus, Peters Ron, Roos Yvo, Segers Annelise, Slagboom Ton, Bounameaux Henry, Hirsh Jack, Samama Meyer Michel, Wedel Hans, Porcari Anthony, Sanders Paul, Sisson Melanie, Sullivan Beth, Auerbach Jennifer, Cesario Lynne, Crawford Jennifer, Gordon Margot, Noble Melanie, Pennington Ann, Reinhold Peggy, Simmons Melanie, Urwin Keri, Ceresetto Jose, McRae Simon, Pabinger Ingrid, Pereira Adamastor Humberto, Spencer Fred, Wang Chen, Zhang Jiwei, Gorican Karel, Husted Steen Elkiaer Oral Apixaban for the Treatment of Acute Venous Thromboembolism New England journal of medicine 2013;369 (9):799-808 [PubMed]
• Apostolakis Stavros, Lane Deirdre A., Guo Yutao, Buller Harry, Lip Gregory Y. H. Performance of the HEMORR 2 HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in nonwarfarin anticoagulated atrial fibrillation patients Journal of the American College of Cardiology 2013;61 (3):386-387 [PubMed]
• Apostolakis Stavros, Guo Yuotao, Lane Deirdre A., Buller Harry, Lip Gregory Y. H. Renal function and outcomes in anticoagulated patients with non-valvular atrial fibrillation: the AMADEUS trial European heart journal 2013;34 (46):3572-3579 [PubMed]
• Apostolakis Stavros, Lane Deirdre A., Guo Yutao, Buller Harry, Lip Gregory Y. H. Reply Journal of the American College of Cardiology 2013;61 (4):482-483 [PubMed]
• Majoor Christof J., Kamphuisen Pieter W., Zwinderman Aeilko H., ten Brinke Anneke, Amelink Marijke, Rijssenbeek-Nouwens Lucia, Sterk Peter J., Büller Harry R., Bel Elisabeth H. Risk of deep vein thrombosis and pulmonary embolism in asthma European respiratory journal 2013;42 (3):655-661 [PubMed]
• den Exter Paul L., van Es Josien, Klok Frederikus A., Kroft Lucia J., Kruip Marieke J. H. A., Kamphuisen Pieter Willem, Büller Harry R., Huisman Menno V. Risk profile and clinical outcome of symptomatic subsegmental acute pulmonary embolism Blood 2013;122 (7):1144-9; quiz 1329 [PubMed]
• Cohen Alexander T., Spiro Theodore E., Büller Harry R., Haskell Lloyd, Hu Dayi, Hull Russell, Mebazaa Alexandre, Merli Geno, Schellong Sebastian, Spyropoulos Alex C., Tapson Victor, Cohen A. T., Haskell L., Hu D., Hull R., Mebazaa A., Merli G., Schellong S., Spiro T., Spyropoulos A. C., Tapson V., Francis C., Kobayashi S., Leizorovicz A., Lowe G., Roberts R., Brandges D., Kolbach D., Limburg M. L., Mac Gillavry M. R., Otten H. M., Peters R. G. J., Prins M. [=Martin H.], Robben S., Voorend M., Hemmrich M., Li L., Meng I., Mühlhofer E., Beckmann H., Desanctis Y., Duszczyszyn A., Fielding L., Twomey T., Müller K., Byra W., Nessel C., Atkinson Sarah, Bottaro F. J., Caberlotto O. Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients New England journal of medicine 2013;368 (6):513-523 [PubMed]
• Verhamme Peter, Gunn Sophie, Sonesson Elisabeth, Peerlinck Kathelijne, Vanassche Thomas, Vandenbriele Christophe, Ageno Walter, Glazer Steven, Prins Martin, Buller Harry, Tangelder Marco Single-dose TB-402 or rivaroxaban for the prevention of venous thromboembolism after total hip replacement. A randomised, controlled trial Thrombosis and haemostasis 2013;109 (6):1091-1098 [PubMed]
• Nguyen Cu Dinh, Andersson Charlotte, Jensen Thomas Bo, Gjesing Anne, Schjerning Olsen Anne-Marie, Malta Hansen Carolina, Büller Harry, Torp-Pedersen Christian, Gislason Gunnar H. Statin treatment and risk of recurrent venous thromboembolism: a nationwide cohort study BMJ open 2013;3 (11):e003135 [PubMed]
• Biere-Rafi Sara, Hutten Barbara A., Squizzato Alessandro, Ageno Walter, Souverein Patrick C., de Boer Anton, Gerdes Victor E. A., Büller Harry R., Kamphuisen Pieter W. Statin treatment and the risk of recurrent pulmonary embolism European heart journal 2013;34 (24):1800-1806 [PubMed]
• Lucassen Wim A. M., Kuijs-Augustijn Marlous, Erkens Petra M. G., Geersing Geert-Jan, Büller Harry R., van Weert Henk C. P. M. The additional value of the CRP test in patients in whom the primary care physician excluded pulmonary embolism European journal of general practice 2013;19 (3):143-149 [PubMed]
• Ageno W., Squizzato A., Wells P. S., Büller H. R., Johnson G. The diagnosis of symptomatic recurrent pulmonary embolism and deep vein thrombosis: guidance from the SSC of the ISTH Journal of thrombosis and haemostasis 2013;11 (8):1597-1602 [PubMed]
• Verkleij Chantal J. N., Stuijver Danka J. F., van Zaane Bregje, Squizzato Alessandro, Brandjes Dees P. M., Büller Harry R., Meijers Joost C. M., Gerdes Victor E. A. Thrombin-activatable fibrinolysis inhibitor in hypothyroidism and hyperthyroxinaemia Thrombosis and haemostasis 2013;109 (2):214-220 [PubMed]
• Stuijver Danka J. F., Majoor Christof J., van Zaane Bregje, Souverein Patrick C., de Boer Anthonius, Dekkers Olaf M., Büller Harry R., Gerdes Victor E. A. Use of oral glucocorticoids and the risk of pulmonary embolism: a population-based case-control study Chest 2013;143 (5):1337-1342 [PubMed]
• van der Hulle T., den Exter P. L., Erkens P. G. M., van Es J., Mos I. C. M., ten Cate H., Kamphuisen P. W., Hovens M. M. C., Büller H. R., Klok F. A., Huisman M. V. Variable D-dimer thresholds for diagnosis of clinically suspected acute pulmonary embolism Journal of thrombosis and haemostasis 2013;11 (11):1986-1992 [PubMed]
• Jacobson B. F., Louw S., Büller H., Mer M., de Jong P. R., Rowji P., Schapkaitz E., Adler D., Beeton A., Hsu H.-C., Wessels P., Haas S. Venous thromboembolism: prophylactic and therapeutic practice guideline South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2013;103 (4 Part 2):261-267 [PubMed]
• Berger J., Eikelboom J. W., Quinlan D. J., Guyatt G., Büller H. R., Sobieraj-Teague M., Harrington R. A., Hirsh J. Venous thromboembolism prophylaxis: do trial results enable clinicians and patients to evaluate whether the benefits justify the risk? Proceedings of an Ad Hoc Working Group Meeting Journal of thrombosis and haemostasis 2013;11 (4):778-782 [PubMed]
• Kleinjan Ankie Venous thrombosis in cancer patients: prediction, diagnosis and management 2013. 225p. ISBN 9789461823175. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Büller H. R., Kamphuisen P. W.; Co-supervisors: Nieuwland R., Di Nisio M.)

2012

• Moret Karin E., Grootendorst Diana C., Dekker Friedo W., Boeschoten Elizabeth W., Krediet Raymond T., Houterman Saskia, Beerenhout Charles H., Kooman Jeroen P., Apperloo A. J., Bijlsma J. A., Boekhout M., Boer W. H., van der Boog P. J. M., Büller H. R., van Buren M., de Charro F. Th, Doorenbos C. J., van den Dorpel M. A., van Es A., Fagel W. J., Feith G. W., de Fijter C. W. H., Frenken L. A. M., van Geelen J. A. C. A., Gerlag P. G. G., Gorgels J. P. M. C., Grave W., Huisman R. M., Jager K. J., Jie K., Koning-Mulder W. A. H., Koolen M. I., Kremer Hovinga T. K., Lavrijssen A. T. J., Luik A. J., van der Meulen J., Parlevliet K. J., Raasveld M. H. M., van der Sande F. M., Schonck M. J. M., Schuurmans M. M. J., Siegert C. E. H., Stegeman C. A., Stevens P., Thijssen J. G. P., Valentijn R. M., Vastenburg G. H., Verburgh C. A., Vincent H. H., Vos P. F. Agreement between different parameters of dialysis dose in achieving treatment targets: results from the NECOSAD study Nephrology, dialysis, transplantation 2012;27 (3):1145-1152 [PubMed]
• Bendermacher Bianca L. W., Teijink Joep A. W., Willigendael Edith M., Bartelink Marie-Louise, Peters Ron J. G., Langenberg Machteld, Büller Harry R., Prins Martin H. Applicability of the ankle-brachial-index measurement as screening device for high cardiovascular risk: an observational study BMC cardiovascular disorders 2012;12 (1):59 [PubMed]
• Erkens Petra M. G., ten Cate Hugo, Büller Harry R., Prins Martin H. Benchmark for Time in Therapeutic Range in Venous Thromboembolism: A Systematic Review and Meta-Analysis PLoS ONE 2012;7 (9):e42269 [PubMed]
• Mos I. C. M., Douma R. A., Erkens P. M. G., Nizet T. A. C., Durian M. F., Hovens M. M., van Houten A. A., Hofstee H. M. A., Klok F. A., ten Cate H., Ullmann E. F., Büller H. R., Kamphuisen P. W., Huisman M. V. Betrouwbaarheid klinische beslisregels bij diagnostiek van acute longembolie Nederlands tijdschrift voor geneeskunde 2012;156 (34):A4216 [PubMed]
• Lucassen Wim, van Weert Henk C., Büller Harry Clinical Decision Rules for Excluding Pulmonary Embolism RESPONSE Annals of internal medicine 2012;156 (2):169-170 [PubMed]
• van Doormaal Frederiek F., Kleinjan Ankie, Berckmans René J., Mackman Nigel, Manly David, Kamphuisen Pieter W., Richel Dick J., Büller Harry R., Sturk Auguste, Nieuwland Rienk Coagulation activation anc microparticle-associated coagulant activity in cancer patients An exploratory prospective study Thrombosis and haemostasis 2012;108 (1):160-165 [PubMed]
• ten Cate-Hoek A. J., van der Velde E. F., Toll D. B., van Weert H. C. P. M., Moons K. G. M., Büller H. R., Hoes A. W., Joore M. A., Oudega R., Prins M. H., Stoffers H. E. J. H. Common alternative diagnoses in general practice when deep venous thrombosis is excluded Netherlands journal of medicine 2012;70 (3):130-135 [PubMed]
• Eerenberg Elise S., Levi Marcel, Büller Harry R. Contra: "Antidotes for novel anticoagulants?" - Do we really need them Thrombosis and haemostasis 2012;108 (4):623-624 [PubMed]
• Büller Harry R., Gallus Alex S., Pillion Gerard, Prins Martin H., Raskob Gary E., Raskob Gary, Decousus Hervé, Charbonnier Bernard, Leizorovicz Alain, Laporte Silvy, Quenet Sara, Brandjes Dees P. M., Middeldorp Saskia, Blüguermann J., Amuchastegui L., Ahuad Guerrero R., Oberti P., Alvarez C., Cassettari A., Santos D., Macin S., Santini F., Ward C., Coughlin P., Salem H., Gan E., Leyden M., Prosser I., Crispin P., Carroll P., Gallus A., McRae S., Waites J., Pilger E., Koppensteiner R., Kyrle P., Schinko H., Mrochek A., Mitkovskaya N., Prystrom A., Motte S., Ninane V., Delcroix M., Hainaut P., Schneider E., Saraiva J., Maia L., Barreto S., Fernandes Manenti E., Araujo G. Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial Lancet 2012;379 (9811):123-129 [PubMed]
• Biere-Rafi Sara, Tuinenburg A., Haak B. W., Peters M., Huijgen R., de Groot E., Verhamme P., Peerlinck K., Visseren F. L. J., Kruip M. J. H. A., Laros-van Gorkom B. A. P., Gerdes V. E. A., Buller H. R., Schutgens R. E. G., Kamphuisen P. W. Factor VIII deficiency does not protect against atherosclerosis Journal of thrombosis and haemostasis 2012;10 (1):30-37 [PubMed]
• Stuijver Danka J. F., Debeij Jan, van Zaane Bregje, Dekkers Olaf M., Smit Jan W. A., Büller Harry R., Rosendaal Frits R., Gerdes Victor E. A., Cannegieter Suzanne C. Levels of prolactin in relation to coagulation factors and risk of venous thrombosis Results of a large population-based case-control study (MEGA-study) Thrombosis and haemostasis 2012;108 (3):499-507 [PubMed]
• Kleinjan A., van Doormaal F. F., Prins M. H., Büller H. R., Otten J. M. M. B. Limitations of screening for occult cancer in patients with idiopathic venous thromboembolism Netherlands journal of medicine 2012;70 (7):311-317 [PubMed]
• Hoogeveen Ellen K., Halbesma Nynke, Rothman Kenneth J., Stijnen Theo, van Dijk Sandra, Dekker Friedo W., Boeschoten Elisabeth W., de Mutsert Renée, Apperloo A. J., Bijlsma J. A., Boekhout M., Boer W. H., van der Boog P. J. M., Büller H. R., van Buren M., de Charro F. Th, Doorenbos C. J., van den Dorpel M. A., van Es A., Fagel W. J., Feith G. W., de Fijter C. W. H., Frenken L. A. M., Grave W., van Geelen J. A. C. A., Gerlag P. G. G., Gorgels J. P. M. C., Huisman R. M., Jager K. J., Jie K., Koning-Mulder W. A. H., Koolen M. I., Kremer Hovinga T. K., Lavrijssen A. T. J., Luik A. J., van der Meulen J., Parlevliet K. J., Raasveld M. H. M., van der Sande F. M., Schonck M. J. M., Schuurmans M. M. J., Siegert C. E. H., Stegeman C. A., Stevens P., Thijssen J. G. P., Valentijn R. M., Vastenburg G. H., Verburgh C. A., Vincent H. H., Vos P. F. Obesity and mortality risk among younger dialysis patients Clinical journal of the American Society of Nephrology 2012;7 (2):280-288 [PubMed]
• Buller Harry R., Lensing Anthonie W. A., Prins Martin H. Oral Rivaroxaban for Pulmonary Embolism REPLY New England journal of medicine 2012;366 (26):2526-2527
• Büller Harry R., Prins Martin H., Lensin Anthonie W. A., Decousus Hervé, Jacobson Barry F., Minar Erich, Chlumsky Jaromir, Verhamme Peter, Wells Phil, Agnelli Giancarlo, Cohen Alexander, Berkowitz Scott D., Bounameaux Henri, Davidson Bruce L., Misselwitz Frank, Gallus Alex S., Raskob Gary E., Schellong Sebastian, Segers Annelise, Berkowitz Scott, Gallus Alexander, Lensing Anthonie W. A., Haskell Lloyd, Raskob Gary, Bauersachs Rupert, van Bellen Bonno, Boda Zoltán, Borris Lars, Brenner Benjamin, Brighton Tim, Davidson Bruce, Decousus Herve, Eriksson Henry, Jacobson Barry, Kakkar Ajay, Kwong Yok-Lam, Lee Lai Heng, Meijer Karina, van der Meer Jan, Monreal Manuel, Piovella Franco, Sandset Per Morten, Smith Mark, Tomkowski Witold, Wang Yuqi, Brandjes Dees, Mac Gillavry Melvin, Otten Hans-Martin, Carlsson Anders, Kamphuisen P. Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism New England journal of medicine 2012;366 (14):1287-1297 [PubMed]
• Schapkaitz Elise, Sherman Gayle Gillian, Jacobson Barry Frank, Haas Sylvia, Buller Harry R., Davies Victor, Diar Hitesh, Peters Marjolein, Shuttleworth Margaret, Velaphi Sithembiso Paediatric Anticoagulation Guidelines South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2012;102 (3):171-175 [PubMed]
• Apostolakis Stavros, Lane Deirdre A., Guo Yutao, Buller Harry, Lip Gregory Y. H. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED Bleeding Risk-Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation Journal of the American College of Cardiology 2012;60 (9):861-867 [PubMed]
• Eerenberg Elise S., Sijpkens Meertien K., Meijers Joost C. M., Buller Harry R., Levi Marcel, Kamphuisen Pieter W. Response to Letters Regarding Article, "Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate: A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects" Circulation 2012;125 (16):E616
• Geersing Geert-Jan, Erkens Petra M. G., Lucassen Wim A. M., Büller Harry R., Cate Hugo Ten, Hoes Arno W., Moons Karel G. M., Prins Martin H., Oudega Ruud, van Weert Henk C. P. M., Stoffers Henri E. J. H. Safe exclusion of pulmonary embolism using the Wells rule and qualitative D-dimer testing in primary care: prospective cohort study BMJ (Clinical research ed.) 2012;345:e6564 [PubMed]
• van Dijk Sandra, van den Beukel Tessa O., Dekker Friedo W., le Cessie Saskia, Kaptein Adrian A., Honig Adriaan, Siegert Carl E., Boeschoten Elisabeth W., Krediet Ray T., Verduijn Marion, Apperloo A. J., Bijlsma J. A., Boekhout M., Boer W. H., van der Boog B. J. M., Büller H. R., van Buren M., de Charro F. T., Doorenbos C. J., van der Dorpel M. A., van Es A., Fagel W. J., Feith G. W., de Fijter C. W. H., Frenken L. A. M., Grave W., van Geelen J. A. C. A., Gerlag P. G. G., Gorgels J. P. M. C., Huisman R. M., Jager K. J., Jie K., Koning-Mulder W. A. H., Koolen M. I., Kremer Hovinga T. K., Lavrijssen A. T. J., Luik A. J., van der Meulen J., Parlevliet K. J., Raasveld M. H. M., van der Sande F. M., Schonck M. J. M., Schuurmans M. M. J., Siegert C. E. H., Stegeman C. A., Stevens P., Thijssen J. G. P., Valentijn R. M., Vastenburg G. H., Verburgh C. A. Short-Term Versus Long-Term Effects of Depressive Symptoms on Mortality in Patients on Dialysis Psychosomatic medicine 2012;74 (8):854-860 [PubMed]
• Cohn Danny M., Hermanides Jeroen, DeVries J. Hans, Kamphuisen Pieter-Willem, Kuhls Silvia, Homering Martin, Hoekstra Joost B. L., Lensing Anthonie W. A., Büller Harry R. Stress-induced hyperglycaemia and venous thromboembolism following total hip or total knee arthroplasty Analysis from the RECORD trials Thrombosis and haemostasis 2012;107 (2):225-231 [PubMed]
• van Es Josien, Mos Inge, Douma Renée, Erkens Petra, Durian Marc, Nizet Tessa, van Houten Anja, Hofstee Herman, ten Cate Hugo, Ullmann Eric, Büller Harry, Huisman Menno, Kamphuisen P. W. The combination of four different clinical decision rules and an age-adjusted D-dimer cut-off increases the number of patients in whom acute pulmonary embolism can safely be excluded Thrombosis and haemostasis 2012;107 (1):167-171 [PubMed]
• Stuijver Danka J. F. The hormonal influence on the haemostatic system and the risk of thrombosis 2012. 351p. ISBN 9789461914606. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Büller H. R., Brandjes D. P. M.; Co-supervisors: Gerdes V. E. A., van Zaane B.)
• Kruidenier L. M., Viechtbauer W., Nicolaï S. P., Büller H., Prins M. H., Teijink J. A. W. Treatment for intermittent claudication and the effects on walking distance and quality of life Vascular 2012;20 (1):20-35 [PubMed]

2011

• van Wissen M., Keller T. T., van Gorp E. C. M., Gerdes V. E. A., Meijers J. C. M., van Doornum G. J. J., Büller H. R., Brandjes D. P. M. Acute respiratory tract infection leads to procoagulant changes in human subjects Journal of thrombosis and haemostasis 2011;9 (7):1432-1434 [PubMed]
• van Zaane B., Squizzato A., Debeij J., Dekkers O. M., Meijers J. C. M., van Zanten A. P., Büller H. R., Gerdes V. E. A., Cannegieter S. C., Brandjes D. P. M. Alterations in coagulation and fibrinolysis after levothyroxine exposure in healthy volunteers: a controlled randomized crossover study Journal of thrombosis and haemostasis 2011;9 (9):1816-1824 [PubMed]
• Biere-Rafi Sara Association between cardiovascular risk factors, hyper- and hypocoagulability 2011. 187p. ISBN 9789494616912. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Büller H. R.; Co-supervisors: Gerdes V. E. A., Kamphuisen P. W.)
• Lane Deirdre A., Kamphuisen Pieter W., Minini Pascal, Büller Harry R., Lip Gregory Y. H. Bleeding risk in patients with atrial fibrillation: the AMADEUS study Chest 2011;140 (1):146-155 [PubMed]
• Biere-Rafi S., Baarslag M. A., Peters M., Kruip M. J. H. A., Kraaijenhagen R. A., den Heijer M., Büller H. R., Kamphuisen P. W. Cardiovascular risk assessment in haemophilia patients Thrombosis and haemostasis 2011;105 (2):274-278 [PubMed]
• Drechsler Christiane, Grootendorst Diana C., Boeschoten Elisabeth W., Krediet Raymond T., Wanner Christoph, Dekker Friedo W., Apperloo A. J., Bijlsma J. A., Boekhout M., Boer W. H., Büller H. R., de Charro F. T. H., de Fijter C. W. H., Doorenbos C. J., Fagel W. J., Feith G. W., Frenken L. A. M., Gerlag P. G. G., Gorgels J. P. M. C., Grave W., Huisman R. M., Jager K. J., Jie K., Koning-Mulder W. A. H., Koolen M. I., Kremer Hovinga T. K., Lavrijssen A. T. J., Luik A. J., Parlevliet K. J., Raasveld M. H. M., Schonck M. J. M., Schuurmans M. M. J., Siegert C. E. H., Stegeman C. A., Stevens P., Thijssen J. G. P., Valentijn R. M., van Buren M., van den Dorpel M. A., van der Boog P. J. M., van der Meulen J., van der Sande F. M., van Es A., van Geelen J. A. C. A., Vastenburg G. H., Verburgh C. A., Vincent H. H., Vos P. F. Changes in parathyroid hormone, body mass index and the association with mortality in dialysis patients Nephrology, dialysis, transplantation 2011;26 (4):1340-1346 [PubMed]
• Lucassen Wim, Geersing Geert-Jan, Erkens Petra M. G., Reitsma Johannes B., Moons Karel G. M., Büller Harry, van Weert Henk C. Clinical decision rules for excluding pulmonary embolism: a meta-analysis Annals of internal medicine 2011;155 (7):448-460 [PubMed]
• van der Velde Eit Frits, Toll Diane B., ten Cate-Hoek Arina J., Oudega Ruud, Stoffers Henri E. J. H., Bossuyt Patrick M., Büller Harry R., Prins Martin H., Hoes Arno W., Moons Karel G. M., van Weert Henk C. P. M. Comparing the Diagnostic Performance of 2 Clinical Decision Rules to Rule Out Deep Vein Thrombosis in Primary Care Patients Annals of family medicine 2011;9 (1):31-36 [PubMed]
• Büller H. R., Destors J. M., Gallus A., Prins M. H., Raskob G., Charbonnier B., Decousus H., Leizorovicz A., Laporte S., Brandjes D. P. M. B., Middeldorp S., Pillion G., Ceresetto J. M., Hendler H., Xavier D. L., Santini F., del Carmen Gallo M., Coughlin P., Chong B., Leahy M., Ward C., Leyden M., Prosser I., Carroll P., Gan E., McRae S., Salem H., Pilger E., Koppensteiner R., Jurecka W., Forstner K., Hainaut P., Motte S., Vermassen F., Araujo G. R., Timi J. Rufino Ribas, Costa J. A., Manenti F., Yoshida W. B., Kovacs M., Delle Siega A., Rodger M., Miron M. J., Anderson D., Yeo E., Kassis J., Spacek R., Klimsa Z., Patek F., Kamphuisen P. Efficacy and safety of once weekly subcutaneous idrabiotaparinux in the treatment of patients with symptomatic deep venous thrombosis Journal of thrombosis and haemostasis 2011;9 (1):92-99 [PubMed]
• van Sluis G. L., Brüggemann L. W., Esmon C. T., Kamphuisen P. W., Richel D. J., Büller H. R., van Noorden C. J. F., Spek C. A. Endogenous activated protein C is essential for immune-mediated cancer cell elimination from the circulation Cancer letters 2011;306 (1):106-110 [PubMed]
• Cohen Alexander Thomas, Spiro Theodore Erich, Büller Harry Roger, Haskell Lloyd, Hu Dayi, Hull Russell, Mebazaa Alexandre, Merli Geno, Schellong Sebastian, Spyropoulos Alex, Tapson Victor Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol Journal of thrombosis and thrombolysis 2011;31 (4):407-416 [PubMed]
• Beyer-Westendorf J., Büller H. External and internal validity of open label or double-blind trials in oral anticoagulation: better, worse or just different? Journal of thrombosis and haemostasis 2011;9 (11):2153-2158 [PubMed]
• van Es J., Eerenberg E. S., Kamphuisen P. W., Büller H. R. How to prevent, treat, and overcome current clinical challenges of VTE Journal of thrombosis and haemostasis 2011;9 (Suppl. 1):265-274 [PubMed]
• Roshani Sara, Cohn Danny M., Stehouwer Alexander C., Wolf Hans, van der Post Joris A. M., Büller Harry R., Kamphuisen Pieter W., Middeldorp Saskia Incidence of postpartum haemorrhage in women receiving therapeutic doses of low-molecular-weight heparin: results of a retrospective cohort study BMJ open 2011;1 (2):e000257 [PubMed]
• van Wissen Matthijs Infections, coagulation annd thrombosis 2011. 143p. ISBN 9789461082015. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Meijers J. C. M., Büller H R.; Co-supervisors: van Gorp E. C. M., Gerdes V. E. A.)
• van Doormaal F. F., Terpstra W., van der Griend R., Prins M. H., Nijziel M. R., van de Ree M. A., Büller H. R., Dutilh J. C., ten Cate-Hoek A., van den Heiligenberg S. M., van der Meer J., Otten J. M. Is extensive screening for cancer in idiopathic venous thromboembolism warranted? Journal of thrombosis and haemostasis 2011;9 (1):79-84 [PubMed]
• Eerenberg Elise S., van Es Josien, Sijpkens Meertien K., Büller Harry R., Kamphuisen Pieter W. New anticoagulants: moving on from scientific results to clinical implementation Annals of medicine 2011;43 (8):606-616 [PubMed]
• Buller H.-R., Combe S. New treatments of veinous thrombo-embolic disease Revue de medecine interne / fondee ... par la Societe nationale francaise de medecine interne 2011;32:10-12
• de Peuter Olav R., Souverein Patrick C., Klungel Olaf H., Büller Harry R., de Boer Anthonius, Kamphuisen Pieter W. Non-selective vs. selective beta-blocker treatment and the risk of thrombo-embolic events in patients with heart failure European journal of heart failure 2011;13 (2):220-226 [PubMed]
• Biere-Rafi Sara, Di Nisio Marcello, Gerdes Victor, Porreca Ettore, Souverein Patrick, de Boer Anthonius, Büller Harry, Kamphuisen Pieter Non-steroidal anti-inflammatory drugs and risk of pulmonary embolism Pharmacoepidemiology and drug safety 2011;20 (6):635-642 [PubMed]
• Combe S., Büller H.-R. Nouveaux traitements de la maladie thrombo-embolique veineuse Journal des maladies vasculaires 2011;36 (Suppl. 1):S16-S19 [PubMed]
• Janssen K. J. M., van der Velde E. F., ten Cate A. J., Prins M. H., van Weert H. C. P. M., Stoffers H. E. J. H., Büller H. R., Oudega R., Hoes A. W., Toll D. B., Moons K. G. M. Optimisation of the diagnostic strategy for suspected deep-vein thrombosis in primary care Thrombosis and haemostasis 2011;105 (1):154-160 [PubMed]
• Buller Harry R., Lensing Anthonie W. A., Prins Martin H. Oral Rivaroxaban for Symptomatic Venous Thromboembolism REPLY New England journal of medicine 2011;364 (12):1178
• Douma Renée A., Mos Inge C. M., Erkens Petra M. G., Nizet Tessa A. C., Durian Marc F., Hovens Marcel M., van Houten Anja A., Hofstee Herman M. A., Klok Frederikus A., ten Cate Hugo, Ullmann Erik F., Büller Harry R., Kamphuisen Pieter W., Huisman Menno V., Beenen L. F., Bossuyt P. M. M., van den Dool E. J., Hofstee H. M. A., Kramer M. H. H., Hovens M. M., Kaasjager K., Nizet T. A. C., Ullmann E. F., Eikenboom H. C. J., Heringhaus C., Huisman M. V., Klok F. A., van Kralingen K. W., Kroft L. J. M., Mos I. C. M., de Roos A., Boomars K., ten Cate H., Erkens P. M. G., Durian M. F., Kruip M. J. H. A., van Houten A. A. Performance of 4 clinical decision rules in the diagnostic management of acute pulmonary embolism: a prospective cohort study Annals of internal medicine 2011;154 (11):709-718 [PubMed]
• Warkentin Theodore E., Davidson Bruce L., Büller Harry R., Gallus Alexander, Gent Michael, Lensing Anthonie W. A., Piovella Franco, Prins Martin H., Segers Annelise E. M., Kelton John G. Prevalence and risk of preexisting heparin-induced thrombocytopenia antibodies in patients with acute VTE Chest 2011;140 (2):366-373 [PubMed]
• van Zaane Bregje, Squizzato Alessandro, Reuwer Anne Q., van Zanten Anton P., Twickler Marcel T. B., Dekkers Olaf M., Cannegieter Suzanne C., Büller Harry R., Gerdes Victor E. A., Brandjes Dees P. M. Prolactin and Venous Thrombosis Indications for a Novel Risk Factor? Arteriosclerosis, thrombosis, and vascular biology 2011;31 (3):672-677 [PubMed]
• Michels Wieneke M., van Dijk Sandra, Verduijn Marion, le Cessie Saskia, Boeschoten Elisabeth W., Dekker Friedo W., Krediet Raymond T., Apperloo A. J., Bijlsma J. A., Boekhout M., Boer W. H., van der Boog P. J. M., Büller H. R., van Buren M., de Charro F. Th, Doorenbos C. J., van den Dorpel M. A., van Es A., Fagel W. J., Feith G. W., de Fijter C. W. H., Frenken L. A. M., Grave W., van Geelen J. A. C. A., Gerlag P. G. G., Gorgels J. P. M. C., Huisman R. M., Jager K. J., Jie K., Koning-Mulder W. A. H., Koolen M. I., Kremer Hovinga T. K., Lavrijssen A. T. J., Luik A. J., van der Meulen J., Parlevliet K. J., Raasveld M. H. M., van der Sande F. M., Schonck M. J. M., Schuurmans M. M. J., Siegert C. E. H., Stegeman C. A., Stevens P., Thijssen J. G. P., Valentijn R. M., Vastenburg G. H., Verburgh C. A., Vincent H. H., Vos P. F. Quality of life in automated and continuous ambulatory peritoneal dialysis Peritoneal dialysis international 2011;31 (2):138-147 [PubMed]
• Tanck M. W. T., Wichers I. M., Meijers J. C. M., Büller H. R., Reitsma P. H., Middeldorp S. Quantitative trait locus for protein C in a family with thrombophilia Thrombosis and haemostasis 2011;105 (1):199-201 [PubMed]
• van Doormaal Frederiek F., Di Nisio Marcello, Otten Hans-Martin, Richel Dick J., Prins Martin, Buller Harry R. Randomized Trial of the Effect of the Low Molecular Weight Heparin Nadroparin on Survival in Patients With Cancer Journal of clinical oncology 2011;29 (15):2071-2076 [PubMed]
• Eerenberg Elise S., Kamphuisen Pieter W., Sijpkens Meertien K., Meijers Joost C., Buller Harry R., Levi Marcel Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects Circulation 2011;124 (14):1573-1579 [PubMed]
• Roshani S., Lijfering W. M., Coppens M., Hamulyák K., Prins M. H., Büller H. R., Middeldorp S. Risk factors of arterial cardiovascular complications in patients with prior venous thromboembolism Netherlands journal of medicine 2011;69 (1):27-30 [PubMed]
• Roach Rachel E. J., Roshani Sara, Meijer Karina, Hamulyák Karly, Lijfering Willem M., Prins Martin H., Büller Harry R., Middeldorp Saskia Risk of cardiovascular disease in double heterozygous carriers and homozygous carriers of F5 R506Q (factor V Leiden) and F2 (prothrombin) G20210A: a retrospective family cohort study British journal of haematology 2011;153 (1):134-136 [PubMed]
• Verhamme P., Tangelder M., Verhaeghe R., Ageno W., Glazer S., Prins M. [=Martin H.], Jacquemin M., Büller H., de Deene A., Gunn S., Segers A., Buysschaert I., Peerlinck K., Angelov S., Boshnakov D., Kostadinov I., Rosmanov V., Stavrev V., Agar G., Brenner B., Nyska M., Salai M., Tauber C., Itzchaki M., Benkovich V., Zeltser D., Baurovskis A., Vigulis V., Peredistijs A., Skowronski J., Deszczynski J., Grecu D. C., Petrec S., Lucaciu D. O., Belenkiy I. G., Kornilov N. N., Kravtsov A., Parfeev S. G., Dryagin V. G., Kuropatkin G. V., Safronov A. A., Nikolaev N. N., Sulyma V. S., Chernyak V. P., Polivoda O. N. Single intravenous administration of TB-402 for the prophylaxis of venous thromboembolism after total knee replacement: a dose-escalating, randomized, controlled trial Journal of thrombosis and haemostasis 2011;9 (4):664-671 [PubMed]
• Schroijen Marielle A., Dekkers Olaf M., Grootendorst Diana C., Noordzij Marlies, Romijn Johannes A., Krediet Raymond T., Boeschoten Elisabeth W., Dekker Friedo W., Apperloo A. J., Bijlsma J. A., Boekhout M., Boer W. H., van der Boog P. J. M., Büller H. R., van Buren M., de Charro F. Th, Doorenbos C. J., van den Dorpel M. A., van Es A., Fagel W. J., Feith G. W., de Fijter C. W. H., Frenken L. A. M., van Geelen J. A. C. A., Gerlag P. G. G., Gorgels J. P. M. C., Grave W., Huisman R. M., Jager K. J., Jie K., Koning-Mulder W. A. H., Koolen M. I., Kremer Hovinga T. K., Lavrijssen A. T. J., Luik A. J., van der Meulen J., Parlevliet K. J., Raasveld M. H. M., van der Sande F. M., Schonck M. J. M., Schuurmans M. M. J., Siegert C. E. H., Stegeman C. A., Stevens P., Thijssen J. G. P., Valentijn R. M., Vastenburg G. H., Verburgh C. A., Vincent H. H., Vos P. F. Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition BMC nephrology 2011;12 (1):69 [PubMed]
• de Peuter Olav R. The ABC of heart failure. Adrenergic receptors, beta-blockers and coagulation 2011. 169p. ISBN 9789085592709. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Büller Harry R.; Co-supervisor: Kamphuisen P. W.)
• Biere-Rafi S., Haak B. W., Peters M., Gerdes V. E. A., Büller H. R., Kamphuisen P. W. The impairment in daily life of obese haemophiliacs Haemophilia 2011;17 (2):204-208 [PubMed]
• Squizzato Alessandro, van Zaane Bregje, Gerdes Victor E. A., Büller Harry R. The Influence of Pituitary, Adrenal, and Parathyroid Hormones on Hemostasis and Thrombosis Seminars in thrombosis and hemostasis 2011;37 (1):41-48 [PubMed]
• Grootendorst Diana C., Michels Wieneke M., Richardson Jermaine D., Jager Kitty J., Boeschoten Elisabeth W., Dekker Friedo W., Krediet Raymond T., Apperloo A. J., Bijlsma J. A., Boekhout M., Boer W. H., van der Boog P. J. M., Büller H. R., van Buren M., de Charro F. Th, Doorenbos C. J., van den Dorpel M. A., van Es A., Fagel W. J., Feith G. W., de Fijter C. W. H., Frenken L. A. M., van Geelen J. A. C. A., Gerlag P. G. G., Gorgels J. P. M. C., Grave W., Huisman R. M., Jie K., Koning-Mulder W. A. H., Koolen M. I., Kremer Hovinga T. K., Lavrijssen A. T. J., Luik A. J., van der Meulen J., Parlevliet K. J., Raasveld M. H. M., van der Sande F. M., Schonck M. J. M., Schuurmans M. M. J., Siegert C. E. H., Stegeman C. A., Stevens P., Thijssen J. G. P., Valentijn R. M., Vastenburg G. H., Verburgh C. A., Vincent H. H., Vos P. F. The MDRD formula does not reflect GFR in ESRD patients Nephrology, dialysis, transplantation 2011;26 (6):1932-1937 [PubMed]
• van Vlijmen Elizabeth F. W., Veeger Nic J. G. M., Middeldorp Saskia, Hamulyák Karly, Prins Martin H., Büller Harry R., Meijer Karina Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception Blood 2011;118 (8):2055-61; quiz 2375 [PubMed]
• de Peuter Olav R., Lip Gregory Y. H., Souverein Patrick C., Klungel Olaf H., de Boer Anthonius, Büller Harry R., Kamphuisen Pieter W. Time-trends in treatment and cardiovascular events in patients with heart failure: a pharmacosurveillance study European journal of heart failure 2011;13 (5):489-495 [PubMed]

2010

• Di Nisio M., van Sluis G. L., Bossuyt P. M. M., Büller H. R., Porreca E., Rutjes A. W. S. Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review Journal of thrombosis and haemostasis 2010;8 (4):684-692 [PubMed]
• Surie Sulaiman, Gibson Nadine S., Gerdes Victor E. A., Bouma Berto J., van Eck-Smit Berthe L. F., Buller Harry R., Bresser Paul Active search for chronic thromboembolic pulmonary hypertension does not appear indicated after acute pulmonary embolism Thrombosis research 2010;125 (5):E202-E205 [PubMed]
• Douma Renée A., Kamphuisen Pieter W., Büller Harry R. Acute pulmonary embolism. Part 1: epidemiology and diagnosis Nature reviews. Cardiology 2010;7 (10):585-596 [PubMed]
• van Es Josien, Douma Renée A., Gerdes Victor E. A., Kamphuisen Pieter W., Büller Harry R. Acute pulmonary embolism. Part 2: treatment Nature reviews. Cardiology 2010;7 (11):613-622 [PubMed]
• Gibson N. S., Douma R. A., Squizzato A., Söhne M., Büller H. R., Gerdes V. E. A. Application of a decision rule and a D-dimer assay in the diagnosis of pulmonary embolism Thrombosis and haemostasis 2010;103 (4):849-854 [PubMed]
• Kaandorp Stef P., Goddijn Mariëtte, Van Der Post Joris A.M., Hutten Barbara A., Verhoeve Harold R., Hamulyák Karly, Willem Mol Ben, Folkeringa Nienke, Nahuis Marleen, Papatsonis Dimitri N.M., Büller Harry R., Van Der Veen Fulco, Middeldorp Saskia Aspirin plus heparin or aspirin alone in women with recurrent miscarriage Obstetrical & gynecological survey 2010;65 (10):621-622
• Kaandorp Stef P., Goddijn Mariëtte, van der Post Joris A. M., Hutten Barbara A., Verhoeve Harold R., Hamulyák Karly, Mol Ben Willem, Folkeringa Nienke, Nahuis Marleen, Papatsonis Dimitri N. M., Büller Harry R., van der Veen Fulco, Middeldorp Saskia Aspirin plus heparin or aspirin alone in women with recurrent miscarriage New England journal of medicine 2010;362 (17):1586-1596 [PubMed]
• van Sluis Geerte L. Cancer, haemostasis and coagulans 2010. 249p. ISBN 9789090252124. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Büller Harry R., van Noorden C. J. F.; Co-supervisors: Spek C. A., Richel D. J.)
• Douma R. A., van Sluis G. L., Kamphuisen P. W., Söhne M., Leebeek F. W. G., Bossuyt P. M. M., Büller H. R. Clinical decision rule and D-dimer have lower clinical utility to exclude pulmonary embolism in cancer patients Explanations and potential ameliorations Thrombosis and haemostasis 2010;104 (4):831-836 [PubMed]
• Gibson Nadine S., Sohne Maaike, Gerdes Victor E. A., Meijers Joost C. M., Buller Harry R. Clinical usefulness of prothrombin fragment 1+2 in patients with suspected pulmonary embolism Thrombosis research 2010;125 (1):97-99 [PubMed]
• Struijk-Mulder M. C., Ettema H. B., Verheyen C. C., Büller H. R. Comparing consensus guidelines on thromboprophylaxis in orthopedic surgery Journal of thrombosis and haemostasis 2010;8 (4):678-683 [PubMed]
• Douma Renée A., Hofstee Herman M. A., Schaefer-Prokop Cornelia, van Waesberghe Jan Hein T. M., Lely Rutger J., Kamphuisen Pieter W., Gerdes Victor E. A., Kramer Mark H. H., Büller Harry R. Comparison of 4- and 64-slice CT scanning in the diagnosis of pulmonary embolism Thrombosis and haemostasis 2010;103 (1):242-246 [PubMed]
• Rensing K. L., Houttuijn Bloemendaal F. M., Weijers E. M., Richel D. J., Büller H. R., Koolwijk P., van der Loos C. M., Twickler Th B., von der Thüsen J. H. Could recombinant insulin compounds contribute to adenocarcinoma progression by stimulating local angiogenesis? Diabetologia 2010;53 (5):966-970 [PubMed]
• Struijk-Mulder M. C., van Wijhe W., Sze Y. K., Knollema S., Verheyen C. C., Büller H. R., Fritschy W. M., Ettema H. B. Death and venous thromboembolism after lower extremity amputation Journal of thrombosis and haemostasis 2010;8 (12):2680-2684 [PubMed]
• Squizzato Alessandro, Micieli Evy, Galli Matteo, Gibson Nadine, Gerdes Victor E. A., Dentali Francesco, Buller Harry, Ageno Walter, Venco Achille Diagnosis and management of venous thromboembolism: Results of a survey on current clinical practice Thrombosis research 2010;125 (2):134-136 [PubMed]
• Mäkelburg Anja B. U., Veeger Nic J. G. M., Middeldorp Saskia, Hamulyák Karly, Prins Martin H., Büller Harry R., Lijfering Willem M. Different risk of deep vein thrombosis and pulmonary embolism in carriers with factor V Leiden compared with non-carriers, but not in other thrombophilic defects. Results from a large retrospective family cohort study Haematologica 2010;95 (6):1030-1033 [PubMed]
• Lucassen Wim A. M., Douma Renee A., Toll Diane B., Buller Harry R., van Weert Henk C. P. M. Excluding pulmonary embolism in primary care using the Wells-rule in combination with a point-of care D-dimer test: a scenario analysis BMC family practice 2010;11 (1):64 [PubMed]
• Schreijer A. J. M., Hoylaerts M. F., Meijers J. C. M., Lijnen H. R., Middeldorp S., Büller H. R., Reitsma P. H., Rosendaal F. R., Cannegieter S. C. Explanations for coagulation activation after air travel Journal of thrombosis and haemostasis 2010;8 (5):971-978 [PubMed]
• van Doormaal Frederiek F., Büller Harry R. Heparin and Survival in Cancer Patients Hematology/oncology clinics of North America 2010;24 (4):777-+ [PubMed]
• van Zaane Bregje Hormones, haemostasis en the risk of thrombosis 2010. 295p. ISBN 9789090253718. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Büller H R., Ageno W.; Co-supervisors: Gerdes V. E. A., Brandjes D. P. M., Cannegieter S. C.)
• van Doormaal Frederiek F., Atalay Selma, Brouwer Henk J., van der Velde Eit-Frits, Büller Harry R., van Weert Henk C. Idiopathic Superficial Thrombophlebitis and the Incidence of Cancer in Primary Care Patients Annals of family medicine 2010;8 (1):47-50 [PubMed]
• van Doormaal F. F., Cohen A. T., Davidson B. L., Decousus H., Gallus A. S., Gent M., Piovella F., Prins M. H., Raskob G. E., Büller H. R. Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: A subgroup analysis of the Van Gogh DVT trial Thrombosis and haemostasis 2010;104 (1):86-91 [PubMed]
• Di Nisio Marcello, Ferrante Noemi, de Tursi Michele, Iacobelli Stefano, Cuccurullo Franco, Büller Harry R., Feragalli Beatrice, Porreca Ettore Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy Thrombosis and haemostasis 2010;104 (5):1049-1054 [PubMed]
• Douma Renée A., Kok Maayke G. M., Verberne Lisa M., Kamphuisen Pieter W., Büller Harry R. Incidental venous thromboembolism in cancer patients: prevalence and consequence Thrombosis research 2010;125 (6):E306-E309 [PubMed]
• Cohn D. M., Repping S., Büller H. R., Meijers J. C. M., Middeldorp S. Increased sperm count may account for high population frequency of factor V Leiden Journal of thrombosis and haemostasis 2010;8 (3):513-516 [PubMed]
• van Zaane Bregje, Squizzato Alessandro, Huijgen Roeland, van Zanten Anton P., Fliers Eric, Cannegieter Suzanne C., Büller Harry R., Gerdes Victor E. A., Brandjes Dees P. M. Increasing levels of free thyroxine as a risk factor for a first venous thrombosis: a case-control study Blood 2010;115 (22):4344-4349 [PubMed]
• Douma Renée A., Kessels Jasper B. F., Buller Harry R., Gerdes Victor E. A. Knowledge of the D-dimer test result influences clinical probability assessment of pulmonary embolism Thrombosis research 2010;126 (4):E271-E275 [PubMed]
• Bauersachs Rupert, Berkowitz Scott D., Brenner Benjamin, Buller Harry R., Decousus Herve, Gallus Alex S., Lensing Anthonie W., Misselwitz Frank, Prins Martin H., Raskob Gary E., Segers Annelise, Verhamme Peter, Wells Phil, Agnelli Giancarlo, Bounameaux Henri, Cohen Alexander, Davidson Bruce L., Piovella Franco, Schellong Sebastian Oral Rivaroxaban for Symptomatic Venous Thromboembolism New England journal of medicine 2010;363 (26):2499-2510 [PubMed]
• Douma Renée A., Le Gal Grégoire, Söhne Maaike, Righini Marc, Kamphuisen Pieter W., Perrier Arnaud, Kruip Marieke J. H. A., Bounameaux Henri, Büller Harry R., Roy Pierre-Marie Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: a retrospective analysis of three large cohorts BMJ (Clinical research ed.) 2010;340:c1475 [PubMed]
• Douma Renée A. Pulmonary embolism: advances in diagnosis and prognosis 2010. 250p. ISBN 9789461080493. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Büller H R.; Co-supervisors: Kamphuisen P. W., Gerdes V. E. A.)
• Klok F. A., Cohn D. M., Middeldorp S., Scharloo M., Büller H. R., van Kralingen K. W., Kaptein A. A., Huisman M. V. Quality of life after pulmonary embolism: validation of the PEmb-QoL Questionnaire Journal of thrombosis and haemostasis 2010;8 (3):523-532 [PubMed]
• Lijfering Willem M., Middeldorp Saskia, Veeger Nic J. G. M., Hamulyák Karly, Prins Martin H., Büller Harry R., van der Meer Jan Risk of Recurrent Venous Thrombosis in Homozygous Carriers and Double Heterozygous Carriers of Factor V Leiden and Prothrombin G20210A Circulation 2010;121 (15):1706-1712 [PubMed]
• Shurlock Barry, Bueller Harry R. Spotlight: Harry R. Buller, MD, PhD Circulation 2010;122 (23):F133-F137
• van Zaane B., Nur E., Squizzato A., Gerdes V. E. A., Büller H. R., Dekkers O. M., Brandjes D. P. M. Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors Journal of thrombosis and haemostasis 2010;8 (11):2483-2493 [PubMed]
• Biere-Rafi S., Zwiers M., Peters M., van der Meer J., Rosendaal F. R., Büller H. R. The effect of haemophilia and von Willebrand disease on arterial thrombosis: a systematic review Netherlands journal of medicine 2010;68 (5):207-214 [PubMed]
• van Sluis Geerte L., Büller Harry R., Spek C. Arnold The role of activated protein C in cancer progression Thrombosis research 2010;125 (Suppl. 2):S138-S142 [PubMed]
• Cohn Danny M. Thrombophilia ad dies vitae 2010. 184p. ISBN 9789090250052. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Büller H. R.; Co-supervisors: Middeldorp S., Kamphuisen P. W.)
• Squizzato Alessandro Thyroid disease and haemostasis. A relatonship with clinical implcations? 2010. 203p. ISBN 9789090253817. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Büller H. R., Ageno W.; Co-supervisors: Gerdes V. E. A., Brandjes D. P. M., Cannegieter S. C.)
• Bueller Harry R. Treating VTE: is there life after warfarin? European journal of haematology 2010;85 (Suppl. 72):12-19
• Wichers Iris M. Unsolved issues in etiology and treatment of venous thrombosis 2010. 188p. ISBN 9789490122980. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Büller Harry R.; Co-supervisors: Middeldorp S., Tanck M. W. T.)

2009

• Kuipers Saskia Air travel and venous thrombosisLeiden: 2009. 117p. ISBN 9789490122492. [UvA Dissertations Online] Rijksuniversiteit Leiden: Faculteit Geneeskunde. (Supervisors: Rosendaal Frits R., Büller Harry R.; Co-supervisors: Middeldorp Saskia, Cannegieter Suzanne C.)
• Lijfering Willem M., Veeger Nic J. G. M., Middeldorp Saskia, Hamulyák Karly, Prins Martin H., Büller Harry R., van der Meer Jan A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families Blood 2009;114 (10):2031-2036 [PubMed]
• Douma R. A., Kamphuisen P. W., Rijnders A. J. M., ten Wolde M., Büller H. R. An alternative diagnostic strategy in young women with suspected pulmonary embolism Journal of thrombosis and haemostasis 2009;7 (4):725-727 [PubMed]
• Wichers Iris M., Tanck Michael W. T., Meijers Joost C. M., Lisman Ton, Reitsma Pieter H., Rosendaal Frits R., Büller Harry R., Middeldorp Saskia Assessment of coagulation and fibrinolysis in families with unexplained thrombophilia Thrombosis and haemostasis 2009;101 (3):465-470 [PubMed]
• Drechsler Christiane, de Mutsert Renée, Grootendorst Diana C., Boeschoten Elisabeth W., Krediet Raymond T., le Cessie Saskia, Wanner Christoph, Dekker Friedo W., Apperloo A. J., Bijlsma J. A., Boekhout M., Boer W. H., Büller H. R., de Charro F. T. H., de Fijter C. W. H., Doorenbos C. J., Fagel W. J., Feith G. W., Frenken L. A. M., Gerlag P. G. G., Gorgels J. P. M. C., Grave W., Huisman R. M., Jager K. J., Jie K., Koning-Mulder W. A. H., Koolen M. I., Kremer Hovinga T. K., Lavrijssen A. T. J., Luik A. J., Parlevliet K. J., Raasveld M. H. M., Schonck M. J. M., Schuurmans M. M. J., Siegert C. E. H., Stegeman C. A., Stevens P., Thijssen J. G. P., Valentijn R. M., van Buren M., van den Dorpel M. A., van der Boog P. J. M., van der Meulen J., van der Sande F. M., van Es A., van Geelen J. A. C. A., Vastenburg G. H., Verburgh C. A., Vincent H. H., Vos P. F. Association of body mass index with decline in residual kidney function after initiation of dialysis American journal of kidney diseases 2009;53 (6):1014-1023 [PubMed]
• Lussana Federico, Caberlon Sabrina, Pagani Chiara, Kamphuisen Pieter W., Büller Harry R., Cattaneo Marco Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: A systematic review Thrombosis research 2009;124 (4):409-417 [PubMed]
• de Peuter O. R., Lussana F., Peters R. J. G., Büller H. R., Kamphuisen P. W. A systematic review of selective and non-selective beta blockers for prevention of vascular events in patients with acute coronary syndrome or heart failure Netherlands journal of medicine 2009;67 (9):284-294 [PubMed]
• van Doormaal F. F., Kleinjan A., Di Nisio M., Büller H. R., Nieuwland R. Cell-derived microvesicles and cancer Netherlands journal of medicine 2009;67 (7):266-273 [PubMed]
• Djurabi R. Karami, Klok F. A., Nijkeuter M., Kaasjager K., Kamphuisen P. W., Kramer M. H. H., Kruip M. J. H. A., Leebeek F. W. G., Büller Harry R., Huisman M. V. Comparison of the clinical usefulness of two quantitative D-Dimer tests in patients with a low clinical probability of Pulmonary Embolism Thrombosis research 2009;123 (5):771-774 [PubMed]
• ten Cate-Hoek A. J., Toll D. B., Büller H. R., Hoes A. W., Moons K. G. M., Oudega R., Stoffers H. E. J. H., van der Velde E. F., van Weert H. C. P. M., Prins M. H., Joore M. A. Cost-effectiveness of ruling out deep venous thrombosis in primary care versus care as usual Journal of thrombosis and haemostasis 2009;7 (12):2042-2049 [PubMed]
• Schulman Sam, Kearon Clive, Kakkar Ajay K., Mismetti Patrick, Schellong Sebastian, Eriksson Henry, Baanstra David, Schnee Janet, Goldhaber Samuel Z., Schulman S., Eriksson H., Goldhaber S., Kakkar A., Kearon C., Mismetti P., Schellong S., Minar E., Bergqvist D., Tijssen J., Prins M. [=Martin H.], Büller H., Otten J., Peters R., Mac Gillavry M., Pol S., Burroughs A., Gilmore I., Bluguermann J., Carlevaro O., Dipaola L., Gitelman P., Santos D., Schygiel P., Baker R., Blombery P., Gallus A., Gan E., Gibbs H., Salem H., Baghestanian M., Pilger E., Sturm W., Debing E., Gadisseur A., Hainaut P., Verhamme P., Wautrecht J.-C., Zicot M., Bizzachi J. M. Annichino, Araujo G. Dabigatran versus warfarin in the treatment of acute venous thromboembolism New England journal of medicine 2009;361 (24):2342-2352 [PubMed]
• van Beek Edwin J. R., Büller Harry R., Oudkerk Matthijs Deep Vein Thrombosis and Pulmonary EmbolismS.l.: Wiley-Blackwell; 2009. ISBN 9780470517178
• Noordzij Marlies, Voormolen Nora M. C., Boeschoten Elisabeth W., Dekker Friedo W., Bos Willem J., Krediet Raymond T., Korevaar Johanna C., Apperloo A. J., Bijlsma J. A., Boekhout M., Boer W. H., van der Boog P. J. M., Büller H. R., van Buren M., de Charro F. Th, Doorenbos C. J., van den Dorpel M. A., van Es A., Fagel W. J., Feith G. W., de Fijter C. W. H., Frenken L. A. M., Grave W., van Geelen J. A. C. A., Gerlag P. G. G., Gorgels J. P. M. C., Huisman R. M., Jager K. J., Jie K., Koning-Mulder W. A. H., Koolen M. I., Kremer Hovinga T. K., Lavrijssen A. T. J., Luik A. J., Parlevliet K. J., Raasveld M. H. M., van der Sande F. M., Schonck M. J. M., Schuurmans M. M. J., Siegert C. E. H., Stegeman C. A., Stevens P., Thijssen J. G. P., Valentijn R. M., Vastenburg G. H., Verburgh C. A., Verstappen V. M. C., Vincent H. H., Vos P. F. Disordered mineral metabolism is not a risk factor for loss of residual renal function in dialysis patients Nephrology, dialysis, transplantation 2009;24 (5):1580-1587 [PubMed]
• Ettema Harmen B., Mulder Marieke C., Nurmohamed Michael T., Buller Harry R., Verheyen Cees C. P. M. Dutch orthopedic thromboprophylaxis: a 5-year follow-up survey Acta orthopaedica 2009;80 (1):109-112 [PubMed]
• van Sluis Geerte L., Niers Tatjana M. H., Esmon Charles T., Tigchelaar Wikky, Richel Dick J., Buller Harry R., van Noorden Cornelis J. F., Spek C. Arnold Endogenous activated protein C limits cancer cell extravasation through sphingosine-1-phosphate receptor 1-mediated vascular endothelial barrier enhancement Blood 2009;114 (9):1968-1973 [PubMed]
• Kamphuisen Pieter W., Rosendaal Frits R., Büller Harry R. Hemostatic abnormalities and arterial thrombosis Seminars in thrombosis and hemostasis 2009;35 (5):449-450 [PubMed]
• Abdelmalik N., Ruhé H. G., Barwari K., van den Dool E. J., Meijers J. C. M., Middeldorp S., Büller H. R., Schene A. H., Kamphuisen P. W. Het effect van de selectieve serotonineheropnameremmer paroxetine op de bloedplaatjesfunctie wordt beïnvloed door een SLC6A4-serotoninetransporterpolymorfisme Nederlands tijdschrift voor hematologie 2009;6 (6):211-219
• van Zaane Bregje, Reuwer Anne Q., Büller Harry R., Kastelein John J. P., Gerdes Victor E. A., Twickler Marcel Th B. Hormones and Cardiovascular Disease: A Shift in Paradigm with Clinical Consequences? Seminars in thrombosis and hemostasis 2009;35 (5):478-487 [PubMed]
• van Zaane Bregje, Nur Erfan, Squizzato Alessandro, Dekkers Olaf M., Twickler Marcel Th B., Fliers Eric, Gerdes Victor E. A., Büller Harry R., Brandjes Dees P. M. Hypercoagulable State in Cushing's Syndrome: A Systematic Review Journal of clinical endocrinology and metabolism 2009;94 (8):2743-2750 [PubMed]
• Niers T. M. H., Brüggemann L. W., van Sluis G. L., Liu R. D., Versteeg H. H., Büller H. R., van Noorden C. J. F., Reitsma P. H., Spek C. A., Richel D. J. Long-term thrombin inhibition promotes cancer cell extravasation in a mouse model of experimental metastasis Journal of thrombosis and haemostasis 2009;7 (9):1595-1597 [PubMed]
• Mäkelburg Anja B. U., Lijfering Willem M., Middeldorp Saskia, Hamulyák Karly, Veeger Nic J. G. M., Prins Martin H., Büller Harry R., van der Meer Jan Low absolute risk of venous and arterial thrombosis in hyperhomocysteinaemia - A prospective family cohort study in asymptomatic subjects Thrombosis and haemostasis 2009;101 (1):209-212 [PubMed]
• van Dijk Sandra, Scharloo Margreet, Kaptein Adrian A., Thong Melissa S. Y., Boeschoten Elisabeth W., Grootendorst Diana C., Krediet Raymond T., Dekker Friedo W., Apperloo A. J., Bijlsma J. A., Boekhout M., Boer W. H., van der Boog P. J. M., Büller H. R., van Buren M., de Charro F. Th, Doorenbos C. J., van den Dorpel M. A., van Es A., Fagel W. J., Feith G. W., de Fijter C. W. H., Frenken L. A. M., van Geelen J. A. C. A., Gerlag P. G. G., Grave W., Gorgels J. P. M. C., Huisman R. M., Jager K. J., Jie K., Koning-Mulder W. A. H., Koolen M. I., Kremer Hovinga T. K., Lavrijssen A. T. J., Luik A. J., van der Meulen J., Parlevliet K. J., Raasveld M. H. M., van der Sande F. M., Schonck M. J. M., Schuurmans M. M. J., Siegert C. E. H., Stegeman C. A., Stevens P., Thijssen J. G. P., Valentijn R. M., Vastenburg G. H., Verburgh C. A., Vincent H. H., Vos P. F. Patients' representations of their end-stage renal disease: relation with mortality Nephrology, dialysis, transplantation 2009;24 (10):3183-3185 [PubMed]
• Krekel N. M. A., Coppens M., Büller H. R., Middeldorp S. Reliability of questionnaires on the use of thromboprophylaxis Journal of thrombosis and haemostasis 2009;7 (6):1042-1043 [PubMed]
• Büller Harry R., ten Cate-Hoek Arina J., Hoes Arno W., Joore Manuela A., Moons Karel G. M., Oudega Ruud, Prins Martin H., Stoffers Henri E. J. H., Toll Diane B., van der Velde Eit F., van Weert Henk C. P. M. Safely Ruling Out Deep Venous Thrombosis in Primary Care Annals of internal medicine 2009;150 (4):229-235 [PubMed]
• Gibson N. S., Schellong S. M., El Kheir D. Y., Beyer J., Gallus A. S., Mc Rae S., Schutgens R. E. G., Piovella F., Gerdes V. E. A., Buller H. R. Safety and sensitivity of two ultrasound strategies in patients with clinically suspected deep venous thrombosis: a prospective management study Journal of thrombosis and haemostasis 2009;7 (12):2035-2041 [PubMed]
• Lijfering Willem M., Brouwer Jan-Leendert P., Veeger Nic J. G. M., Bank Ivan, Coppens Michiel, Middeldorp Saskia, Hamulyak Karly, Prins Martin H., Buller Harry R., van der Meer Jan Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives Blood 2009;113 (21):5314-5322 [PubMed]
• de Mutsert Renée, Grootendorst Diana C., Boeschoten Elisabeth W., Brandts Hans, van Manen Jeannette G., Krediet Raymond T., Dekker Friedo W., Apperloo A. J., Bijlsma J. A., Boekhout M., Boer W. H., van der Boog P. J. M., Büller H. R., van Buren M., de Charro F. Th, Doorenbos C. J., van den Dorpel M. A., van Es A., Fagel W. J., Feith G. W., de Fijter C. W. H., Frenken L. A. M., van Geelen J. A. C. A., Gerlag P. G. G., Gorgels J. P. M. C., Grave W., Huisman R. M., Jager K. J., Jie K., Koning-Mulder W. A. H., Koolen M. I., Kremer Hovinga T. K., Lavrijssen A. T. J., Luik A. J., van der Meulen J., Parlevliet K. J., Raasveld M. H. M., van der Sande F. M., Schonck M. J. M., Schuurmans M. M. J., Siegert C. E. H., Stegeman C. A., Stevens P., Thijssen J. G. P., Valentijn R. M., Vastenburg G. H., Verburgh C. A., Vincent H. H., Vos P. F. Subjective global assessment of nutritional status is strongly associated with mortality in chronic dialysis patients American journal of clinical nutrition 2009;89 (3):787-793 [PubMed]
• de Peuter Olav R., Kok Wouter E. M., Torp-Pedersen Christian, Büller Harry R., Kamphuisen Pieter W. Systolic Heart Failure: A Prothrombotic State Seminars in thrombosis and hemostasis 2009;35 (5):497-504 [PubMed]
• Jong Eefje, Louw Susan, Meijers Joost C. M., de Kruif Martijn D., ten Cate Hugo, Büller Harry R., Mulder Jan Willem, van Gorp Eric C. M. The Hemostatic Balance in HIV-Infected Patients with and without Antiretroviral Therapy: Partial Restoration with Antiretroviral Therapy AIDS patient care and STDs 2009;23 (12):1001-1007 [PubMed]
• Folkeringa Nienke, Korteweg Fleurisca J., Veeger Nic J. G. M., Middeldorp Saskia, Hamulyak Karly, Prins Martin H., Erwich Jan Jaap H. M., Büller Harry R., van der Meer Jan Thrombin activatable fibrinolysis inhibitor (TAFI) is not associated with fetal loss, a retrospective study Thrombosis research 2009;123 (3):511-514 [PubMed]
• van Sluis G. L., Buller H. R. Treatment of Cancer-Associated Venous Thrombosis Cancer investigation 2009;27 (Suppl. 1):1-6
• van Doormaal Frederiek F., Raskob Gary E., Davidson Bruce L., Decousus Hervé, Gallus Alexander, Lensing Anthie W. A., Piovella Franco, Prins Martin H., Büller Harry R. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials Thrombosis and haemostasis 2009;101 (4):762-769 [PubMed]
• Douma Renée A., Gibson Nadine S., Gerdes Victor E. A., Büller Harry R., Wells Philip S., Perrier Arnaud, Le Gal Grégoire Validity and clinical utility of the simplified Wells rule for assessing clinical probability for the exclusion of pulmonary embolism Thrombosis and haemostasis 2009;101 (1):197-200 [PubMed]
• van Doormaal Frederiek F. Venous thromboembolism, coagulation and cancer 2009. 229p. ISBN 9789094901224. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Büller Harry R., Richel Dick J.; Co-supervisor: Otten J. M. M. B.)
• Jacobson B. F., Louw S., Mer M., Haas S., Büller H. R., Abdul-Carim A. T. O., Adler D., Beaton A., de Jong P. R., van der Jagt D., Levy B., Pearl J., Schapkaitz E., Wessels P. Venous thromboembolism--prophylactic and therapeutic practice guideline South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2009;99 (6):467-8, 470-3 [PubMed]
• Hermanides J., Cohn D. M., DeVries J. Hans, Kamphuisen P. W., Huijgen R., Meijers J. C. M., Hoekstra J. B. L., Büller H. R. Venous thrombosis is associated with hyperglycemia at diagnosis: a case-control study Journal of thrombosis and haemostasis 2009;7 (6):945-949 [PubMed]

2008

• Folkeringa Nienke, Coppens Michiel, Veeger Nic J. G. M., Bom Victor J. J., Middeldorp Saskia, Hamulyak Karly, Prins Martin H., Büller Harry R., van der Meer Jan Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels Thrombosis and haemostasis 2008;100 (1):38-44 [PubMed]
• Buller Harry R., Lensing Anthonie W. A., Prins Martin H., Agnelli Giancarlo, Cohen Alexander, Gallus Alexander S., Misselwitz Frank, Raskob Gary, Schellong Sebastian, Segers Annelise A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study Blood 2008;112 (6):2242-2247 [PubMed]
• Buller Harry A higher international normalized ratio may be better for your patient CMAJ 2008;179 (3):217 [PubMed]
• Wichers I. M., Haighton M., Büller H. R., Middeldorp S. A retrospective analysis of patients treated for superficial vein thrombosis Netherlands journal of medicine 2008;66 (10):423-427 [PubMed]
• Thong Melissa S. Y., Kaptein Adrian A., Benyamini Yael, Krediet Raymond T., Boeschoten Elisabeth W., Dekker Friedo W., Apperloo A. J., Bijlsma J. A., Boekhout M., Boer W. H., van der Boog P. J. M., Büller H. R., van Buren M., de Charro F. Th, Doorenbos C. J., van den Dorpel M. A., van Es A., Fagel W. J., Feith G. W., de Fijter C. W. H., Frenken L. A. M., Grave W., van Geelen J. A. C. A., Gerlag P. G. G., Gorgels J. P. M. C., Huisman R. M., Jager K. J., Jie K., Koning-Mulder W. A. H., Koolen M. I., Kremer Hovinga T. K., Lavrijssen A. T. J., Luik A. J., van der Meulen J., Parlevliet K. J., Raasveld M. H. M., van der Sande F. M., Schonck M. J. M., Schuurmans M. M. J., Siegert C. E. H., Stegeman C. A., Stevens P., Thijssen J. G. P., Valentijn R. M., Vastenburg G. H., Verburgh C. A., Vincent H. H., Vos P. F. Association between a self-rated health question and mortality in young and old dialysis patients: a cohort study American journal of kidney diseases 2008;52 (1):111-117 [PubMed]
• Levi Marcel, Hovingh G. Kees, Cannegieter Suzanne C., Vermeulen Marinus, Büller Harry R., Rosendaal Frits R. Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based Blood 2008;111 (9):4471-4476 [PubMed]
• Stein Paul D., Sostman H. Dirk, Bounameaux Henri, Buller Harry R., Chenevert Thomas L., Dalen James E., Goodman Lawrence R., Gottschalk Alexander, Hull Russell D., Leeper Kenneth V., Pistolesi Massimo, Raskob Gary E., Wells Philip S., Woodard Pamela K. Challenges in the diagnosis of acute pulmonary embolism American journal of medicine 2008;121 (7):565-571 [PubMed]
• Niers Tatjana M. H. Coagulation, angiogenesis and cancer 2008. 199p. ISBN 9789064642579. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Richel D. J., van Noorden C. J.; Co-supervisors: Büller H. R., Spek C. A.)
• Bousser M. G., Bouthier J., Büller H. R., Cohen A. T., Crijns H., Davidson B. L., Halperin J., Hankey G., Levy S., Pengo V., Prandoni P., Prins M. H., Tomkowski W., Thorp-Pedersen C., Wyse D. G. Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial Lancet 2008;371 (9609):315-321 [PubMed]
• van Doormaal F. F., Büller H. R., Middeldorp S. Development in anticoagulant therapy Critical reviews in oncology/hematology 2008;66 (2):145-154 [PubMed]
• Büller H. R., Halperin J. L., Bounameaux H., Prins M. [=Martin H.] Double-blind studies are not always optimum for evaluation of a novel therapy: the case of new anticoagulants Journal of thrombosis and haemostasis 2008;6 (2):227-229 [PubMed]
• Abdelmalik N., Ruhé H. G., Barwari K., van den Dool E.-J., Meijers J. C. M., Middeldorp S., Büller H. R., Schene A. H., Kamphuisen P. W. Effect of the selective serotonin reuptake inhibitor paroxetine on platelet function is modified by a SLC6A4 serotonin transporter polymorphism Journal of thrombosis and haemostasis 2008;6 (12):2168-2174 [PubMed]
• Buller H., Deitchman D., Prins M. [=Martin H.], Segers A., Brenner B., Brighton T., Chlumsky J., Davidson B., Decousus H., Eriksson H., Jacobson B., van der Meer J., Minar E., Piovella F., Tomkowski W., Baarslag H., Brandjes D., Bergqvist D., Laporte S., Mismetti P., Baker R., Blombery P., Chong B., Gallus A., Gan E., Salem H., Hirschl M., Pilger E., Kovarova K., Malý J., Matoska P., Patek F., Spacek R., Vitovec M., Zak J., Emmerich J., Lacroix P., Mottier D., Quere I., Roy P., Schmidt J., Elias M., Gavish D., Hoffman R., Hussein O., Lishner M., Lugassy G., Schliamser L., Shpilberg O., Middeldorp S. Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study Journal of thrombosis and haemostasis 2008;6 (8):1313-1318 [PubMed]
• Nijkeuter Mathilde, Tick Lidwine W., Sohne Maaike, Kruip Marieke J. H. A., Buller Harry R., Leebeek Frank W. G., Kramer Mark H. H., Klok Frederikus A., Prins Martin H., Huisman Menno V. Excluding pulmonary embolism without imaging tests - Can our diagnostic algorithm be optimized? Thrombosis and haemostasis 2008;100 (6):1203-1206 [PubMed]
• Douma R. A., Kamphuisen P. W., Huisman M. V., Büller H. R. False normal results on multidetector-row spiral computed tomography in patients with high clinical probability of pulmonary embolism Journal of thrombosis and haemostasis 2008;6 (11):1978-1979 [PubMed]
• Gibson Nadine S., Sohne Maaike, Kruip Marieke J. H. A., Tick Lidwine W., Gerdes Victor E., Bossuyt Patrick M., Wells Philip S., Buller Harry R. Further validation and simplification of the Wells clinical decision rule in pulmonary embolism Thrombosis and haemostasis 2008;99 (1):229-234 [PubMed]
• Klok F. A., Djurabi R. Karami, Nijkeuter M., Eikenboom H. C. J., Leebeek F. W. G., Kramer M. H. H., Kaasjager K., Kamphuisen P. W., Büller H. R., Huisman M. V. High D-dimer level is associated with increased 15-d and 3 months mortality through a more central localization of pulmonary emboli and serious comorbidity British journal of haematology 2008;140 (2):218-222 [PubMed]
• Tick L. W., Nijkeuter M., Kramer M. H. H., Hovens M. M. C., Büller H. R., Leebeek F. W. G., Huisman M. V. High D-dimer levels increase the likelihood of pulmonary embolism Journal of internal medicine 2008;264 (2):195-200 [PubMed]
• Louw Susan, Jacobson Barry F., Büller Harry Human immunodeficiency virus infection and acute deep vein thromboses Clinical and applied thrombosis/hemostasis 2008;14 (3):352-355 [PubMed]
• Lijfering Willem M., Coppens Michiel, Veeger Nic J. G. M., Middeldorp Saskia, Hamulyák Karly, Prins Martin H., Büller Harry R., van der Meer Jan Hyperhomocysteinemia is not a risk factor for venous and arterial thrombosis, and is associated with elevated factor VIII levels Thrombosis research 2008;123 (2):244-250 [PubMed]
• Nijkeuter M., Kwakkel-van Erp J. M., Kruip M. J. H. A., Sohne M., Büller H. R., Leebeek F. W. G., Huisman M. V. Incidence of diagnosis of subsegmental pulmonary emboli using multidetector row and single-detector row computed tomography Journal of thrombosis and haemostasis 2008;6 (2):384-386 [PubMed]
• Gibson Nadine S., Buller Harry R. Longembolieënin: E. E. van der Wall, F. Van de Werf, F. Zijlstra, editors. Cardiologie. Houten: Bohn Stafleu Van Loghum; 2008. p. 435-442, ISBN 9789031348299
• Lussana Federico, Painter Rebecca C., Ocke Marga C., Buller Harry R., Bossuyt Patrick M., Roseboom Tessa J. Prenatal exposure to the Dutch famine is associated with a preference for fatty foods and a more atherogenic lipid profile American journal of clinical nutrition 2008;88 (6):1648-1652 [PubMed]
• Ettema H. B., Kollen B. J., Verheyen C. C. P. M., Büller H. R. Prevention of venous thromboembolism in patients with immobilization of the lower extremities: a meta-analysis of randomized controlled trials Journal of thrombosis and haemostasis 2008;6 (7):1093-1098 [PubMed]
• Bernardi Enrico, Camporese Giuseppe, Buller Harry R., Siragusa Sergio, Imberti Davide, Berchio Arrigo, Ghirarduzzi Angelo, Verlato Fabio, Anastasio Raffaela, Prati Carolina, Piccioli Andrea, Pesavento Raffaele, Bova Carlo, Maltempi Patrizia, Zanatta Nello, Cogo Alberto, Cappelli Roberto, Bucherini Eugenio, Cuppini Stefano, Noventa Franco, Prandoni Paolo Serial 2-point ultrasonography plus D-Dimer vs whole-leg color-coded doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis - A randomized controlled trial JAMA 2008;300 (14):1653-1659 [PubMed]
• Ettema Harmen B. Some dilemmas in orthopedic thromboprophylaxis 2008. 206p. ISBN 9789071382765. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Büller H. R.; Co-supervisor: Verheyen C. C. P. M.)
• Gibson Nadine S. The diagnosis and prognosis of venous thromboembolism. Variations on a theme 2008. 173p. ISBN 9789090233857. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Büller H. R.; Co-supervisors: Gerdes V. E. A., Söhne M.)
• Gibson Nadine S., Sohne Maaike, Gerdes Victor E. A., Nijkeuter Mathilde, Buller Harry R. The importance of clinical probability assessment in interpreting a normal d-dimer in patients with suspected pulmonary embolism Chest 2008;134 (4):789-793 [PubMed]
• Coppens Michiel Thrombophilia 2008. 135p. ISBN 9789090227450. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Buller Harry R.; Co-supervisor: Middeldorp S.)

2007

• Bank Ivan, van de Poel Marlène H. W., Coppens Michiel, Hamulyák Karly, Prins Martin H., van der Meer Jan, Veeger Nic J. G. M., Büller Harry R., Middeldorp Saskia Absolute annual incidences of first events of venous thromboembolism and arterial vascular events in individuals with elevated FVIII:c. A prospective family cohort study Thrombosis and haemostasis 2007;98 (5):1040-1044 [PubMed]
• Bendermacher Bianca L. W., Teijink Joep A. W., Willigendael Edith M., Bartelink Marie-Louise, Peters Ron J. G., de Bie Rob A., Buller Harry R., Boiten Jelis, Langenberg Machteld, Prins Martin H. A clinical prediction model for the presence of peripheral arterial disease - the benefit of screening individuals before initiation of measurement of the ankle-brachial index: an observational study Vascular medicine (London, England) 2007;12 (1):5-11 [PubMed]
• Dinh T., Nieuwlaat R., Tieleman R. G., Buller H. R., Mensing van Charante N. A., Prins M. H., Crijns H. J. G. M. Antithrombotic drug prescription in atrial fibrillation and its rationale among general practitioners, internists and cardiologists in The Netherlands - The EXAMINE-AF study. A questionnaire survey International journal of clinical practice 2007;61 (1):24-31 [PubMed]
• Buller H. R., van Doormaal F. F., van Sluis G. L., Kamphuisen P. W. Cancer and thrombosis: from molecular mechanisms to clinical presentations Journal of thrombosis and haemostasis 2007;5 (Suppl. 1):246-254 [PubMed]
• Douma Renee A., Kamphuisen P. W., Buller H. R. Clinical decision rules in the diagnostic work-up of patients with clinically suspected pulmonary embolism Imaging decisions 2007;11 (3):8-13
• Nijkeuter Mathilde, Erp Hanneke Kwakkel-van, Sohne Maaike, Tick Lidwine W., Kruip Marieke J. H. A., Ullmann Eric F., Kramer Mark H. H., Buller Harry R., Prins Martin H., Leebeek Frank W. G., Huisman Menno V. Clinically suspected acute recurrent pulmonary embolism: a diagnostic challenge Thrombosis and haemostasis 2007;97 (6):944-948 [PubMed]
• Squizzato A., Romualdi E., Buller H. R., Gerdes V. E. A. Clinical review: Thyroid dysfunction and effects on coagulation and fibrinolysis: A systematic review Journal of clinical endocrinology and metabolism 2007;92 (7):2415-2420 [PubMed]
• Tulevski Igor I., ten Wolde Marye, van Veldhuisen Dirk J., Mulder Jasper W. M., van der Wall Ernst E., Büller Harry R., Mulder Barbara J. M. Combined utility of brain natriuretic peptide and cardiac troponin T may improve rapid triage and risk stratification in normotensive patients with pulmonary embolism International journal of cardiology 2007;116 (2):161-166 [PubMed]
• Coppens M., van Mourik J. A., Eckmann C. M., Buller H. R., Middeldorp S. Current practise of testing for inherited thrombophilia Journal of thrombosis and haemostasis 2007;5 (9):1979-1981 [PubMed]
• Eriksson Bengt I., Dahl Ola E., Rosencher Nadia, Kurth Andreas A., van Dijk C. Niek, Frostick Simon P., Prins Martin H., Hettiarachchi Rohan, Hantel Stefan, Schnee Janet, Bueller Harry R. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial Lancet 2007;370 (9591):949-956 [PubMed]
• Di Nisio M., Squizzato A., Rutjes A. W. S., Büller H. R., Zwinderman A. H., Bossuyt P. M. M. Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review Journal of thrombosis and haemostasis 2007;5 (2):296-304 [PubMed]
• Davidson B. L., Bueller H. R., Decousus H., Gallus A., Gent M., Piovella F., Prins M. H., Raskob G. E., Segers A. E. M., Lensing A. W. A. Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials Journal of thrombosis and haemostasis 2007;5 (6):1191-1194 [PubMed]
• Buller Harry R., Cohen Ander T., Davidson Bruce, Decousus Herve, Gallus Alex S., Gent Michael, Pillion Gerard, Piovella Franco, Prins Martin H., Raskob Gary E. Extended prophylaxis of venous thromboembolism with idraparinux New England journal of medicine 2007;357 (11):1105-1112 [PubMed]
• van der Velde E. F., Wichers I. M., Toll D. B., van Weert H. C. P. M., Bueller H. R. Feasibility and accuracy of a rapid 'point-of-care' D-dimer test performed with a capillary blood sample Journal of thrombosis and haemostasis 2007;5 (6):1327-1330 [PubMed]
• Buller Harry R., Cohen Ander T., Davidson Bruce, Decousus Herve, Gallus Alex S., Gent Michael, Pillion Gerard, Piovella Franco, Prins Martin H., Raskob Gary E. Idraparinux versus standard therapy for venous thromboembolic disease New England journal of medicine 2007;357 (11):1094-1104 [PubMed]
• van Wissen Matthijs, Keller Tymen T., Ronkes Brechje, Gerdes Victor E. A., Zaaijer Hans L., van Gorp Eric C. M., Brandjes Dees P. M., Levi Marcel, Buller Harry R. Influenza infection and risk of acute pulmonary embolism Thrombosis journal 2007;5 (1):16 [PubMed]
• Coppens M., Schreijer A. J. M., Berger F. H., Cannegieter S. C., Rosendaal F. R., Bueller H. R. Mechanical prophylaxis for travellers' thrombosis: a comparison of three interventions that promote venous outflow Journal of thrombosis and haemostasis 2007;5 (7):1556-1567 [PubMed]
• Niers T. M. H., Klerk C. P. W., DiNisio M., van Noorden C. J. F., Büller H. R., Reitsma P. H., Richel D. J. Mechanisms of heparin induced anti-cancer activity in experimental cancer models Critical reviews in oncology/hematology 2007;61 (3):195-207 [PubMed]
• Eriksson B. I., Dahl O. E., Rosencher N., Kurth A. A., van Dijk C. N., Frostick S. P., Kälebo P., Christiansen A. V., Hantel S., Hettiarachchi R., Schnee J., Büller H. R. Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial Journal of thrombosis and haemostasis 2007;5 (11):2178-2185 [PubMed]
• Coppens M., Folkeringa N., Teune M. J., Hamulyak K., van der Meer J., Prins M. H., Buller H. R., Middeldorp S. Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutation: reply to a rebuttal Journal of thrombosis and haemostasis 2007;5 (9):1992-1994 [PubMed]
• Coppens M., Folkeringa N., Teune M. J., Hamulyak K., van der Meer J., Prins M. H., Buller H. R., Middeldorp S. Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutations Journal of thrombosis and haemostasis 2007;5 (7):1444-1448 [PubMed]
• Sohne M., Buller H. R. Pijn op de borstin: G. K. Hovingh, G. A. Somsen, editors. Probleemgeoriënteerd denken in de cardiologie en vasculaire geneeskunde; een praktijkboek voor de opleiding en de kliniek. Utrecht: De Tijdstroom; 2007. p. 239-248, ISBN 9789058981080
• Biemond Bart J., Perzborn Elisabeth, Friederich Philip W., Levi Marcel, Buetehorn Ulf, Buller Harry R. Prevention and treatment of experimental thrombosis in rabbits with rivaroxaban (BAY 597939) - an oral, direct factor Xa inhibitor Thrombosis and haemostasis 2007;97 (3):471-477 [PubMed]
• Niers T. M. H., Di Nisio M., Klerk C. P. W., Baarslag H. J., Bueller H. R., Biemond B. J. Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo-controlled study Journal of thrombosis and haemostasis 2007;5 (9):1878-1882 [PubMed]
• Squizzato Alessandro, Vitale Josè, Gerdes Victor Ea, Romualdi Erica, Büller Harry R., Ageno Walter Recurrent deep venous thrombosis during optimal anticoagulation and overt hyperthyroidism: a case report Blood coagulation & fibrinolysis 2007;18 (8):801-803 [PubMed]
• Squizzato Alessandro, Romualdi Erica, Piantanida Eliana, Gerdes Victor E. A., Bueller Harry R., Tanda Maria, Bartalena Luigi, Venco Achille, Ageno Walter Subclinical hypothyroidism and deep venous-thrombosis - A pilot cross-sectional study Thrombosis and haemostasis 2007;97 (5):803-806 [PubMed]
• Kuipers Saskia, Cannegieter Suzanne C., Middeldorp Saskia, Robyn Luc, Buller Harry R., Rosendaal Frits R. The absolute risk of venous thrombosis after air travel: a cohort study of 8,755 employees of international organisations PLoS medicine 2007;4 (9):e290-1514 [PubMed]
• Squizzato A., Gerdes V. E. A., Ageno W., Büller H. R. The coagulation system in endocrine disorders: a narrative review Internal and emergency medicine 2007;2 (2):76-83 [PubMed]
• Nijkeuter Mathilde, Sohne Maaike, Tick Lidwine W., Kamphuisen Pieter Willem, Kramer Mark H. H., Laterveer Laurens, van Houten Anja A., Kruip Marieke J. H. A., Leebeek Frank W. G., Buller Harry R., Huisman Menno V. The natural course of hemodynamically stable pulmonary embolism: Clinical outcome and risk factors in a large prospective cohort study Chest 2007;131 (2):517-523 [PubMed]
• Lijfering Willem M., Coppens Michiel, van de Poel Marlene H. W., Middeldorp Saskia, Hamulyak Karly, Bank Ivan, Veeger Nic J. G. M., Prins Martin H., Bueller Harry R., van der Meer Jan The risk of venous and arterial thrombosis in hyperhomocysteinaemia is low and mainly depends on concomitant thrombophilic defects Thrombosis and haemostasis 2007;98 (2):457-463 [PubMed]
• Di Nisio Marcello Thrombosis and cancer: advances in diagnosis and prognosis 2007. 212p. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Richel Dick J., Buller Harry R.; Co-supervisor: Middeldorp S.)
• Kuipers S., Schreijer A. J. M., Cannegieter S. C., Bueller H. R., Rosendaal F. R., Middeldorp S. Travel and venous thrombosis: a systematic review Journal of internal medicine 2007;262 (6):615-634 [PubMed]
• Büller H. R., Kastelein J. J. P., Stroes E. S. G. Vasculaire Geneeskunde, 3e herziene drukAlphen aan de Rijn: Van Zuiden Communications; 2007. ISBN 9789085231516

2006

• Sohne M., Kruip M. J. H. A., Nijkeuter M., Tick L., Kwakkel H., Halkes S. J. M., Huisman M. V., Buller H. R. Accuracy of clinical decision rule, D-dimer and spiral computed tomography in patients with malignancy, previous venous thromboembolism, COPD or heart failure and in older patients with suspected pulmonary embolism Journal of thrombosis and haemostasis 2006;4 (5):1042-1046 [PubMed]
• Schreijer A. J. M., Cannegieter S. C., Meijers J. C. M., Middeldorp S., Büller H. R., Rosendaal F. R. Activation of coagulation system during air travel: a crossover study Lancet 2006;367 (9513):832-838 [PubMed]
• Schreijer A. J. M., Cannegieter S. C., Buller H. R., Rosendaal F. R. Activation of coagulation system during air travel - Reply Lancet 2006;368 (9529):26
• Keller T. T. Acute respiratory tract infections and (athero)thrombotic disease 2006. 211p. ISBN 9789090213095. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Büller H. R., Levi M. M.; Co-supervisors: Brandjes D. P. M., Gerdes V. E. A.)
• Nijkeuter M., Prins M. H., Buller H. R., Huisman M. V. An algorithm for managing suspected pulmonary embolism - Reply JAMA 2006;295 (22):2604
• de Pont A. C. J. M. Anticoagulation in severe sepsis and the multiple organ dysfunction syndrome 2006. 147p. ISBN 9789090204062. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Vroom M. B., Büller H. R.; Co-supervisors: Levi M. M., de Jonge E.)
• Coppens Michiel, van de Poel Marlene H., Bank Ivan, Hamulyak Karly, van der Meer Jan, Veeger Nic J., Prins Martin H., Buller Harry R., Middeldorp Saskia A prospective cohort study on the absolute incidence of venous thromboembolism and arterial cardiovascular disease in asymptomatic carriers of the prothrombin 20210A mutation Blood 2006;108 (8):2604-2607 [PubMed]
• Kruip M. J. H. A., Söhne M., Nijkeuter M., Kwakkel-van Erp H. M., Tick L. W., Halkes S. J. M., Prins M. H., Kramer M. H. H., Huisman M. V., Büller H. R., Leebeek F. W. G. A simple diagnostic strategy in hospitalized patients with clinically suspected pulmonary embolism Journal of internal medicine 2006;260 (5):459-466 [PubMed]
• Söhne M., ten Wolde M., Boomsma F., Reitsma J. B., Douketis J. D., Büller H. R. Brain natriuretic peptide in hemodynamically stable acute pulmonary embolism Journal of thrombosis and haemostasis 2006;4 (3):552-556 [PubMed]
• Gerdes Victor E. A., Kwa Vincent I. H., ten Cate Hugo, Brandjes Dees P. M., Büller Harry R., Stam Jan Cerebral white matter lesions predict both ischemic strokes and myocardial infarctions in patients with established atherosclerotic disease Atherosclerosis 2006;186 (1):166-172 [PubMed]
• Di Nisio M., Rutjes A. W. S., Büller H. R. Combined use of clinical pretest probability and D-dimer test in cancer patients with clinically suspected deep venous thrombosis Journal of thrombosis and haemostasis 2006;4 (1):52-57 [PubMed]
• Gibson Nadine S., Büller Harry R. Could D-dimer provide a definitive diagnosis in patients with suspected pulmonary embolism? Nature clinical practice. Cardiovascular medicine 2006;3 (12):654-655 [PubMed]
• Levi M. [=Marcel M.], Rosendaal F. R., Büller H. R. Diepe veneuze trombose en longembolie door een vliegreis Nederlands tijdschrift voor geneeskunde 2006;150 (45):2474-2478 [PubMed]
• Miller Andrew, Campbell Ian, Fennerty Tony, Raskob Gary E., Büller Harry R. Duration of warfarin in pulmonary embolism Chest 2006;130 (1):299; author reply 299-299; author reply 300 [PubMed]
• van Belle Arne, Büller Harry R., Huisman Menno V., Huisman Peter M., Kaasjager Karin, Kamphuisen Pieter W., Kramer Mark H. H., Kruip Marieke J. H. A., Kwakkel-van Erp Johanna M., Leebeek Frank W. G., Nijkeuter Mathilde, Prins Martin H., Sohne Maaike, Tick Lidwine W. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography JAMA 2006;295 (2):172-179 [PubMed]
• Keller Tymen T., van der Sluijs Koen F., de Kruif Martijn D., Gerdes Victor E. A., Meijers Joost C. M., Florquin Sandrine, van der Poll Tom, van Gorp Eric C. M., Brandjes Dees P. M., Büller Harry R., Levi Marcel Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1 Circulation research 2006;99 (11):1261-1269 [PubMed]
• de Pont Anne-Cornélie J. M., Bakhtiari Kamran, Hutten Barbara A., de Jonge Evert, Vlasuk George P., Rote William E., Levi Marcel, Büller Harry R., Meijers Joost C. M. Endotoxaemia induces resistance to activated protein C in healthy humans British journal of haematology 2006;134 (2):213-219 [PubMed]
• van Sluis G. L., Söhne M., El Kheir D. Y., Tanck M. W., Gerdes V. E. A., Büller H. R. Family history and inherited thrombophilia Journal of thrombosis and haemostasis 2006;4 (10):2182-2187 [PubMed]
• El Kheir D. Y. M. Further optimization of the diagnostic management of deep venous thrombosis 2006. 112p. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Büller H. R.; Co-supervisor: Gerdes V. E. A.)
• Vink R., Levi M. [=Marcel M.], Büller H. R. Het ALIFE-onderzoek: herhaalde miskramen en het mogelijke nut van antistollingsbehandeling bij vrouwen met en zonder erfelijke trombofilie Internisten vademecum 2006;11 (6)
• Coppens M., van Doormaal F. F., Schreijer A. J. M., Rosendaal F. R., Büller H. R. Intermittent mechanical compression for prevention of travellers' thrombosis Journal of thrombosis and haemostasis 2006;4 (8):1836-1838 [PubMed]
• Hoppener Marnix R., Ettema Harmen B., Henny Chris P., Verheyen Cees C. P. M., Büller Harry R. Low incidence of deep vein thrombosis after knee arthroscopy without thromboprophylaxis: a prospective cohort study of 335 patients Acta orthopaedica 2006;77 (5):767-771 [PubMed]
• Ettema H. B., Hoppener M. R., Veeger N. J. G. M., Büller H. R., van der Meer J. Low incidence of venographically detected deep vein thrombosis after knee arthroscopy without thromboprophylaxis: a prospective cohort study Journal of thrombosis and haemostasis 2006;4 (6):1411-1413 [PubMed]
• van Weert H., Dolan G., Wichers I., de Vries C., ter Riet G., Büller H. R. Oppervlakkige tromboflebitis verhoogt het risico op een veneuze trombose Huisarts en wetenschap 2006;49 (8):414-417
• Levi M. [=Marcel M.], Vink R., van den Brink R. B. A., Büller H. R. Perioperatieve interruptie van antistolling bij patiënten met boezemfibrilleren en met mechanische hartklepprothesen Hart Bulletin 2006;37 (1):9-12
• de Pont Anne-Cornélie J. M., Bouman Catherine S. C., Bakhtiari Kamran, Schaap Marianne C. L., Nieuwland Rienk, Sturk Augueste, Hutten Barbara A., de Jonge Evert, Vroom Margreeth B., Meijers Joost C. M., Büller Harry R. Predilution versus postdilution during continuous venovenous hemofiltration: a comparison of circuit thrombogenesis ASAIO journal (American Society for Artificial Internal Organs 2006;52 (4):416-422 [PubMed]
• van der Heiden Pim L. J., Prins Martin H., de Monyé Wouter, van Strijen Marco L. J., Banga Jan Dirk, Postmus Piet E., ten Wolde Marije, Büller Harry R., Brandjes Desiderius P. M., Huisman Menno V. Pulmonary embolism as a first clinical sign of occult malignancy: a prospective follow-up study Thrombosis and haemostasis 2006;95 (3):584-585 [PubMed]
• van Weert H., Dolan G., Wichers I., de Vries C., ter Riet G., Buller H. Spontaneous superficial venous thrombophlebitis: does it increase risk for thromboembolism? A historic follow-up study in primary care Journal of family practice 2006;55 (1):52-57 [PubMed]
• Bendermacher Bianca L. W., Teijink Joep A. W., Willigendael Edith M., Bartelink Marie-Louise, Büller Harry R., Peters Ron J. G., Boiten Jelis, Langenberg Machteld, Prins Martin H. Symptomatic peripheral arterial disease: the value of a validated questionnaire and a clinical decision rule British journal of general practice 2006;56 (533):932-937 [PubMed]
• Kuipers S., Cannegieter S. C., Middeldorp S., Rosendaal F. R., Büller H. R. Use of preventive measures for air travel-related venous thrombosis in professionals who attend medical conferences Journal of thrombosis and haemostasis 2006;4 (11):2373-2376 [PubMed]
• Bresser P., Büller H. R. Wat is de rol van bedrust bij de behandeling van longembolie? Longartsen vademecum 2006;9 (15):16 okt

2005

• Reitsma Pieter H., van der Heijden Jeroen F., Groot Angelique P., Rosendaal Frits R., Büller Harry R. A C1173T dimorphism in the VKORC1 gene determines coumarin Sensitivity and bleeding risk PLoS medicine 2005;2 (10):996 e312-998 [PubMed]
• Eriksson B. I., Dahl O. E., Büller H. R., Hettiarachchi R., Rosencher N., Bravo M.-L., Ahnfelt L., Piovella F., Stangier J., Kälebo P., Reilly P. A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial Journal of thrombosis and haemostasis 2005;3 (1):103-111 [PubMed]
• Büller Harry, Agnelli Giancarlo Anticoagulation management - Time to change? Introduction Pathophysiology of haemostasis and thrombosis 2005;34 (Suppl. 1):1 [PubMed]
• Dörffler-Melly J., Koopman M. M. W., Prins M. H., Büller H. R. Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment Cochrane database of systematic reviews (Online) 2005;2005 (1):CD002071 [PubMed]
• Klerk C. P. W. Cancer, coagulation and thrombotics 2005. 232p. ISBN 9789051709872. [UvA Dissertations Online] University of Amsterdam. (Supervisors: van Noorden C. J. F., Büller H. R.; Co-supervisors: Richel D. J., Smorenburg S. M.)
• Willigendael Edith M., Teijink Joep A. W., Bartelink Marie-Louise, Langenberg Machteld, Welten Rob J. Th J., Büller Harry R., Prins Martin H. Combined training of GPs and practice-assistants on peripheral arterial disease: positive effects after six months Family practice 2005;22 (5):520-522 [PubMed]
• Ettema Harmen B., Hoppener Marnix R., Henny Christiaan P., Büller Harry R., Verheyen Cees C. P. M. Compliance of Dutch orthopedic departments with national guidelines on thromboprophylaxis. A survey of Dutch orthopedic thromboprohylaxis Acta orthopaedica 2005;76 (1):99-103 [PubMed]
• Di Nisio M., Sohne M., Kamphuisen P. W., Büller H. R. D-dimer test in cancer patients with suspected acute pulmonary embolism Journal of thrombosis and haemostasis 2005;3 (6):1239-1242 [PubMed]
• Di Nisio M., Otten H. M., Piccioli A., Lensing A. W. A., Prandoni P., Büller H. R., Prins M. H. Decision analysis for cancer screening in idiopathic venous thromboembolism Journal of thrombosis and haemostasis 2005;3 (11):2391-2396 [PubMed]
• Söhne Maaike, Kamphuisen Pieter W., van Mierlo Patricia J. W. B., Büller Harry R. Diagnostic strategy using a modified clinical decision rule and D-dimer test to rule out pulmonary embolism in elderly in- and outpatients Thrombosis and haemostasis 2005;94 (1):206-210 [PubMed]
• van Strijen M. J. L., ten Wolde M., Pattynama P. M. T., Postmus P. E., Buller H. R., Kieft G. J., Banga J. D., Huisman M. V. Diagnostiek bij longembolie; de beste strategieën volgens de resultaten van een grote Nederlandse multicenterstudie Nederlands tijdschrift voor geneeskunde 2005;149 (21):1190
• van Strijen M. J. L., ten Wolde M., Pattynama P. M. T., Postmus P. E., Büller H. R., Kieft G. J., Banga J. D., Huisman M. V. Diagnostiek bij longembolie; de beste strategieën volgens de resultaten van een grote Nederlandse multicenterstudie Nederlands tijdschrift voor geneeskunde 2005;149 (11):568-576 [PubMed]
• Di Nisio Marcello, Middeldorp Saskia, Büller Harry R. Direct thrombin inhibitors New England journal of medicine 2005;353 (10):1028-1040 [PubMed]
• Di Nisio Marcello, Buller Harry R., Porreca Ettore Do low-molecular-weight heparins improve the survival of cancer patients? Nature clinical practice. Oncology 2005;2 (12):612-613 [PubMed]
• Di Nisio Marcello, Bijsterveld Nick R., Meijers Joost C. M., Levi Marcel, Büller Harry R., Peters Ron J. G. Effects of clopidogrel on the rebound hypercoagulable state after heparin discontinuation in patients with acute coronary syndromes Journal of the American College of Cardiology 2005;46 (8):1582-1583 [PubMed]
• Di Nisio M., Nisio M. D., ten Wolde M., Meijers J. C., Buller H. R. Effects of high plasma lipoprotein (a) levels on tissue factor pathway inhibitor and the protein C pathway Journal of thrombosis and haemostasis 2005;3 (9):2123-2125 [PubMed]
• Squizzato Alessandro, Gerdes Victor E. A., Büller Harry R. Effects of human cytomegalovirus infection on the coagulation system Thrombosis and haemostasis 2005;93 (3):403-410 [PubMed]
• Levi Marcel, Peters Marjolein, Büller Harry R. Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A systematic review Critical care medicine 2005;33 (4):883-890 [PubMed]
• Bank I., Libourel E. J., Middeldorp S., Hamulyák K., van Pampus E. C. M., Koopman M. M. W., Prins M. H., van der Meer J., Büller H. R. Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis Journal of thrombosis and haemostasis 2005;3 (1):79-84 [PubMed]
• Büller Harry General discussion Pathophysiology of haemostasis and thrombosis 2005;34 (Suppl. 1):31-34 [PubMed]
• Jansen Angelique C. M., van Aalst-Cohen Emily S., Hutten Barbara A., Büller Harry R., Kastelein John J. P., Prins Martin H. Guidelines were developed for data collection from medical records for use in retrospective analyses Journal of clinical epidemiology 2005;58 (3):269-274 [PubMed]
• Gerdes V. E. A., Büller H. R. Hemostase en trombosein: W. D. Reitsma, J. W. F. Elte, D. Overbosch, editors. Differentiële diagnostiek in de interne geneeskunde. S.l.: Bohn Stafleu Van Loghum; 2005. p. 313-326
• Nieuwdorp Max, Stroes Erik S. G., Meijers Joost C. M., Büller Harry Hypercoagulability in the metabolic syndrome Current opinion in pharmacology 2005;5 (2):155-159 [PubMed]
• Segers A. E. M., Prins M. H., Lensing A. W. A., Buller H. R. Is contrast venography a valid surrogate outcome measure in venous thromboembolism prevention studies? Journal of thrombosis and haemostasis 2005;3 (5):1099-1102 [PubMed]
• de Booys M., Levi M. [=Marcel M.], Peters R. [=Ron J. G.], Büller H. Machtstrijd om vergoeding clopidogrel. Ingegraven posities ondermijnen patiëntenbelang Medisch contact 2005;60 (42):1684-ev
• Büller H. R., Vanderschueren S. Mini-symposium: What's new in venous thromboembolism? European journal of internal medicine 2005;16 (4):229
• Hoppener Marnix R., Büller Harry R. New anticoagulants and thromboprophylaxis British journal of surgery 2005;92 (3):259-261 [PubMed]
• Di Nisio Marcello, Niers Tatjana M., Reitsma Pieter H., Buller Harry R. Plasma cytokine and P-selectin levels in advanced malignancy - Prognostic value and impact of low-molecular weight heparin administration Cancer 2005;104 (10):2275-2281 [PubMed]
• Gibson Nadine S., Sohne Maaike, Buller Harry R. Prognostic value of echocardiography and spiral computed tomography in patients with pulmonary embolism Current opinion in pulmonary medicine 2005;11 (5):380-384 [PubMed]
• Libourel Eduard J., Bank Ivan, Veeger Nic J. G. M., Hamulyàk Karly, Middeldorp Saskia, Prins Martin H., Büller Harry R., van der Meer Jan Protein S type III deficiency is no risk factor for venous and arterial thromboembolism in 168 thrombophilic families: a retrospective study Blood coagulation & fibrinolysis 2005;16 (2):135-140 [PubMed]
• de Pont Anne-Cornélie J. M., Bakhtiari Kamran, Hutten Barbara A., de Jonge Evert, Vroom Margreeth B., Meijers Joost C. M., Büller Harry R., Levi Marcel Recombinant human activated protein C resets thrombin generation in patients with severe sepsis - a case control study Critical care (London, England) 2005;9 (5):R490-R497 [PubMed]
• Vink Roel, Rienstra Michiel, van Dongen Carlo J. J., Levi Marcel, Büller Harry R., Crijns Harry J., van Gelder Isabelle C. Risk of thromboembolism and bleeding after general surgery in patients with atrial fibrillation American journal of cardiology 2005;96 (6):822-824 [PubMed]
• Willigendael Edith M., Teijink Joep A. W., Bartelink Marie-Louise, Peters Ron J. G., Büller Harry R., Prins Martin H. Smoking and the patency of lower extremity bypass grafts: A meta-analysis Journal of vascular surgery 2005;42 (1):67-74 [PubMed]
• Hoppener M. R., Ettema H. B., Henny C. P., Verheyen C. C. P. M., Büller H. B. Symptomatic deep vein thrombosis and immobilization after day-care arthroscopy of the knee Journal of thrombosis and haemostasis 2005;3 (1):185-187 [PubMed]
• Söhne M. The diagnosis and perognosis of pulmonary embolism 2005. 183p. ISBN 9789090198026. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Büller H. R.; Co-supervisor: Gerdes V. E. A.)
• Klerk Clara P. W., Smorenburg Susanne M., Otten Hans-Martin, Lensing Anthonie W. A., Prins Martin H., Piovella Franco, Prandoni Paolo, Bos Monique M. E. M., Richel Dick J., van Tienhoven Geertjan, Büller Harry R. The effect of low molecular weight heparin on survival in patients with advanced malignancy Journal of clinical oncology 2005;23 (10):2130-2135 [PubMed]
• Douketis J. D., Leeuwenkamp O., Grobara P., Johnston M., Söhne M., ten Wolde M., Büller H. The incidence and prognostic significance of elevated cardiac troponins in patients with submassive pulmonary embolism Journal of thrombosis and haemostasis 2005;3 (3):508-513 [PubMed]
• Di Nisio M., Klerk C. P. W., Meijers J. C. M., Büller H. R. The prognostic value of the D-dimer test in cancer patients treated with and without low-molecular-weight heparin Journal of thrombosis and haemostasis 2005;3 (7):1531-1533 [PubMed]
• Tormene D. Thrombophilia and thrombosis in adults and children 2005. 160p. ISBN 9788887264920. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Büller H. R., Prandoni P.; Co-supervisors: Lensing A. W. A., Simioni P.)
• Squizzato A., Gerdes V. E. A., Brandjes D. P. M., Büller H. R., Stam J. Thyroid diseases and cerebrovascular disease Stroke; a journal of cerebral circulation 2005;36 (10):2302-2310 [PubMed]
• Wichers Iris M., Di Nisio Marcello, Büller Harry R., Middeldorp Saskia Treatment of superficial vein thrombosis to prevent deep vein thrombosis and pulmonary embolism: a systematic review Haematologica 2005;90 (5):672-677 [PubMed]
• Buller H. R., Sohne M., Middeldorp S. Treatment of venous thromboembolism Journal of thrombosis and haemostasis 2005;3 (8):1554-1560 [PubMed]
• Hoppener M. R. Venous thrombosis; etiology, diagnosis and prophylaxis in surgery 2005. 131p. ISBN 9789090198064. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Büller H. R.; Co-supervisors: Henny C. P., Kraaijenhagen R. A.)

2004

• van Dongen C. J. J. An evidence based approach to optimizing anticoagulant strategies 2004. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Bossuyt P. M. M., Prins M. H.; Co-supervisors: Büller H. R., Hutten B. A.)
• Büller H. R., Cohen A. T., Lensing A. W. A., Monreal M., Prins M. H., Schulman S., Lassen M. R., van Amsterdam R. G. M. A novel long-acting synthetic factor Xa inhibitor (SanOrg34006) to replace warfarin for secondary prevention in dep vein thrombosis. A phase II evaluation Journal of thrombosis and haemostasis 2004;2 (1):47-53
• Klerk C. P. W., Smorenburg S. M., Büller H. R. Antimalignant properties of antithrombotic agentsin: G. Lugassy, A. Falanga, A. K. Kakkar, F. R. Rickles, editors. Thrombosis and cancer. London: Dunitz; 2004. p. 207-222, ISBN 9781841842875
• Di Nisio Marcello, Squizzato Alessandro, Klerk Clara P. W., Richel Dick J., Büller Harry R. Antithrombotic therapy and cancer Current opinion in hematology 2004;11 (3):187-191 [PubMed]
• Büller Harry R., Agnelli Giancarlo, Hull Russel D., Hyers Thomas M., Prins Martin H., Raskob Gary E. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 2004;126 (3 Suppl):401S-428S [PubMed]
• Gerdes V. E. A. Atherosclerosis; aspects of a multicultural disease 2004. 97p. ISBN 9789051707946. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Büller H. R., ten Cate H.; Co-supervisor: Brandjes D. P. M.)
• Hoppener M. R., Kraaijenhagen R. A., Hutten B. A., Büller H. R., Peters R. J. G., Levi M. [=Marcel M.] Beta-receptor blockade decreases elevated plasma levels of factor VIII:C in patients with deep vein thrombosis Journal of thrombosis and haemostasis 2004;2 (8):1316-1320 [PubMed]
• Levi Marcel, van der Poll Tom, Büller Harry R. Bidirectional relation between inflammation and coagulation Circulation 2004;109 (22):2698-2704 [PubMed]
• Söhne Maaike, ten Wolde Marije, Büller Harry R. Biomarkers in pulmonary embolism Current opinion in cardiology 2004;19 (6):558-562 [PubMed]
• Wiegman Albert, Hutten Barbara A., de Groot Eric, Rodenburg Jessica, Bakker Henk D., Büller Harry R., Sijbrands Eric J. G., Kastelein John J. P. Efficacy and safety of statin therapy in children with familial hypercholesterolemia - A randomized controlled trial JAMA 2004;292 (3):331-337 [PubMed]
• Melis Floortje, Vandenbrouke Jan P., Büller Harry R., Colly Louisa P., Bloemenkamp Kitty W. M. Estimates of risk of venous thrombosis during pregnancy and puerperium are not influenced by diagnostic suspicion and referral basis American journal of obstetrics and gynecology 2004;191 (3):825-829 [PubMed]
• Büller Harry R., Davidson Bruce L., Decousus Hervé, Gallus Alexander, Gent Michael, Piovella Franco, Prins Martin H., Raskob Gary, Segers Annelise E. M., Cariou Roger, Leeuwenkamp Oscar, Lensing Anthonie W. A. Fondaparinux or Enoxaparin for the initial treatment of symptomatic deep venous thrombosis - A randomized trial Annals of internal medicine 2004;140 (11):867-873 [PubMed]
• Büller H. R. Has time come for screening for occult cancer in patients with venous thromboembolism? Journal of thrombosis and haemostasis 2004;2 (6):874-875 [PubMed]
• Libourel Eduard J., Baljé-Volkers Degrees Corine P., Hamulyàk Karly, Prins Martin H., Middeldorp Saskia, Büller Harry R., van der Meer Jan High factor VIII plasma levels as a risk factor for venous thrombosis: no evidence of inheritance from a family cohort study Haematologica 2004;89 (1):118-120 [PubMed]
• Gerdes V. E. A., Kremer Hovinga H. A., ten Cate H., Macgillavry M. R., Leijte A., Reitsma P. H., Brandjes D. P. M., Büller H. R. Homocysteine and markers of coagulation and endothelial cell activation Journal of thrombosis and haemostasis 2004;2 (3):445-451 [PubMed]
• Willigendael Edith M., Teijink Joep A. W., Bartelink Marie-Louise, Kuiken Barthold W., Boiten Jelis, Moll Frans L., Büller Harry R., Prins Martin H. Influence of smoking on incidence and prevalence of peripheral arterial disease Journal of vascular surgery 2004;40 (6):1158-1165 [PubMed]
• Moons A. H. M., Bijsterveld N. R., Koch K. T., Meijers J. C. M., Tijssen J. G. P., van der Poll T., Büller H. R., Peters R. J. G. Inhibition of the tissue factor pathway of coagulation by recombinant nematode anticoagulant protein c2 during elective coronary stent implantation Netherlands heart journal 2004;12 (2):48-54
• Baarslag Henk J., Koopman Maria M. W., Hutten Barbara A., Linthorst Homan May W., Büller Harry R., Reekers Jim A., van Beek Edwin J. R. Long-term follow-up of patients with suspected deep vein thrombosis of the upper extremity: survival, risk factors and post-thrombotic syndrome European journal of internal medicine 2004;15 (8):503-507 [PubMed]
• Vink R. Management of antithrombotic therapy in venous and arterial thromboembolism 2004. 165p. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Levi M. M., Büller H. R.; Co-supervisor: van den Brink R. B. A.)
• van der Heijden J. F., Rekké B., Hutten B. A., van der Meer F. J. M., Remkes M. G. H., Vermeulen M., Büller H. R., Reitsma P. H. Non-fatal major bleeding during treatment with vitamin K antagonists: influence of soluble thrombomodulin and mutations in the propeptide of coagulation factor IX Journal of thrombosis and haemostasis 2004;2 (7):1104-1109 [PubMed]
• ten Wolde M., Hagen P. J., Macgillavry M. R., Pollen I. J., Mairuhu A. T. A., Koopman M. M. W., Prins M. H., Hoekstra O. S., Brandjes D. P. M., Postmus P. E., Büller H. R. Non-invasive diagnostic work-up of patients with clinically suspected pulmonary embolism; results of a management study Journal of thrombosis and haemostasis 2004;2 (7):1110-1117 [PubMed]
• Leclercq M. G. L., Kruip M. J. H. A., Mac Gillavry M. R., van Marwijk Kooy M., Büller H. R. Observer variability in the assessment of clinical probability in patients with suspected pulmonary embolism Journal of thrombosis and haemostasis 2004;2 (7):1204-1206 [PubMed]
• El Kheir Dalia, Büller Harry One-time comprehensive ultrasonography to diagnose deep venous thrombosis: is that the solution? Annals of internal medicine 2004;140 (12):1052-1053 [PubMed]
• Willigendael E. M., Teijink J. A. W., Bartelink M.-L., Boiten J., Moll F. L., Büller H. R., Prins M. H. Peripheral arterial disease: Public and patient awareness in the Netherlands European journal of vascular and endovascular surgery 2004;27 (6):622-628 [PubMed]
• Willigendael Edith M., Teijink Joep A. W., Bartelink Marie-Louise, Boiten Jelis, Büller Harry R., Prins Martin H. Peripheral arterial disease: the gap between common practice and the Dutch College of General Practitioners guideline European journal of general practice 2004;10 (3):106-107 [PubMed]
• ten Wolde Marije, Söhne Maaike, Quak Elske, Mac Gillavry Melvin R., Büller Harry R. Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism Archives of internal medicine 2004;164 (15):1685-1689 [PubMed]
• Bank Ivan, Libourel Eduard J., Middeldorp Saskia, van Pampus Elisabeth C. M., Koopman Maria M. W., Hamulyák Karly, Prins Martin H., van der Meer Jan, Büller Harry R. Prothrombin 20210A mutation - A mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study Archives of internal medicine 2004;164 (17):1932-1937 [PubMed]
• Bijsterveld Nick R., Vink Roel, van Aken Benien E., Fennema Hein, Peters Ron J. G., Meijers Joost C. M., Büller Harry R., Levi Marcel Recombinant factor VIIa reverses the anticoagulant effect of the long-acting pentasaccharide idraparinux in healthy volunteers British journal of haematology 2004;124 (5):653-658 [PubMed]
• de Pont A. C. J. M., Moons A. H. M., de Jonge E., Meijers J. C. M., Vlasuk G. P., Rote W. E., Büller H. R., van der Poll T., Levi M. [=Marcel M.] Recombinant nematode anticoagulant protein c2, an inhibitor of tissue factor/factor VIIa, attenuates coagulation and the interleukin-10 response in human endotoxemia Journal of thrombosis and haemostasis 2004;2 (1):65-70 [PubMed]
• van der Heijden J. F. Risk factors for bleeding during treatment with anti-thrombotics 2004. 160p. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Reitsma P. H., Vermeulen M.; Co-supervisor: Büller H. R.)
• Bank Ivan, Scavenius Michael P. R. B., Büller Harry R., Middeldorp Saskia Social aspects of genetic testing for factor V leiden mutation in healthy individuals and their importance for daily practice Thrombosis research 2004;113 (1):7-12 [PubMed]
• Gerdes V. E. A., Kremer Hovinga J. A., ten Cate H., Brandjes D. P. M., Büller H. R. Soluble thrombomodulin in patients with established atherosclerosis Journal of thrombosis and haemostasis 2004;2 (1):200-201 [PubMed]
• Middeldorp Saskia, van de Poel Marlène H., Bank Ivan, Hamulyák Karly, Libourel Eduard J., Koopman Maria M. W., Prins Martin H., van der Meer Jan, Büller Harry R. Unselected women with elevated levels of factor VIII:C or homocysteine are not at increased risk for obstetric complications Thrombosis and haemostasis 2004;92 (4):787-790 [PubMed]
• Büller H. R., Kastelein J. J. P., Stroes E. S. G. Vasculaire geneeskundeAlphen a/d Rijn: Van Zuiden; 2004.
• Büller H. R., Kastelein J. J. P., Stroes E. S. G. Vasculaire geneeskundeAlphen a/d Rijn: Van Zuiden; 2004.
• Klerk C. P. W., Otten J. M. M. B., Büller H. R. Zin van screenen op kanker bij veneuze thrombo-embolie Nederlands tijdschrift voor hematologie 2004 (1):3-7

2003

• Bank Ivan, Tick Lidwien W., Hutten Barbara A., Kramer Mark H. H., Middeldorp Saskia, Büller Harry R. Acquired and inherited thrombophilic factors and the risk for residual venous thrombosis Pathophysiology of haemostasis and thrombosis 2003;33 (4):192-196 [PubMed]
• Bank I. Aetiology and treatment of venous thromboembolism 2003. 196p. ISBN 9789009017110. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Büller H. R.; Co-supervisor: Middeldorp S.)
• Levi Marcel, Dörffler-Melly Janine, Reitsma Pieter, Buller Harry, Florquin Sandrine, van der Poll Tom, Carmeliet Peter Aggravation of endotoxin-induced disseminated intravascular coagulation and cytokine activation in heterozygous protein-C-deficient mice Blood 2003;101 (12):4823-4827 [PubMed]
• van Wissen S. Aggressive lipid lowering in patients with familial hypercholesterolaemia 2003. 150p. ISBN 9789051706901. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Kastelein J. J. P., Stalenhoef A. F. H.; Co-supervisor: Büller H. R.)
• Dörffler-Melly J., Koopman M. M., Adam D. J., Büller H. R., Prins M. H. Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery Cochrane database of systematic reviews (Online) 2003;2003 (3):CD000535 [PubMed]
• Dörffler-Melly J., Büller H. R., Koopman M. M., Prins M. H. Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery Cochrane database of systematic reviews (Online) 2003;2003 (4):CD000536 [PubMed]
• ten Wolde M., Tulevski I. I., Mulder J. W. M., Söhne M., Boomsma F., Mulder B. J. M., Büller H. R. Brain natriuretic peptide as a predictor of adverse outcome in patients with pulmonary embolism Circulation 2003;107 (16):2082-2084 [PubMed]
• Kraaijenhagen R. A., Wallis J., Koopman M. M. W., de Groot M. R., Piovella F., Prandoni P., Büller H. R. Can causes of false-normal D-dimer test [SimpliRED] results be identified? Thrombosis research 2003;111 (3):155-158 [PubMed]
• Tans Guido, Bouma Bonno N., Büller Harry R., Rosing Jan Changes of hemostatic variables during oral contraceptive use Seminars in vascular medicine 2003;3 (1):61-68 [PubMed]
• Gerdes Victor E. A., Verkooyen Roel P., Kwa Vincent I. H., de Groot Eric, van Gorp Eric C. M., ten Cate Hugo, Brandjes Dees P. M., Büller Harry R. Chlamydial LPS antibodies, intima-media thickness and ischemic events in patients with established atherosclerosis Atherosclerosis 2003;167 (1):65-71 [PubMed]
• Selten Jean-Paul, Büller Harry Clozapine and venous thromboembolism: further evidence Journal of clinical psychiatry 2003;64 (5):609 [PubMed]
• Harenberg Job, Riess Hanno, Büller Harry R., Brom Joachim, Weidinger Gottfried, Huisman Menno V. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin Haematologica 2003;88 (10):1157-1162 [PubMed]
• Bernardi E. Diagnostic and therapeutic management of venous and arterial diseases..l.: 2003. 206p. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Büller H. R., Prandoni P.; Co-supervisors: Lensing A. W. A., Prins M. H.)
• Kruip Marieke J. H. A., Leclercq Monique G. L., van der Heul Cees, Prins Martin H., Büller Harry R. Diagnostic strategies for excluding pulmonary embolism in clinical outcome studies - A systematic review Annals of internal medicine 2003;138 (12):941-951 [PubMed]
• Bank I., Mac Gillavry M. R., Brandjes D. P. M., Büller H. R. Does the location of deep venous thrombosis of the leg determine the risk of the post-thrombotic syndrome? Journal of thrombosis and haemostasis 2003;1 (9):2058-2059 [PubMed]
• Friederich Philip W., Henny Christiaan P., Messelink Embert J., Geerdink Mark G., Keller Tymen, Kurth Karl-Heinz, Büller Harry R., Levi Marcel Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial Lancet 2003;361 (9353):201-205 [PubMed]
• Büller Harry R. Factor Xa is a superior target to factor IIa for antithrombotic therapies Seminars in thrombosis and hemostasis 2003;29 (Suppl. 1):37 [PubMed]
• ten Wolde M., Koopman M. M. W., Büller H. R. Fibrinolytic therapy in venous thromboembolismin: F. W. A. Verheugt, editors. Fibrinolytic therapy in clinical practice. London: Martin Dunitz; 2003. p. 131-149, ISBN 9781841840819
• Bijsterveld N. R. Heparin derivatives in acute coronary syndromes 2003. 146p. ISBN 9789051706963. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Büller H. R., Levi M. M.; Co-supervisor: Peters R. J. G.)
• Bank I., Libourel E. J., Middeldorp S., van der Meer J., Büller H. R. High rate of skin complications due to low-molecular-weight heparins in pregnant women Journal of thrombosis and haemostasis 2003;1 (4):859-861 [PubMed]
• Vink R., Kraaijenhagen R. A., Levi M. [=Marcel M.], Büller H. R. Individualized duration of oral anticoagulant therapy for deep vein thrombosis based on a decision model Journal of thrombosis and haemostasis 2003;1 (12):2523-2530 [PubMed]
• Rosendaal F. R., Büller H. R., Kesteven P., Toff W. D. Long haul flights and deep vein thrombosis: Who is at risk? British journal of haematology 2003;120 (2):367 [PubMed]
• Buller H. R., Prins M. H. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism - The editorialists reply New England journal of medicine 2003;349 (22):2167
• van Dongen Carlo J. J., Prins Martin H., Büller Harry R. Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism New England journal of medicine 2003;349 (4):398-400; author reply 398-400 [PubMed]
• ten Wolde M. Management of venous thromboembolism. Etiology, diagnosis, prognosis and treatment 2003. 148p. ISBN 9789090167169. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Büller H. R.; Co-supervisor: Koopman M. M. W.)
• Levi M. [=Marcel M.], Peters R. J. G., Piek J. J., Büller H. R. Nieuwe anticoagulantia Nederlands tijdschrift voor geneeskunde 2003;147 (19):909-915 [PubMed]
• Locadia Mirjam, Sprangers Mirjam A. G., de Haes Hanneke C. J. M., Büller Harry R., Prins Martin H. Quality of life and the duration of treatment with vitamin K antagonists in patients with deep venous thrombosis Thrombosis and haemostasis 2003;90 (1):101-107 [PubMed]
• Moons Arno H. M., Peters Ron J. G., Bijsterveld Nick R., Piek Jan J., Prins Martin H., Vlasuk George P., Rote William E., Büller Harry R. Recombinant nematode anticoagulant protein c2, an inhibitor of the tissue factor/factor VIIa complex, in patients undergoing elective coronary angioplasty Journal of the American College of Cardiology 2003;41 (12):2147-2153 [PubMed]
• van Dongen Carlo J., Vink Roel, Hutten Barbara A., Buller Harry R., Prins Martin H. Recurrent thromboembolism after treatment with vitamin k antagonists Archives of internal medicine 2003;163 (22):2793 [PubMed]
• Middeldorp S., Büller H. R., Prins M. H. Risk for venous thromboembolism in carriers of the factor V Leiden mutation - In response Annals of internal medicine 2003;138 (1):76-77
• Leclercq Monique G. L., Lutisan Johan G., van Marwijk Kooy Marinus, Kuipers Bart F., Oostdijk Ad H. J., van der Leur Jef J. C. M., Büller Harry R. Ruling out clinically suspected pulmonary embolism by assessment of clinical probability and D-dimer levels: a management study Thrombosis and haemostasis 2003;89 (1):97-103 [PubMed]
• Kamphuisen P. W., ten Wolde M., Jacobs E. M. G., Ullmann E. F., Büller H. R. Screening of high factor VIII levels is not recommended in patients with recently diagnosed pulmonary embolism Journal of thrombosis and haemostasis 2003;1 (10):2239-2240 [PubMed]
• Büller Harry R., Prins Martin H. Secondary prophylaxis with warfarin for venous thromboembolism New England journal of medicine 2003;349 (7):702-704 [PubMed]
• Koopman M. M. W., Büller H. R. Short- and long-acting synthetic pentasaccharides Journal of internal medicine 2003;254 (4):335-342 [PubMed]
• Büller H. R., Davidson B. L., Decousus H., Gallus A., Gent M., Piovella F., Prins M. H., Raskob G., van den Berg-Segers A. E. M., Cariou R., Leeuwenkamp O., Lensing A. W. A. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism New England journal of medicine 2003;349 (18):1695-1702 [PubMed]
• Moons A. H. M. The extrinsic coagulation pathway in coronary artery disease and endotoxemia 2003. 163p. ISBN 9789090169071. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Büller H. R.; Co-supervisor: Peters R. J. G.)
• Bijsterveld Nick R., Moons Arno H., Meijers Joost C. M., Levi Marcel, Büller Harry R., Peters Ron J. G. The impact on coagulation of an intravenous loading dose in addition to a subcutaneous regimen of low-molecular-weight heparin in the initial treatment of acute coronary syndromes Journal of the American College of Cardiology 2003;42 (3):424-427 [PubMed]
• van Dongen Carlo J. J., Vink Roel, Hutten Barbara A., Büller Harry R., Prins Martin H. The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event - A meta-analysis Archives of internal medicine 2003;163 (11):1285-1293 [PubMed]
• Vink Roel, Kraaijenhagen Roderik A., Hutten Barbara A., van den Brink Renee B. A., de Mol Bas A., Büller Harry R., Levi Marcel The optimal intensity of vitamin K antagonists in patients with mechanical heart valves - A meta-analysis Journal of the American College of Cardiology 2003;42 (12):2042-2048 [PubMed]
• Haverkamp D., Hutten B. A., Büller H. R., Gallus A. S., Lensing A. W. A., Prins M. H. The use of specific antidotes as a response to bleeding complications during anticoagulant therapy for venous thromboembolism Journal of thrombosis and haemostasis 2003;1 (1):69-73 [PubMed]
• Ettema H. B., Hoppener M. R., Büller H. R., Henny C. P., Verheyen C. C. P. M. [Thrombosis prophylaxis in orthopaedic surgery: considerations and uncertainties] Nederlands tijdschrift voor geneeskunde 2003;147 (38):1856-1860
• Klerk Clara P. W., Smorenburg Susanne M., Büller Harry R. Thrombosis prophylaxis in patient populations with a central venous catheter - A systematic review Archives of internal medicine 2003;163 (16):1913-1921 [PubMed]
• ten Wolde Marije, Kraaijenhagen Roderik A., Schiereck Jan, Hagen Petronella J., Mathijssen Joost J., Mac Gillavry Melvin R., Koopman Maria M. W., Büller Harry R. Travel and the risk of symptomatic venous thromboembolism Thrombosis and haemostasis 2003;89 (3):499-505 [PubMed]
• de Pont Anne Cornélie J. M., Bouman Catherine S. C., de Jonge Evert, Vroom Margreeth B., Büller Harry R., Levi Marcel Treatment with recombinant human activated protein C obviates additional anticoagulation during continuous venovenous hemofiltration in patients with severe sepsis Intensive care medicine 2003;29 (7):1205 [PubMed]
• Ettema H. B., Hoppener M. R., Büller H. R., Henny Ch P., Verheyen C. C. Tromboseprofylaxe in de orthopedische chirurgie: inzichten en onzekerheden Nederlands tijdschrift voor geneeskunde 2003;147 (38):1842-1847 [PubMed]
• Prins Martin H., Büller Harry R. When do we need what evidence? Journal of clinical epidemiology 2003;56 (8):709-710 [PubMed]

2002

• Bijsterveld Nick R., Moons Arno H., Boekholdt S. Matthijs, van Aken Benien E., Fennema Hein, Peters Ron J. G., Meijers Joost C. M., Büller Harry R., Levi Marcel Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers Circulation 2002;106 (20):2550-2554 [PubMed]
• van Wijk F. H., Wolf H., Piek J. M. J., Büller H. R. Administration of low molecular weight heparin within two hours before caesarean section increases the risk of wound haematoma BJOG 2002;109 (8):955-957 [PubMed]
• Middeldorp Saskia, van der Meer Jan, Hamulyák Karly, Büller Harry R. A rebuttal: Counseling pregnant women with factor V Leiden homozygosity: Use absolute instead of relative risks Thrombosis and haemostasis 2002;87 (2):360-361 [PubMed]
• Gerdes Victor E. A., ten Cate Hugo, de Groot Eric, Kwa Vincent I. H., Prins Martin H., Reitsma Pieter H., Büller Harry R., Brandjes Dees P. M. Arterial wall thickness and the risk of recurrent ischemic events in carriers of the prothrombin G20210A mutation with clinical manifestations of atherosclerosis Atherosclerosis 2002;163 (1):135-140 [PubMed]
• Turpie Alexander G. G., Büller Harry R. Benefit of selective factor inhibition Seminars in thrombosis and hemostasis 2002;28 (Suppl. 2):49-50 [PubMed]
• Dörffler-Melly Janine, de Jonge Evert, Pont Anne-Corneliede, Meijers Joost, Vroom Margreet B., Büller Harry R., Levi Marcel Bioavailability of subcutaneous low-molecular-weight heparin to patients on vasopressors Lancet 2002;359 (9309):849-850 [PubMed]
• Libourel Eduard J., Bank Ivan, Meinardi Johan R., Baljé -Volkers Corinne P., Hamulyak Karly, Middeldorp Saskia, Koopman Maria M. W., van Pampus Elisabeth C. M., Prins Martin H., Büller Harry R., van der Meer Jan Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism Haematologica 2002;87 (10):1068-1073 [PubMed]
• Büller H. R. Diagnostiek bij aanwijzingen voor longembolie: nog niet optimaal Nederlands tijdschrift voor geneeskunde 2002;146 (44):2073-2074 [PubMed]
• Weitz Jeffrey I., Buller Harry R. Direct thrombin inhibitors in acute coronary syndromes - Present and future Circulation 2002;105 (8):1004-1011 [PubMed]
• de Monyé Wouter, Sanson Bernd-Jan, Mac Gillavry Melvin R., Pattynama Peter M. T., Büller Harry R., van den Berg-Huysmans Annette A., Huisman Menno V. Embolus location affects the sensitivity of a rapid quantitative D-dimer assay in the diagnosis of pulmonary embolism American journal of respiratory and critical care medicine 2002;165 (3):345-348 [PubMed]
• de Jongh S. Familial hypercholesterolemia in childhood 2002. 159p. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Kastelein J. J. P., Heymans H. S. A.; Co-supervisors: Bakker H. D., Büller H. R.)
• Umans-Eckenhausen M. A. W. Genetic insights, clinical efficacy and practical implications of genetic screening for familial hypercholesterolemia 2002. 165p. ISBN 9789051706574. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Büller H. R., Kastelein J. J. P.; Co-supervisor: Defesche J. C.)
• de Sauvage Nolting P. R. W. Genetics and therapy of familial hypercholesterolemia 2002. 173p. ISBN 9789064640858. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Kastelein J. J. P., Büller H. R.)
• Middeldorp S., Büller H. R., Vandenbroucke J. P., Helmerhorst F. M., Rosendaal F. R. Nadelige cardiovasculaire effecten van postmenopauzale hormonale suppletie Nederlands tijdschrift voor geneeskunde 2002;146 (45):2123-2127 [PubMed]
• Turpie A. G. G., Büller H. R. New standards in antithrombotic therapy: Concepts, clinical evidence, and applications: iIntroduction Seminars in thrombosis and hemostasis 2002;28 (Suppl. 2):1-2
• Strebel Niklaus, Prins Martin, Agnelli Giancarlo, Büller Harry R. Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery? Archives of internal medicine 2002;162 (13):1451-1456 [PubMed]
• Bijsterveld Nick R., Moons Arno H., Meijers Joost C. M., Tijssen Jan G. P., Büller Harry R., Levi Marcel, Peters Ron J. G. Rebound thrombin generation after heparin therapy in unstable angina - A Randomized comparison between unfractionated and low-molecular-weight heparin Journal of the American College of Cardiology 2002;39 (5):811-817 [PubMed]
• Moons Arno H. M., Peters Ron J. G., Cate Hugo Ten, Bauer Kenneth A., Vlasuk George P., Büller Harry R., Levi Marcel Recombinant nematode anticoagulant protein c2, a novel inhibitor of tissue factor-factor VIIa activity, abrogates endotoxin-induced coagulation in chimpanzees Thrombosis and haemostasis 2002;88 (4):627-631 [PubMed]
• Otten J. M. M. B., Smorenburg S. M., de Meij M. A., van der Schoor C. A., Brandjes D. P. M., Büller H. R. Screening for cancer in patients with idiopathic venous thromboembolism: The clinical practice Pathophysiology of haemostasis and thrombosis 2002;32 (2):76-79 [PubMed]
• Monreal Manuel, Büller Harry, Lensing Anthonie W. A., Bonet Montserrat, Roncales Javier, Muchart Jordi, Fraile Manuel Should patients with deep vein thrombosis alone be treated as those with concomitant asymptomatic pulmonary embolism? A prospective study Thrombosis and haemostasis 2002;88 (6):938-942 [PubMed]
• Kraaijenhagen Roderik A., Piovella Franco, Bernardi Enrico, Verlato Fabio, Beckers Erik A. M., Koopman Maria M. W., Barone Marisa, Camporese Giuseppe, Potter van Loon Bert Jan, Prins Martin H., Prandoni Paolo, Büller Harry R. Simplification of the diagnostic management of suspected deep vein thrombosis Archives of internal medicine 2002;162 (8):907-911 [PubMed]
• Büller H. R. Terecht, te laat, gevaarlijk: redactioneel Nieuwsbrief vasculaire geneeskunde 2002;1 (voorjaar):3
• ten Wolde Marije, Kraaijenhagen Roderik A., Prins Martin H., Büller Harry R. The clinical usefulness of D-dimer testing in cancer patients with suspected deep venous thrombosis Archives of internal medicine 2002;162 (16):1880-1884 [PubMed]
• Meinardi Johan R., Middeldorp Saskia, de Kam Pieter J., Koopman Maria M. W., van Pampus Elisabeth C. M., Hamulyák Karly, Prins Martin H., Büller Harry R., van der Meer Jan The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant thrombophilic disorders British journal of haematology 2002;116 (3):625-631 [PubMed]
• de Monyé Wouter, Sanson Bernd-Jan, Büller Harry R., Pattynama Peter M. T., Huisman Menno V. The performance of two rapid quantitative D-dimer assays in 287 patients with clinically suspected pulmonary embolism Thrombosis research 2002;107 (6):283-286 [PubMed]
• van Ommen C. Heleen, Ottenkamp Jaap, Lam Jan, Brennickmeier Machteld, Heijmans Hugo S. A., Büller Harry R., Peters Marjolein The risk of postthrombotic syndrome in children with congenital heart disease Journal of pediatrics 2002;141 (4):582-586 [PubMed]
• Trip M. D. The spectrum of premature atherosclerosis: from single gene to complex genetic disorder 2002. 248p. ISBN 9789090164601. [UvA Dissertations Online] University of Amsterdam. (Supervisor: Kastelein J. J. P.; Co-supervisors: Büller H. R., Reitsma P. H.)
• Otten J. M. M. B. Thrombosis and cancer. A two way association 2002. 135p. ISBN 9789051706499. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Büller H. R., Prins M. H.; Co-supervisors: van Noorden C. J. F., Richel D. J.)
• Büller Harry R. Treatment of symptomatic venous thromboembolism: Improving outcomes Seminars in thrombosis and hemostasis 2002;28 (Suppl. 2):41-48 [PubMed]
• van der Heijden J. F., Remkes M. G. H., Büller H. R., Vermeulen M. Treatment with vitamin K antagonists: Frequency of indications and appropriateness of continuation Pathophysiology of haemostasis and thrombosis 2002;32 (3):111-114 [PubMed]
• Kruip Marieke J. H. A., Slob Marjan J., Schijen Joost H. E. M., van der Heul Cees, Büller Harry R. Use of a clinical decision rule in combination with D-dimer concentration in diagnostic workup of patients with suspected pulmonary embolism - A prospective management study Archives of internal medicine 2002;162 (14):1631-1635 [PubMed]
• Büller H. R., Kastelein J. J. P., Stroes E. S. G. Vasculaire geneeskundeAlphen a/d Rijn: Van Zuiden Communications; 2002. ISBN 9789076906348
• van Ommen C. H. Venous thromboembolic disease in childhood epidemiology, risk factors and outcome 2002. 143p. ISBN 9789090156583. [UvA Dissertations Online] University of Amsterdam. (Supervisors: Heymans H. S. A., Büller H. R., Peters M.)
• van der Heijden J. F., Hutten B. A., Büller H. R., Prins M. H. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism Cochrane database of systematic reviews (Online) 2002;2002 (1):CD002001 [PubMed]

2001

• Friederich P. W., Levi M. [=Marcel M.], Bauer K. A., Vlasuk G. P., Rote W. E., Breederveld D., Keller T., Spataro M., Barzegar S., Büller H. R. Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects Circulation 2001;103 (21):2555-2559 [PubMed]
• Fisher L. D., Gent M., Büller H. R. Active-control trials: how would a new agent compare with placebo? A method illustrated with clopidogrel, aspirin, and placebo American heart journal 2001;141 (1):26-32 [PubMed]
• Hartmann I. J., Prins M. H., Büller H. R., Banga J. D. Acute pulmonary embolism: impact of selection bias in prospective diagnostic studies. ANTELOPE Study Group. Advances in New Technologies Evaluating the Localization of Pulmonary Embolism Thrombosis and haemostasis 2001;85 (4):604-608 [PubMed]
• Middeldorp S., Meinardi J. R., Koopman M. M., van Pampus E. C., Hamulyák K., van der Meer J., Prins M. H., Büller H. R. A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism Annals of internal medicine 2001;135 (5):322-327 [PubMed]
• de Jonge E., Levi M. [=Marcel M.], Büller H. R., Berends F., Kesecioglu J. Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethyl starch (HES 200/0.5/6) in healthy human subjects Intensive care medicine 2001;27 (11):1825-1829 [PubMed]
• Mac Gillavry M. R., Lijmer J. G., Sanson B. J., Büller H. R., Brandjes D. P. Diagnostic accuracy of triage tests to exclude pulmonary embolism Thrombosis and haemostasis 2001;85 (6):995-998 [PubMed]
• Vandenbroucke J. P., Bloemenkamp K. W., Helmerhorst F. M., Büller H. R., Rosendaal F. R. Diagnostic suspicion and referral bias in studies of venous thromboembolism and oral contraceptive use European journal of contraception & reproductive health care 2001;6 (1):56-57 [PubMed]
• Lee A., Agnelli G., Büller H., Ginsberg J., Heit J., Rote W., Vlasuk G., Costantini L., Julian J., Comp P., van der Meer J., Piovella F., Raskob G., Gent M. Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement Circulation 2001;104 (1):74-78 [PubMed]
• Middeldorp S., Rosing J., Bouma B. N., Büller H. R. Effecten van orale anticonceptiva van de tweede en de derde generatie op de hemostase Nederlands tijdschrift voor geneeskunde 2001;145 (6):252-256 [PubMed]
• Middeldorp S., Prins M. H., Büller H. R. Geen indicatie voor trombofilieonderzoek bij patiënten met idiopathische veneuze trombo-embolie en hun familieleden Nederlands tijdschrift voor geneeskunde 2001;145 (22):1047-1051 [PubMed]
• Boekholdt S. M., Bijsterveld N. R., Moons A. H. M., Levi M. [=Marcel M.], Büller H. R., Peters R. J. G. Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review Circulation 2001;104 (25):3063-3068 [PubMed]
• Tulevski I. I., Hirsch A., Sanson B. J., Romkes H., van der Wall E. E., van Veldhuisen D. J., Büller H. R., Mulder B. J. Increased brain natriuretic peptide as a marker for right ventricular dysfunction in acute pulmonary embolism Thrombosis and haemostasis 2001;86 (5):1193-1196 [PubMed]
• Wells P. S., Büller H. R. Outpatient treatment of patients with pulmonary embolism Seminars in vascular medicine 2001;1 (2):229-234 [PubMed]
• van Pampus M. G., Wolf H., Koopman M. M., van den Ende A., Buller H. R., Reitsma P. H. Prothrombin 20210 G: a mutation and Factor V Leiden mutation in women with a history of severe preeclampsia and (H)ELLP syndrome Hypertension in pregnancy 2001;20 (3):291-298 [PubMed]
• Meinardi J. R., Middeldorp S., de Kam P. J., Koopman M. M., van Pampus E. C., Hamulyák K., Prins M. H., Büller H. R., van der Meer J. Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect: a retrospective analysis Blood coagulation & fibrinolysis 2001;12 (8):713-720 [PubMed]
• de Graaff J. C., Ubbink D. T., Büller H. R., Jacobs M. J. The diagnosis of deep venous thrombosis using laser Doppler skin perfusion measurements Microvascular research 2001;61 (1):49-55 [PubMed]
• Smorenburg S. M., Vink R., Otten H. M., Swaneveld F., Büller H. R. The effects of vitamin K-antagonists on survival of patients with malignancy: a systematic analysis Thrombosis and haemostasis 2001;86 (6):1586-1587 [PubMed]
• Middeldorp S., Libourel E. J., Hamulyák K., van der Meer J., Büller H. R. The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden British journal of haematology 2001;113 (2):553-555 [PubMed]
• Mac Gillavry M. R., Büller H. R., Brandjes D. P. The usefulness of compression ultrasonography of the lower limbs in patients with a clinical suspicion of pulmonary embolism Thrombosis and haemostasis 2001;86 (2):726 [PubMed]
• van Ommen C. H., Heijboer H., Büller H. R., Hirasing R. A., Heijmans H. S., Peters M. Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands Journal of pediatrics 2001;139 (5):676-681 [PubMed]

2000

• de Groot M. R., Njo T. L., van Marwijk Kooy M., Büller H. R. Abrupt versus gradual withdrawal of vitamin K antagonist treatment in patients with venous thromboembolic disease: assessment of hypercoagulability and clinical outcome Clinical laboratory 2000;46 (11-12):575-581 [PubMed]
• Wallis J. W., Kruip M., de Jongh-Leuvenink J., Büller H. R. A comparative study of two rapid D-dimer tests for the exclusion of pulmonary embolism in symptomatic patients Thrombosis and haemostasis 2000;84 (5):925 [PubMed]
• Berghout A., Oudkerk M., Hicks S. G., Teng T. H., Pillay M., Büller H. R. Active implementation of a consensus strategy improves diagnosis and management in suspected pulmonary embolism QJM 2000;93 (6):335-340 [PubMed]
• Girolami B., Bernardi E., Prins M. H., ten Cate J. W., Prandoni P., Simioni P., Andreozzi G. M., Girolami A., Büller H. R. Antiplatelet therapy and other interventions after revascularisation procedures in patients with peripheral arterial disease: a meta-analysis European journal of vascular and endovascular surgery 2000;19 (4):370-380 [PubMed]
• Tans G., Curvers J., Middeldorp S., Thomassen M. C., Meijers J. C., Prins M. H., Bouma B. N., Büller H. R., Rosing J. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways Thrombosis and haemostasis 2000;84 (1):15-21 [PubMed]
• Büller H. R., van der Meer J., Oudkerk M. CBO-richtlijn 'Diepveneuze trombose en longembolie'; herziening van eerdere richtlijnen Nederlands tijdschrift voor geneeskunde 2000;144 (32):1531-1537 [PubMed]
• de Groot M. R., Oostdijk A. H., Engelage A. H., van Marwijk Kooy M., Büller H. R. Changes in perfusion scintigraphy in the first days of heparin therapy in patients with acute pulmonary embolism European journal of nuclear medicine 2000;27 (10):1481-1486 [PubMed]
• Mac Gillavry M. R., de Monyé W., Lijmer J. G., Nieuwenhuizen W., Büller H. R., Huisman M. V., Brandjes D. P. Clinical evaluation of a monoclonal antibody-based enzyme immunoassay for fibrin degradation products in patients with clinically suspected pulmonary embolism. ANTELOPE-Study Group Thrombosis and haemostasis 2000;83 (6):892-895 [PubMed]
• Sanson B. J., Lijmer J. G., Mac Gillavry M. R., Turkstra F., Prins M. H., Büller H. R. Comparison of a clinical probability estimate and two clinical models in patients with suspected pulmonary embolism. ANTELOPE-Study Group Thrombosis and haemostasis 2000;83 (2):199-203 [PubMed]
• Mac Gillavry M. R., Sanson B. J., Büller H. R., Brandjes D. P. Compression ultrasonography of the leg veins in patients with clinically suspected pulmonary embolism: is a more extensive assessment of compressibility useful? Thrombosis and haemostasis 2000;84 (6):973-976 [PubMed]
• Broekhuizen-de Gast H. S., Tiel-van Buul M. M., Ubbink M., van Eck-Smit B. L., Büller H. R., van Beek E. J. De waarde van de 'niet-diagnostische' longscan--verdere classificatie naar de kans op longembolie niet betrouwbaar Nederlands tijdschrift voor geneeskunde 2000;144 (32):1537-1542 [PubMed]
• Middeldorp S., Meijers J. C., van den Ende A. E., van Enk A., Bouma B. N., Tans G., Rosing J., Prins M. H., Büller H. R. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study Thrombosis and haemostasis 2000;84 (1):4-8 [PubMed]
• Harenberg J., Schmidt J. A., Koppenhagen K., Tolle A., Huisman M. V., Büller H. R. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators Thrombosis and haemostasis 2000;83 (5):652-656 [PubMed]
• van der Heijden J. F., Prins M. H., Büller H. R. For the initial treatment of venous thromboembolism: are all low-molecular-weight heparin compounds the same? Thrombosis research 2000;100 (2):V121-V130 [PubMed]
• Bank I., Büller H. R. Geeft direct postoperatief toegediende laagmoleculaire heparine voldoende tromboseprofylaxe? Nederlands tijdschrift voor geneeskunde 2000;144 (42):2031 [PubMed]
• Bank I., Middeldorp S., Büller H. R. Hereditary and acquired thrombophilia Seminars in respiratory and critical care medicine 2000;21 (6):483-491 [PubMed]
• Kraaijenhagen R. A., in't Anker P. S., Koopman M. M., Reitsma P. H., Prins M. H., van den Ende A., Büller H. R. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism Thrombosis and haemostasis 2000;83 (1):5-9 [PubMed]
• Middeldorp S., Büller H. R. How to decide on the optimal duration of anticoagulatn therapy in carriers of the factor V Leiden mutation Thrombosis and haemostasis 2000;84 (5):740-741 [PubMed]
• Hutten B. A., Prins M. H., Gent M., Ginsberg J., Tijssen J. G., Büller H. R. Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis Journal of clinical oncology 2000;18 (17):3078-3083 [PubMed]
• Meijers J. C., Middeldorp S., Tekelenburg W., van den Ende A. E., Tans G., Prins M. H., Rosing J., Büller H. R., Bouma B. N. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives Thrombosis and haemostasis 2000;84 (1):9-14 [PubMed]
• van der Heijden J. F., Prins M. H., Büller H. R. Low-molecular-weight heparins: are they interchangeable? Haemostasis 2000;30 (Suppl. 2):148-57; discussion 146-7 [PubMed]
• Bijsterveld N. R., Middeldorp S., Berends F., Büller H. R. Monitoring therapy with vitamin K antagonists in patients with lupus anticoagulant: effect on different tests for INR determination Journal of thrombosis and thrombolysis 2000;9 (3):263-269 [PubMed]
• Cromheecke M. E., Levi M. [=Marcel M.], Colly L. P., de Mol B. J., Prins M. H., Hutten B. A., Mak R., Keyzers K. C., Büller H. R. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison Lancet 2000;356 (9224):97-102 [PubMed]
• Ginsberg J. S., Turkstra F., Buller H. R., MacKinnon B., Magier D., Hirsh J. Postthrombotic syndrome after hip or knee arthroplasty: a cross-sectional study Archives of internal medicine 2000;160 (5):669-672 [PubMed]
• Friederich P. W., Keller T. T., Biemond B. J., Peters R. J., Hornberger W., Büller H. R., Levi M. [=Marcel M.] Successful attenuation of venous thrombus growth in rabbits after the administration of a novel oral thrombin inhibitor Thrombosis and haemostasis 2000;84 (5):858-864 [PubMed]
• van der Velde E. F., Kraaijenhagen R. A., van Weert H. C., Turkstra F., Büller H. R. Survey of the management of deep vein thrombosis in general practice in the Netherlands Netherlands journal of medicine 2000;57 (4):135-141 [PubMed]
• Friederich P. W., Geerdink M. G., Spataro M., Messelink E. J., Henny C. P., Büller H. R., Levi M. [=Marcel M.] The effect of the administration of recombinant activated factor VII (NovoSeven) on perioperative blood loss in patients undergoing transabdominal retropubic prostatectomy: the PROSE study Blood coagulation & fibrinolysis 2000;11 (Suppl. 1):S129-S132 [PubMed]
• van der Heijden J. F., Kraaijenhagen R. A., Büller H. R. The risk of recurrent venous thrombosis New England journal of medicine 2000;342 (3):214-215 [PubMed]
• Kraaijenhagen R. A., Haverkamp D., Koopman M. M., Prandoni P., Piovella F., Büller H. R. Travel and risk of venous thrombosis Lancet 2000;356 (9240):1492-1493 [PubMed]
• Mac Gillavry M. R., Sanson B. J., de Monyé W., Lijmer J. G., Huisman M. V., Büller H. R., Nieuwenhuizen W., Brandjes D. P. Use of a new monoclonal antibody-based enzyme immunoassay for soluble fibrin to exclude pulmonary embolism. ANTELOPE-Study Group Thrombosis and haemostasis 2000;84 (3):474-477 [PubMed]
• de Groot M. R., Turkstra F., van Marwijk Kooy M., Oostdijk A. H., van Beek E. J., Büller H. R. Value of chest X-ray combined with perfusion scan versus ventilation/perfusion scan in acute pulmonary embolism Thrombosis and haemostasis 2000;83 (3):412-415 [PubMed]
• van der Heijden J. F., Hutten B. A., Büller H. R., Prins M. H. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism Cochrane database of systematic reviews (Online) 2000;2000 (4):CD002001 [PubMed]

1999

• Girolami B., Bernardi E., Prins M. H., ten Cate J. W., Prandoni P., Hettiarachchi R., Marras E., Stefani P. M., Girolami A., Büller H. R. Antithrombotic drugs in the primary medical management of intermittent claudication: a meta-analysis Thrombosis and haemostasis 1999;81 (5):715-722 [PubMed]
• Kruip M. J., Slob M. J., Büller H. R., van der Heul C. A prospective clinical study on the feasibility and safety of a combined noninvasive/pulmonary angiography strategy in patients with suspected pulmonary embolism: an interim analysis Clinical and applied thrombosis/hemostasis 1999;5 (4):222-225 [PubMed]
• Hutten B. A., Prins M. H., Redekop W. K., Tijssen J. G., Heisterkamp S. H., Büller H. R. Comparison of three methods to assess therapeutic quality control of treatment with vitamin K antagonists Thrombosis and haemostasis 1999;82 (4):1260-1263 [PubMed]
• Lensing A. W., Prandoni P., Prins M. H., Büller H. R. Deep-vein thrombosis Lancet 1999;353 (9151):479-485 [PubMed]
• Wittekoek M. E., de Groot E., Prins M. H., Trip M. D., Büller H. R., Kastelein J. J. Differences in intima-media thickness in the carotid and femoral arteries in familial hypercholesterolemic heterozygotes with and without clinical manifestations of cardiovascular disease Atherosclerosis 1999;146 (2):271-279 [PubMed]
• Hettiarachchi R. J., Smorenburg S. M., Ginsberg J., Levine M., Prins M. H., Büller H. R. Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread Thrombosis and haemostasis 1999;82 (2):947-952 [PubMed]
• Mainardi J. R., Pelsma P. M., Koning H., van der Meer J., Middeldorp S., Büller H. R., Hamulyák K. Double-homozygosity for factor V Leiden and the prothrombin gene G20210A variant in a young patient with idiopathic venous thrombosis Blood 1999;94 (5):1828-1829 [PubMed]
• Levi M. [=Marcel M.], Hart W., Büller H. R. Fysische diagnostiek--het teken van Homans Nederlands tijdschrift voor geneeskunde 1999;143 (37):1861-1863 [PubMed]
• van Pampus M. G., Dekker G. A., Wolf H., Huijgens P. C., Koopman M. M., von Blomberg B. M., Büller H. R. High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia American journal of obstetrics and gynecology 1999;180 (5):1146-1150 [PubMed]
• Simioni P., Sanson B. J., Prandoni P., Tormene D., Friederich P. W., Girolami B., Gavasso S., Huisman M. V., Büller H. R., ten Cate J. Wouter, Girolami A., Prins M. H. Incidence of venous thromboembolism in families with inherited thrombophilia Thrombosis and haemostasis 1999;81 (2):198-202 [PubMed]
• Meinardi J. R., Middeldorp S., de Kam P. J., Koopman M. M., van Pampus E. C., Hamulyák K., Prins M. H., Büller H. R., van der Meer J. Increased risk for fetal loss in carriers of the factor V Leiden mutation Annals of internal medicine 1999;130 (9):736-739 [PubMed]
• Smorenburg S. M., Vink R., te Lintelo M., Tigchelaar W., Maas A., Büller H. R., van Noorden C. J. In vivo treatment of rats with unfractionated heparin (UFH) or low molecular weight heparin (LMWH) does not affect experimentally induced colon carcinoma metastasis Clinical & experimental metastasis 1999;17 (5):451-456 [PubMed]
• Turkstra F., Karemaker R., Kuijer P. M., Prins M. H., Büller H. R. Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different? Thrombosis and haemostasis 1999;81 (3):345-348 [PubMed]
• Sanson B. J., Büller H. Is there a role for thrombolytic therapy in venous thromboembolism? Haemostasis 1999;29 (Suppl. S1):81-83 [PubMed]
• ten Cate J. W., Büller H. R. Klinisch onderzoekers en farmaceutische industrie. Een relatie met voor- en nadelen Nederlands tijdschrift voor geneeskunde 1999;143 (30):1572-1576 [PubMed]
• van Pampus M. G., Koopman M. M., Wolf H., Büller H. R., Prins M. H., van den Ende A. Lipoprotein(a) concentrations in women with a history of severe preeclampsia--a case control study Thrombosis and haemostasis 1999;82 (1):10-13 [PubMed]
• Prins M. H., Hutten B. A., Koopman M. M., Büller H. R. Long-term treatment of venous thromboembolic disease Thrombosis and haemostasis 1999;82 (2):892-898 [PubMed]
• Rosing J., Middeldorp S., Curvers J., Christella M., Thomassen L. G., Nicolaes G. A., Meijers J. C., Bouma B. N., Büller H. R., Prins M. H., Tans G. Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study Lancet 1999;354 (9195):2036-2040 [PubMed]
• Bijsterveld N. R., Hettiarachchi R., Peters R. [=Ron J. G.], Prins M. H., Levi M. [=Marcel M.], Büller H. R. Low-molecular weight heparins in venous and arterial thrombotic disease Thrombosis and haemostasis 1999;82 (Suppl. 1):139-147 [PubMed]
• Levi M. [=Marcel M.], Middeldorp S., Büller H. R. Oral contraceptives and hormonal replacement therapy cause an imbalance in coagulation and fibrinolysis which may explain the increased risk of venous thromboembolism Cardiovascular research 1999;41 (1):21-24 [PubMed]
• Levi M. [=Marcel M.], Cromheecke M. E., de Jonge E., Prins M. H., de Mol B. J., Briët E., Büller H. R. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints Lancet 1999;354 (9194):1940-1947 [PubMed]
• Kuijer P. M., Hutten B. A., Prins M. H., Büller H. R. Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism Archives of internal medicine 1999;159 (5):457-460 [PubMed]
• Planès A., Samama M. M., Lensing A. W., Büller H. R., Barre J., Vochelle N., Beau B. Prevention of deep vein thrombosis after hip replacement--comparison between two low-molecular heparins, tinzaparin and enoxaparin Thrombosis and haemostasis 1999;81 (1):22-25 [PubMed]
• ten Cate J. W., Büller H. R. Randomised evaluation of treatment modalities in thromboembolic disorders Haematologica 1999;84 (Suppl. EHA-4):85-87 [PubMed]
• Anand S. S., Bates S., Ginsberg J. S., Levine M., Buller H., Prins M. [=Martin H.], Haley S., Kearon C., Hirsh J., Gent M. Recurrent venous thrombosis and heparin therapy: an evaluation of the importance of early activated partial thromboplastin times Archives of internal medicine 1999;159 (17):2029-2032 [PubMed]
• Moons K. G., van Es G. A., Michel B. C., Büller H. R., Habbema J. D., Grobbee D. E. Redundancy of single diagnostic test evaluation Epidemiology (Cambridge, Mass.) 1999;10 (3):276-281 [PubMed]
• Sanson B. J., Meinders A. J., Kraaijenhagen R. A., van Beek E. J., Büller H. R. Requirements for appropriate evaluation of diagnostic tests in suspected pulmonary embolism Haematologica 1999;84 (Suppl. EHA-4):78-81 [PubMed]
• Sanson B. J., Meinders A. J., Kraaijenhagen R. A., van Beek E. J., Büller H. R. Requirements for appropriate evaluation of diagnostic tests in suspected pulmonary embolism Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Universita di Napoli, Secondo ateneo 1999;54 (5):417-421 [PubMed]
• Bloemenkamp K. W., Rosendaal F. R., Büller H. R., Helmerhorst F. M., Colly L. P., Vandenbroucke J. P. Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias Archives of internal medicine 1999;159 (1):65-70 [PubMed]
• Sanson B. J., Lensing A. W., Prins M. H., Ginsberg J. S., Barkagan Z. S., Lavenne-Pardonge E., Brenner B., Dulitzky M., Nielsen J. D., Boda Z., Turi S., Mac Gillavry M. R., Hamulyák K., Theunissen I. M., Hunt B. J., Büller H. R. Safety of low-molecular-weight heparin in pregnancy: a systematic review Thrombosis and haemostasis 1999;81 (5):668-672 [PubMed]
• Smorenburg S. M., Hettiarachchi R. J., Vink R., Büller H. R. The effects of unfractionated heparin on survival in patients with malignancy--a systematic review Thrombosis and haemostasis 1999;82 (6):1600-1604 [PubMed]
• Sanson B. J., Simioni P., Tormene D., Moia M., Friederich P. W., Huisman M. V., Prandoni P., Bura A., Rejto L., Wells P., Mannucci P. M., Girolami A., Büller H. R., Prins M. H. The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study Blood 1999;94 (11):3702-3706 [PubMed]
• de Groot M. R., van Marwijk Kooy M., Pouwels J. G., Engelage A. H., Kuipers B. F., Büller H. R. The use of a rapid D-dimer blood test in the diagnostic work-up for pulmonary embolism: a management study Thrombosis and haemostasis 1999;82 (6):1588-1592 [PubMed]
• Girolami B., Bernardi E., Prins M. H., ten Cate J. W., Hettiarachchi R., Prandoni P., Girolami A., Büller H. R. Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis Archives of internal medicine 1999;159 (4):337-345 [PubMed]
• Peters R. J., Moons A. H., Büller H. R. Trombocytenreceptoren: huidige inzichten en behandelingsmogelijkheden Nederlands tijdschrift voor geneeskunde 1999;143 (39):1952-1957 [PubMed]

1998

• Cogo A., Lensing A. W., Koopman M. M., Piovella F., Siragusa S., Wells P. S., Villalta S., Büller H. R., Turpie A. G., Prandoni P. Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study BMJ (Clinical research ed.) 1998;316 (7124):17-20 [PubMed]
• Kraaijenhagen R. A., Lensing A. W., Wallis J. W., van Beek E. J., ten Cate J. W., Büller H. R. Diagnostic management of venous thromboembolism Baillière s clinical haematology 1998;11 (3):541-586 [PubMed]
• Büller H. R., Kraaijenhagen R. A., Koopman M. M. Early discharge strategies following venous thrombosis Vascular medicine (London, England) 1998;3 (1):47-50 [PubMed]
• Chamuleau S. A., de Winter R. J., Levi M. [=Marcel M.], Adams R., Büller H. R., Prins M. H., Lie K. I., Peters R. J. Low molecular weight heparin as an adjunct to thrombolysis for acute myocardial infarction: the FATIMA study. Fraxiparin Anticoagulant Therapy in Myocardial Infarction Study Amsterdam (FATIMA) Study Group Heart (British Cardiac Society) 1998;80 (1):35-39 [PubMed]
• Koopman M. M., Büller H. R. Low-molecular-weight heparins in the treatment of venous thromboembolism Annals of internal medicine 1998;128 (12 Part 1):1037-1039 [PubMed]
• Hettiarachchi R. J., Prins M. H., Lensing A. W., Buller H. R. Low molecular weight heparin versus unfractionated heparin in the initial treatment of venous thromboembolism Current opinion in pulmonary medicine 1998;4 (4):220-225 [PubMed]
• Turkstra F., van Beek E. J., Büller H. R. Observer and biological variation of a rapid whole blood D-dimer test Thrombosis and haemostasis 1998;79 (1):91-93 [PubMed]
• Büller H. R. Outpatient therapy with low-molecular-weight heparins: new perspectives for treatment of deep vein thrombosis Haemostasis 1998;28 (Suppl. 3):91-94 [PubMed]
• Büller H., ten Cate J. Wouter Primary venous thromboembolism and cancer screening New England journal of medicine 1998;338 (17):1221-1222 [PubMed]
• van den Belt A. G., Bossuyt P. M., Prins M. H., Gallus A. S., Büller H. R. Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis--an economic evaluation. TASMAN Study Group Thrombosis and haemostasis 1998;79 (2):259-263 [PubMed]
• Middeldorp S., Henkens C. M., Koopman M. M., van Pampus E. C., Hamulyák K., van der Meer J., Prins M. H., Büller H. R. The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis Annals of internal medicine 1998;128 (1):15-20 [PubMed]
• Hettiarachchi R. J., Lok J., Prins M. H., Büller H. R., Prandoni P. Undiagnosed malignancy in patients with deep vein thrombosis: incidence, risk indicators, and diagnosis Cancer 1998;83 (1):180-185 [PubMed]
• de Groot M. R., Büller H. R., ten Cate J. W., van Marwijk Kooy M. Use of a heparin nomogram for treatment of patients with venous thromboembolism in a community hospital Thrombosis and haemostasis 1998;80 (1):70-73 [PubMed]
• Levi M. [=Marcel M.], Peters R. J., Büller H. R. Weight watching in cardiology: low molecular weight heparin for acute coronary syndromes Cardiovascular research 1998;37 (3):564-566 [PubMed]

1997

• Biemond B. J., Friederich P. W., Koschinsky M. L., Levi M. [=Marcel M.], Sangrar W., Xia J., Büller H. R., ten Cate J. W. Apolipoprotein(a) attenuates endogenous fibrinolysis in the rabbit jugular vein thrombosis model in vivo Circulation 1997;96 (5):1612-1615 [PubMed]
• Moons K. G., Stijnen T., Michel B. C., Büller H. R., van Es G. A., Grobbee D. E., Habbema J. D. Application of treatment thresholds to diagnostic-test evaluation: an alternative to the comparison of areas under receiver operating characteristic curves Medical decision making 1997;17 (4):447-454 [PubMed]
• Kuijer P. M., Turkstra F., van Beek E. J., ten Cate J. W., Büller H. R. A survey of the diagnostic and therapeutic management of patients with suspected pulmonary embolism in the Netherlands Netherlands journal of medicine 1997;50 (6):261-266 [PubMed]
• Graafsma Y. P., Prins M. H., Lensing A. W., de Haan R. J., Huisman M. V., Büller H. R. Bleeding classification in clinical trials: observer variability and clinical relevance Thrombosis and haemostasis 1997;78 (4):1189-1192 [PubMed]
• Kraaijenhagen R. A., Lensing A. W., Lijmer J. G., Prandoni P., Prins M. H., Ginsberg J. S., Buller H. R. Diagnostic strategies for the management of patients with clinically suspected deep-vein thrombosis Current opinion in pulmonary medicine 1997;3 (4):268-274 [PubMed]
• Turkstra F., Kuijer P. M., van Beek E. J., Brandjes D. P., ten Cate J. W., Büller H. R. Diagnostic utility of ultrasonography of leg veins in patients suspected of having pulmonary embolism Annals of internal medicine 1997;126 (10):775-781 [PubMed]
• tenCate J. W., Buller H. R., Gent M., Hirsh J., Prins M. H., Baildon R., Lensing A. W. A., Anderson D. R., vanBeek E. J. R., Fiesinger J. N., Tijssen J. G. P., vanBarneveld A., Eimers L. T., Graafsma Y. P., Hettiarachchi R., Hutten B., Redekop K., Haley S., LIberale L., Finch T., Whittaker S., Wilkinson L., Prandoni P., Villalta S., Girolami B., Bagatella P., Rossi L., Girolami A., Piovella F., Barone M., Beltrametti C., Serafini S., Siragusa S., Ascari E., Kovacs M. J., Morrow B., Kovacs J., Kuijer P. M. M., Koopman M. M. W., Jagt H., Weitz J., Kearon C., Biagioni L., Haas S., Lossner F., Spengel F. A., Berger M., Demers C., Poulin J., vanderMeer J., Que G. T. H., Smid W. M., Robinson K. S., Boyle E., Leclerc J. R., StJacques B., Finkenbine S., Gallus A. S., Cohlan D., Rich C., Brandjes D. P. M., Hoefnagel C. A., deRijk M., Turkstra F., Desjardins L., CoteDesjardins J., Couture L., Ruel M., Villenueve J., Geerts W. H., Jay R. M., Code E. K. I., Turpie A. G. G., Johnson J., Nguyen P., Cusson J. R., Roy S., Wells P. S., Bormanis J., Goudie D., Cruickshank M., vonLewinski M., Monreal M., Sahuquillo J. C., Lafoz E., Simonneau G., Parent F., Jagot J., Douketis J. D., Kinnon K., Ginsberg J. S., BrillEdwards P., Donovan D., Ockelford P. A., Kassis J., Bornais S., Planchon B., Elkouri D., Pistorius M. A., Escribano M., Garrido G., Chesterman C. N., Chong B. H., Pritchard S., Cade J. F., Bynon T., Stanford J., Brien W. M., Palmer B., Faivre R., Petiteau B., Manucci P. M., Moia M., Bucciarelli P. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism New England journal of medicine 1997;337 (10):657-662 [PubMed]
• Brandjes D. P., Büller H. R., Heijboer H., Huisman M. V., de Rijk M., Jagt H., ten Cate J. W. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis Lancet 1997;349 (9054):759-762 [PubMed]
• van den Belt A. G., Sanson B. J., Simioni P., Prandoni P., Büller H. R., Girolami A., Prins M. H. Recurrence of venous thromboembolism in patients with familial thrombophilia Archives of internal medicine 1997;157 (19):2227-2232 [PubMed]
• van Beek E. J., Kuijer P. M., Büller H. R., Brandjes D. P., Bossuyt P. M., ten Cate J. W. The clinical course of patients with suspected pulmonary embolism Archives of internal medicine 1997;157 (22):2593-2598 [PubMed]
• Michel B. C., Kuijer P. M., McDonnell J., van Beek E. J., Rutten F. F., Büller H. R. The role of a decision rule in symptomatic pulmonary embolism patients with a non-high probability ventilation-perfusion scan Thrombosis and haemostasis 1997;78 (2):794-798 [PubMed]
• Turkstra F., Koopman M. M., Büller H. R. The treatment of deep vein thrombosis and pulmonary embolism Thrombosis and haemostasis 1997;78 (1):489-496 [PubMed]

1996

• Roelse J. C., Koopman M. M., Büller H. R., ten Cate J. W., Montaruli B., van Mourik J. A., Voorbert J. Absence of mutations at the activated protein C cleavage sites of factor VIII in 125 patients with venous thrombosis British journal of haematology 1996;92 (3):740-743 [PubMed]
• Meenan J., Hommes D. W., Mevissen M., Dijkhuizen S., Soule H., Moyle M., Büller H. R., ten Kate F. W., Tytgat G. N., van Deventer S. J. Attenuation of the inflammatory response in an animal colitis model by neutrophil inhibitory factor, a novel beta 2-integrin antagonist Scandinavian journal of gastroenterology 1996;31 (8):786-791 [PubMed]
• Biemond B. J., Friederich P. W., Levi M. [=Marcel M.], Vlasuk G. P., Büller H. R., ten Cate J. W. Comparison of sustained antithrombotic effects of inhibitors of thrombin and factor Xa in experimental thrombosis Circulation 1996;93 (1):153-160 [PubMed]
• Büller H. R., Koopman M. M. Diagnostic and therapeutic management of patients with deep-vein thrombosis: coming to maturity? Netherlands journal of medicine 1996;48 (3):81-84 [PubMed]
• Büller H. R., Koopman M. M., Brandjes D. P., van der Meer J., Prins M. H., ten Cate J. W. Diepe veneuze trombose: leiden de recentelijk verbeterde inzichten tot echte vooruitgang in de directe patiëntenzorg? Nederlands tijdschrift voor geneeskunde 1996;140 (11):587-590 [PubMed]
• ten Cate H., Biemond B. J., Levi M. [=Marcel M.], Wuillemin W. A., Bauer K. A., Barzegar S., Buller H. R., Hack C. E., ten Cate J. W., Rosenberg R. D. Factor XIa induced activation of the intrinsic cascade in vivo Thrombosis and haemostasis 1996;75 (3):445-449 [PubMed]
• van Beek E. J., Reekers J. A., Batchelor D. A., Brandjes D. P., Büller H. R. Feasibility, safety and clinical utility of angiography in patients with suspected pulmonary embolism European radiology 1996;6 (4):415-419 [PubMed]
• Friederich P. W., Sanson B. J., Simioni P., Zanardi S., Huisman M. V., Kindt I., Prandoni P., Büller H. R., Girolami A., Prins M. H. Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis Annals of internal medicine 1996;125 (12):955-960 [PubMed]
• Michel B. C., Seerden R. J., van Beek E. J., Büller H. R., Rutten F. F. Kosten van diagnostiek en behandeling wegens longembolie lager door toepassing van de consensusstrategie Nederlands tijdschrift voor geneeskunde 1996;140 (37):1864-1868 [PubMed]
• Nurmohamed M. T., van Riel A. M., Henkens C. M., Koopman M. M., Que G. T., d'Azemar P., Büller H. R., ten Cate J. W., Hoek J. A., van der Meer J., van der Heul C., Turpie A. G., Haley S., Sicurella A., Gent M. Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery Thrombosis and haemostasis 1996;75 (2):233-238 [PubMed]
• Prins J. M., Büller H. R. Meta-analysis: the final answer, or even more confusion? Lancet 1996;348 (9021):199 [PubMed]
• Turkstra F., van Beek E. J., ten Cate J. W., Büller H. R. Reliable rapid blood test for the exclusion of venous thromboembolism in symptomatic outpatients Thrombosis and haemostasis 1996;76 (1):9-11 [PubMed]
• Knipscheer H. C., Boelen C. C., Kastelein J. J., van Diermen D. E., Groenemeijer B. E., van den Ende A., Büller H. R., Bakker H. D. Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia Pediatric research 1996;39 (5):867-871 [PubMed]
• Michel B. C., Seerden R. J., Rutten F. F., van Beek E. J., Büller H. R. The cost-effectiveness of diagnostic strategies in patients with suspected pulmonary embolism Health economics 1996;5 (4):307-318 [PubMed]
• van Beek E. J., Schenk B. E., Michel B. C., van den Ende B., Brandjes D. P., van der Heide Y. T., Bossuyt P. M., Büller H R. The role of plasma D-dimers concentration in the exclusion of pulmonary embolism British journal of haematology 1996;92 (3):725-732 [PubMed]

1995

• van Beek E. J., Kuyer P. M., Schenk B. E., Brandjes D. P., ten Cate J. W., Büller H. R. A normal perfusion lung scan in patients with clinically suspected pulmonary embolism. Frequency and clinical validity Chest 1995;108 (1):170-173 [PubMed]
• Büller H. R., ten Cate T. Coagulation and platelet activation pathways. A review of the key components and the way in which these can be manipulated European heart journal 1995;16 (Suppl. L):8-10 [PubMed]
• Biemond B. J., Levi M. [=Marcel M.], ten Cate H., Soule H. R., Morris L. D., Foster D. L., Bogowitz C. A., van der Poll T., Büller H. R., ten Cate J. W. Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIa Thrombosis and haemostasis 1995;73 (2):223-230 [PubMed]
• Koopman M. M., Büller H. R., ten Cate J. W. Diagnosis of recurrent deep vein thrombosis Haemostasis 1995;25 (1-2):49-57 [PubMed]
• Prins J. M., Koopmans R. P., Büller H. R., Kuijper E. J., Speelman P. Easier monitoring of aminoglycoside therapy with once-daily dosing schedules European journal of clinical microbiology & infectious diseases 1995;14 (6):531-535 [PubMed]
• Bloemenkamp K. W., Rosendaal F. R., Helmerhorst F. M., Büller H. R., Vandenbroucke J. P. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen Lancet 1995;346 (8990):1593-1596 [PubMed]
• Cogo A., Lensing A. W., Wells P., Prandoni P., Büller H. R. Noninvasive objective tests for the diagnosis of clinically suspected deep-vein thrombosis Haemostasis 1995;25 (1-2):27-39 [PubMed]
• Tange R. A., Dreschler W. A., Prins J. M., Büller H. R., Kuijper E. J., Speelman P. Ototoxicity and nephrotoxicity of gentamicin vs netilmicin in patients with serious infections. A randomized clinical trial Clinical otolaryngology and allied sciences 1995;20 (2):118-123 [PubMed]
• Biemond B. J., Levi M. [=Marcel M.], ten Cate H., van der Poll T., Büller H. R., Hack C. E., ten Cate J. W. Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades Clinical science (London, England 1995;88 (5):587-594 [PubMed]
• ten Cate J. W., Koopman M. M., Prins M. H., Büller H. R. Treatment of venous thromboembolism Thrombosis and haemostasis 1995;74 (1):197-203 [PubMed]

1994

• Biemond B. J., Levi M. [=Marcel M.], Nurmohamed M. T., Büller H. R., ten Cate J. W. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model Thrombosis and haemostasis 1994;72 (3):377-380 [PubMed]
• van Beek E. J., von der Möhlen M. A., ten Cate J. W., Brandjes D. P., Büller H. R. Antithrombin III concentrate in the treatment of DIC: a retrospective follow-up study Netherlands journal of medicine 1994;45 (5):206-210 [PubMed]
• ten Cate H., Schenk B. E., Biemond B. J., Levi M. [=Marcel M.], van der Poll T., Buller H. R., ten Cate J. W. A review of studies of the activation of the blood coagulation mechanism in chimpanzees (Pan troglodytes) Journal of medical primatology 1994;23 (5):280-284 [PubMed]
• Voorberg J., Roelse J., Koopman R., Büller H., Berends F., ten Cate J. W., Mertens K., van Mourik J. A. Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V Lancet 1994;343 (8912):1535-1536 [PubMed]
• van Beek E. J., Büller H. R., Brandjes D. P., Rutten G. C., ten Cate J. W. Diagnosis of clinically suspected pulmonary embolism: a survey of current practice in a teaching hospital Netherlands journal of medicine 1994;44 (2):50-55 [PubMed]
• van der Poll T., Levi M. [=Marcel M.], van Deventer S. J., ten Cate H., Haagmans B. L., Biemond B. J., Büller H. R., Hack C. E., ten Cate J. W. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees Blood 1994;83 (2):446-451 [PubMed]
• van der Poll T., Levi M. [=Marcel M.], Hack C. E., ten Cate H., van Deventer S. J., Eerenberg A. J., de Groot E. R., Jansen J., Gallati H., Büller H. R. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees Journal of experimental medicine 1994;179 (4):1253-1259 [PubMed]
• van Beek E. J., Levi M. [=Marcel M.], Reekers J. A., Hack C. E., Büller H. R., ten Cate J. W. Increased plasma levels of PAI-1 after administration of nonionic contrast medium in patients undergoing pulmonary angiography Radiology 1994;193 (3):821-823 [PubMed]
• Levi M. [=Marcel M.], ten Cate H., Bauer K. A., van der Poll T., Edgington T. S., Büller H. R., van Deventer S. J., Hack C. E., ten Cate J. W., Rosenberg R. D. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees Journal of clinical investigation 1994;93 (1):114-120 [PubMed]
• ten Cate H., Levi M. [=Marcel M.], van der Poll T., Biemond B. J., van Deventer S. J., Buller H. R., ten Cate J. W. Inhibition of extrinsic coagulation activation in endotoxemia; therapeutic implications Progress in clinical and biological research 1994;388:215-219 [PubMed]
• van Beek E. J., Büller H. R., Bounameaux H. Latex D-dimer for diagnosing pulmonary embolism Journal of nuclear medicine 1994;35 (1):189-190 [PubMed]
• Jongbloets L. M., Lensing A. W., Koopman M. M., Büller H. R., ten Cate J. W. Limitations of compression ultrasound for the detection of symptomless postoperative deep vein thrombosis Lancet 1994;343 (8906):1142-1144 [PubMed]
• Prins J. M., Büller H. R., Kuijper E. J., Tange R. A., Speelman P. Once-daily gentamicin versus once-daily netilmicin in patients with serious infections--a randomized clinical trial Journal of antimicrobial chemotherapy 1994;33 (4):823-835 [PubMed]
• Nurmohamed M. T., Büller H. R., ten Cate J. W. Physiological changes due to age. Implications for the prevention and treatment of thrombosis in older patients Drugs & aging 1994;5 (1):20-33 [PubMed]

1993

• Heijboer H., Büller H. R., Lensing A. W., Turpie A. G., Colly L. P., ten Cate J. W. A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients New England journal of medicine 1993;329 (19):1365-1369 [PubMed]
• Verstraete M., Nurmohamed M., Kienast J., Siebeck M., Silling-Engelhardt G., Büller H., Hoet B., Bichler J., Close P. Biologic effects of recombinant hirudin (CGP 39393) in human volunteers. European Hirudin in Thrombosis Group Journal of the American College of Cardiology 1993;22 (4):1080-1088 [PubMed]
• Cogo A., Lensing A. W., Prandoni P., Büller H. R., Girolami A., ten Cate J. W. Comparison of real-time B-mode ultrasonography and Doppler ultrasound with contrast venography in the diagnosis of venous thrombosis in symptomatic outpatients Thrombosis and haemostasis 1993;70 (3):404-407 [PubMed]
• Oudkerk M., van Beek E. J., van Putten W. L., Büller H. R. Cost-effectiveness analysis of various strategies in the diagnostic management of pulmonary embolism Archives of internal medicine 1993;153 (8):947-954 [PubMed]
• Büller H. R. Hirudin in the treatment of arterial and venous thrombotic diseases: a new perspective Zeitschrift für Kardiologie 1993;82 (Suppl. 2):81-82 [PubMed]
• Wortel C. H., van Deventer S. J., Aarden L. A., Lygidakis N. J., Büller H. R., Hoek F. J., Horikx J., ten Cate J. W. Interleukin-6 mediates host defense responses induced by abdominal surgery Surgery 1993;114 (3):564-570 [PubMed]
• Prins J. M., Büller H. R., Kuijper E. J., Tange R. A., Speelman P. Once versus thrice daily gentamicin in patients with serious infections Lancet 1993;341 (8841):335-339 [PubMed]
• van den Bos A. A., Deckers J. W., Heyndrickx G. R., Laarman G. J., Suryapranata H., Zijlstra F., Close P., Rijnierse J. J., Buller H. R., Serruys P. W. Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty Circulation 1993;88 (5 Part 1):2058-2066 [PubMed]
• Gianese F., Nurmohamed M. T., Imbimbo B. P., Büller H. R., Berckmans R. J., ten Cate J. W. The pharmacokinetics and pharmacodynamics of dermatan sulphate MF701 during haemodialysis for chronic renal failure British journal of clinical pharmacology 1993;35 (3):335-339 [PubMed]
• van Beek E. J., Tiel-van Buul M. M., Büller H. R., van Royen E. A., ten Cate J. W. The value of lung scintigraphy in the diagnosis of pulmonary embolism European journal of nuclear medicine 1993;20 (2):173-181 [PubMed]

1992

• Brandjes D. P., Heijboer H., Büller H. R., de Rijk M., Jagt H., ten Cate J. W. Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis New England journal of medicine 1992;327 (21):1485-1489 [PubMed]
• Heijboer H., Jongbloets L. M., Büller H. R., Lensing A. W., ten Cate J. W. Clinical utility of real-time compression ultrasonography for diagnostic management of patients with recurrent venous thrombosis Acta radiologica (Stockholm, Sweden 1992;33 (4):297-300 [PubMed]
• Prandoni P., Lensing A. W., Büller H. R., Carta M., Cogo A., Vigo M., Casara D., Ruol A., ten Cate J. W. Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis Lancet 1992;339 (8791):441-445 [PubMed]
• Levi M. [=Marcel M.], Hack C. E., de Boer J. P., Brandjes D. P., Büller H. R., ten Cate J. W. Contact system dependent fibrinolytic activity in vivo: observations in healthy subjects and factor XII deficient patients Agents and actions. Supplements 1992;38 (2):292-298 [PubMed]
• Lensing A. W., Büller H. R., Prandoni P., Batchelor D., Molenaar A. H., Cogo A., Vigo M., Huisman P. M., ten Cate J. W. Contrast venography, the gold standard for the diagnosis of deep-vein thrombosis: improvement in observer agreement Thrombosis and haemostasis 1992;67 (1):8-12 [PubMed]
• Prandoni P., Lensing A. W., Büller H. R., Cogo A., Prins M. H., Cattelan A. M., Cuppini S., Noventa F., ten Cate J. W. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer New England journal of medicine 1992;327 (16):1128-1133 [PubMed]
• de Boer K., Büller H. R., ten Cate J. W., Levi M. [=Marcel M.] Deep vein thrombosis in obstetric patients: diagnosis and risk factors Thrombosis and haemostasis 1992;67 (1):4-7 [PubMed]
• Heijboer H., Cogo A., Büller H. R., Prandoni P., ten Cate J. W. Detection of deep vein thrombosis with impedance plethysmography and real-time compression ultrasonography in hospitalized patients Archives of internal medicine 1992;152 (9):1901-1903 [PubMed]
• van der Poll T., van Deventer S. J., Hack C. E., Wolbink G. J., Aarden L. A., Büller H. R., ten Cate J. W. Effects on leukocytes after injection of tumor necrosis factor into healthy humans Blood 1992;79 (3):693-698 [PubMed]
• Büller H. R., Dyserinck H. C., Vreeken J., Bakker S. Handleiding of touroperator: wie gidst de clinicus bij het literatuuronderzoek? Nederlands tijdschrift voor geneeskunde 1992;136 (16):797-800 [PubMed]
• van Beek E. J., Büller H. R., van Royen E. A., van Everdingen J. J., ten Cate J. W. Het diagnostisch beleid bij vermoeden van longembolie: resultaten van een enquête onder Nederlandse internisten en longartsen Nederlands tijdschrift voor geneeskunde 1992;136 (7):319-323 [PubMed]
• Levi M. [=Marcel M.], Wilmink J., Büller H. R., Surachno J., ten Cate J. W. Impaired fibrinolysis in cyclosporine-treated renal transplant patients. Analysis of the defect and beneficial effect of fish-oil Transplantation 1992;54 (6):978-983 [PubMed]
• Nurmohamed M. T., Rosendaal F. R., Büller H. R., Dekker E., Hommes D. W., Vandenbroucke J. P., Briët E. Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis Lancet 1992;340 (8812):152-156 [PubMed]
• Escher J. C., de Koning N. D., van Engen C. G., Arora S., Büller H. A., Montgomery R. K., Grand R. J. Molecular basis of lactase levels in adult humans Journal of clinical investigation 1992;89 (2):480-483 [PubMed]
• Dekker E., Büller H. R., Kastelein J. J. Postmenopauzale oestrogeensubstitutie en het risico van atherosclerotische hart- en vaatziekten Nederlands tijdschrift voor geneeskunde 1992;136 (25):1197-1200 [PubMed]
• Hoek J. A., Nurmohamed M. T., Hamelynck K. J., Marti R. K., Knipscheer H. C., ten Cate H., Büller H. R., Magnani H. N., ten Cate J. W. Prevention of deep vein thrombosis following total hip replacement by low molecular weight heparinoid Thrombosis and haemostasis 1992;67 (1):28-32 [PubMed]
• Nicolaides A. N., Arcelus J., Belcaro G., Bergqvist D., Borris L. C., Buller H. R., Caprini J. A., Christopoulos D., Clarke-Pearson D., Clement D. Prevention of venous thromboembolism. European Consensus Statement, 1-5 November 1991, developed at Oakley Court Hotel, Windsor, UK International angiology 1992;11 (3):151-159 [PubMed]
• Hommes D. W., Bura A., Mazzolai L., Büller H. R., ten Cate J. W. Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. A meta-analysis Annals of internal medicine 1992;116 (4):279-284 [PubMed]
• Heijboer H., Ginsberg J. S., Büller H. R., Lensing A. W., Colly L. P., ten Cate J. Wouter The use of the D-dimer test in combination with non-invasive testing versus serial non-invasive testing alone for the diagnosis of deep-vein thrombosis Thrombosis and haemostasis 1992;67 (5):510-513 [PubMed]
• van der Poll T., van Deventer S. J., Pasterkamp G., van Mourik J. A., Büller H. R., ten Cate J. W. Tumor necrosis factor induces von Willebrand factor release in healthy humans Thrombosis and haemostasis 1992;67 (6):623-626 [PubMed]
• Ginsberg J. S., Brill-Edwards P., Burrows R. F., Bona R., Prandoni P., Büller H. R., Lensing A. Venous thrombosis during pregnancy: leg and trimester of presentation Thrombosis and haemostasis 1992;67 (5):519-520 [PubMed]
• Lensing A. W., Prins M. [=Martin H.], Koopman M. M., Buller H. Which heparin for proximal deep-vein thrombosis? Lancet 1992;340 (8814):311-312 [PubMed]

1991

• Prandoni P., Lensing A. W., Huisman M. V., Jonker J. J., Vigo M., Borm J. J., Büller H. R., Sing A. K., Carta M., ten Cate J. W. A new computerized impedance plethysmograph: accuracy in the detection of proximal deep-vein thrombosis in symptomatic outpatients Thrombosis and haemostasis 1991;65 (3):229-232 [PubMed]
• Wiersinga W. M., Prummel M. F., Mourits M. P., Koornneef L., Buller H. R. Classification of the eye changes of Graves' disease Thyroid 1991;1 (4):357-360 [PubMed]
• de Boer K., Büller H. R., ten Cate J. W., Treffers P. E. Coagulation studies in the syndrome of haemolysis, elevated liver enzymes and low platelets British journal of obstetrics and gynaecology 1991;98 (1):42-47 [PubMed]
• van der Poll T., van Deventer S. J., Büller H. R., Sturk A., ten Cate J. W. Comparison of the early dynamics of coagulation activation after injection of endotoxin and tumor necrosis factor in healthy humans Progress in clinical and biological research 1991;367:55-60 [PubMed]
• van der Poll T., van Deventer S. J., Büller H. R., Sturk A., ten Cate J. W. Comparison of the early dynamics of systemic prostacyclin release after administration of tumor necrosis factor and endotoxin to healthy humans Journal of infectious diseases 1991;164 (3):599-601 [PubMed]
• Lensing A. W., Büller H. R., ten Cate J. W., Prandoni P. Confirmation of the failure of computerized impedance plethysmography in the diagnostic management of patients with clinically suspected deep-vein thrombosis Thrombosis and haemostasis 1991;66 (6):744 [PubMed]
• Levi M. [=Marcel M.], Lensing A. W., Büller H. R., Prandoni P., Dooijewaard G., Cuppini S., ten Cate J. W. Deep vein thrombosis and fibrinolysis. Defective urokinase type plasminogen activator release Thrombosis and haemostasis 1991;66 (4):426-429 [PubMed]
• Büller H. R., Lensing A. W., Hirsh J., ten Cate J. W. Deep vein thrombosis: new non-invasive diagnostic tests Thrombosis and haemostasis 1991;66 (1):133-137 [PubMed]
• Heijboer H., ten Cate J. W., Büller H. R. Diagnosis of venous thrombosis Seminars in thrombosis and hemostasis 1991;17 (Suppl. 3):259-268 [PubMed]
• Prandoni P., Lensing A. W., Büller H. R., Carta M., Vigo M., Cogo A., Cuppini S., ten Cate J. W. Failure of computerized impedance plethysmography in the diagnostic management of patients with clinically suspected deep-vein thrombosis Thrombosis and haemostasis 1991;65 (3):233-236 [PubMed]
• van der Poll T., Levi M. [=Marcel M.], Büller H. R., van Deventer S. J., de Boer J. P., Hack C. E., ten Cate J. W. Fibrinolytic response to tumor necrosis factor in healthy subjects Journal of experimental medicine 1991;174 (3):729-732 [PubMed]
• Brandjes D. P., Schenk B. E., Büller H. R., ten Cate J. W. Management of disseminated intravascular coagulation in obstetrics European journal of obstetrics, gynecology, and reproductive biology 1991;42 (Suppl):S87-S89 [PubMed]
• Rosendaal F. R., Heijboer H., Briët E., Büller H. R., Brandjes D. P., de Bruin K., Hommes D. W., Vandenbroucke J. P. Mortality in hereditary antithrombin-III deficiency--1830 to 1989 Lancet 1991;337 (8736):260-262 [PubMed]
• Leyvraz P. F., Bachmann F., Hoek J., Büller H. R., Postel M., Samama M., Vandenbroek M. D. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin BMJ (Clinical research ed.) 1991;303 (6802):543-548 [PubMed]
• Levi M. [=Marcel M.], Hack C. E., de Boer J. P., Brandjes D. P., Büller H. R., ten Cate J. W. Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo Journal of clinical investigation 1991;88 (4):1155-1160 [PubMed]
• Herderscheê D., Limburg M., van Royen E. A., Hijdra A., Büller H. R., Koster P. A. Thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: evaluation with rCBF-SPECT Acta neurologica Scandinavica 1991;83 (5):317-322 [PubMed]
• van der Poll T., Romijn J. A., Endert E., Borm J. J., Büller H. R., Sauerwein H. P. Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans American journal of physiology 1991;261 (4 Part 1):E457-E465 [PubMed]

1990

• van der Poll T., Büller H. R., ten Cate H., Wortel C. H., Bauer K. A., van Deventer S. J., Hack C. E., Sauerwein H. P., Rosenberg R. D., ten Cate J. W. Activation of coagulation after administration of tumor necrosis factor to normal subjects New England journal of medicine 1990;322 (23):1622-1627 [PubMed]
• Heijboer H., Brandjes D. P., Büller H. R., Sturk A., ten Cate J. W. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis New England journal of medicine 1990;323 (22):1512-1516 [PubMed]
• Sturk A., van Deventer S. J., Wortel C. H., Levels J. H., ten Cate J. W., Büller H. R., Sanders G. T. Detection and clinical relevance of human endotoxemia Zeitschrift für medizinische Laboratoriumsdiagnostik 1990;31 (3):147-158 [PubMed]
• Lensing A. W., Levi M. M., Büller H. R., Prandoni P., Vigo M., Agnelli G., Lupatelli L., Huisman M. V., ten Cate J. W. Diagnosis of deep-vein thrombosis using an objective Doppler method Annals of internal medicine 1990;113 (1):9-13 [PubMed]
• de Boer K., Büller H. R., ten Cate J. W., Weenink G. H., Treffers P. E. Diep veneuze trombose in de zwangerschap: diagnostiek, behandeling en preventie Nederlands tijdschrift voor geneeskunde 1990;134 (28):1349-1352 [PubMed]
• Colman Robert W., Rosner Fred, Van Der Poll Tom, Büller Harry R., Ten Cate Jan W., Hack C. Erik Effect of tumor necrosis factor in normal subjects New England journal of medicine 1990;323 (19):1350-1352 [PubMed]
• Van der Poll T., Buller H. R., Ten Cate J. W., Hack C. E. Effect of tumor necrosis factor in normal subjects (Reply) New England journal of medicine 1990;323 (19):1351-1352
• de Vries I., van Deventer S. J., Debets J., Buller H. R., ten Cate J. W., Pauw W., Statius van Eps L. W., Sturk A. Endotoxin-induced cytokines in human septicemia Advances in experimental medicine and biology 1990;256:635-640 [PubMed]
• van Deventer S. J., Büller H. R., ten Cate J. W., Aarden L. A., Hack C. E., Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways Blood 1990;76 (12):2520-2526 [PubMed]
• Stam J., Hommes D. W., van der Does M. C., ten Cate T. J., Büller H. R. Kunnen bijna afgestudeerde artsen hun vakliteratuur interpreteren? Nederlands tijdschrift voor geneeskunde 1990;134 (17):854-857 [PubMed]
• Lensing A. W., Prandoni P., Büller H. R., Casara D., Cogo A., ten Cate J. W. Lower extremity venography with iohexol: results and complications Radiology 1990;177 (2):503-505 [PubMed]
• Nanninga P. B., van Teunenbroek A., Veenhof C. H., Büller H. R., ten Cate J. W. Low prevalence of coagulation and fibrinolytic activation in patients with primary untreated cancer Thrombosis and haemostasis 1990;64 (3):361-364 [PubMed]
• Brandjes D. P., ten Cate J. W., Buller H. R. Pre-surgical identification of the patient at risk for developing venous thromboembolism post-operatively Acta chirurgica Scandinavica 1990;156 (Suppl 556):18-21 [PubMed]

1989

• Büller H. R., ten Cate J. W. Acquired antithrombin III deficiency: laboratory diagnosis, incidence, clinical implications, and treatment with antithrombin III concentrate American journal of medicine 1989;87 (3B):44S-48S [PubMed]
• Lensing A. W., Prandoni P., Brandjes D., Huisman P. M., Vigo M., Tomasella G., Krekt J., ten Cate J. Wouter, Huisman M. V., Büller H. R. Detection of deep-vein thrombosis by real-time B-mode ultrasonography New England journal of medicine 1989;320 (6):342-345 [PubMed]
• Huisman M. V., Büller H. R., ten Cate J. W., Heijermans H. S., van der Laan J., van Maanen D. J. Management of clinically suspected acute venous thrombosis in outpatients with serial impedance plethysmography in a community hospital setting Archives of internal medicine 1989;149 (3):511-513 [PubMed]
• van Deventer S. J., Debets J. M., Büller H. R., ten Cate J. W., van der Linden C. J., Buurman W. A. Nieuwe ontwikkelingen op het gebied van sepsis: tumornecrosisfactor (cachectine) Nederlands tijdschrift voor geneeskunde 1989;133 (1):17-19 [PubMed]
• Hoek J. A., Nurmohamed M. T., ten Cate J. W., Büller H. R., Knipscheer H. C., Hamelynck K. J., Marti R. K., Sturk A. Thrombin-antithrombin III complexes in the prediction of deep vein thrombosis following total hip replacement Thrombosis and haemostasis 1989;62 (4):1050-1052 [PubMed]
• Avvisati G., ten Cate J. W., Büller H. R., Mandelli F. Tranexamic acid for control of haemorrhage in acute promyelocytic leukaemia Lancet 1989;2 (8655):122-124 [PubMed]
• Huisman M. V., Büller H. R., ten Cate J. W., van Royen E. A., Vreeken J., Kersten M. J., Bakx B. Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis Chest 1989;95 (3):498-502 [PubMed]

1988

• ten Cate H., Henny C. P., ten Cate J. W., Büller H. R. Clinical studies with low-molecular-weight heparin(oid)s: an interim analysis American journal of hematology 1988;27 (2):146-153 [PubMed]
• van Deventer S. J., Buller H. R., ten Cate J. W., Sturk A., Pauw W. Endotoxaemia: an early predictor of septicaemia in febrile patients Lancet 1988;1 (8586):605-609 [PubMed]
• van Deventer S. J., de Vries I., Statius van Eps L. W., Pauw W., Büller H. R., Sturk A., ten Cate J. W. Endotoxemia, bacteremia and urosepsis Progress in clinical and biological research 1988;272:213-224 [PubMed]
• van Deventer S. J., Knepper A., Landsman J., Lawson J., ten Cate J. W., Buller H. R., Sturk A., Pauw W. Endotoxins in portal blood Hepato-gastroenterology 1988;35 (5):223-225 [PubMed]
• Huisman M. V., Büller H. R., ten Cate J. W. Utility of impedance plethysmography in the diagnosis of recurrent deep-vein thrombosis Archives of internal medicine 1988;148 (3):681-683 [PubMed]

1987

• Sturk A., Morrien-Salomons W. M., Huisman M. V., Borm J. J., Büller H. R., ten Cate J. W. Analytical and clinical evaluation of commercial protein C assays Clinica chimica acta; international journal of clinical chemistry 1987;165 (2-3):263-270 [PubMed]
• van Deventer S. J., Pauw W., ten Cate J. W., Janssen M. E., Büller H. R., Sturk A. Clinical evaluation in febrile patients of an optimized endotoxin assay in blood Progress in clinical and biological research 1987;231:489-499 [PubMed]
• Huisman M. V., Heijermans H. S., Büller H. R., van der Laan J., ten Cate J. W., van Maanen D. J. Effectiviteit en veiligheid van herhaalde impedantieplethysmografie alléén ter opsporing van diep veneuze trombose Nederlands tijdschrift voor geneeskunde 1987;131 (14):580-584 [PubMed]
• van der Sande J. J., Buller H. R. Intravascular coagulation in surgery for large acoustic neuromas Journal of neurology, neurosurgery, and psychiatry 1987;50 (5):648-649 [PubMed]
• Huisman M. V., Büller H. R., ten Cate J. W. Kosten-effectiviteitsanalyse van de diagnostiek bij patiënten met diep veneuze trombose Nederlands tijdschrift voor geneeskunde 1987;131 (14):584-588 [PubMed]
• ten Cate H., Henny C. P., ten Cate J. W., Büller H. R., Dabhoiwala N. F. Randomized double-blind, placebo controlled safety study of a low molecular weight heparinoid in patients undergoing transurethral resection of the prostate Thrombosis and haemostasis 1987;57 (1):92-96 [PubMed]

1986

• Huisman M. V., Büller H. R., ten Cate J. W., Vreeken J. Serial impedance plethysmography for suspected deep venous thrombosis in outpatients. The Amsterdam General Practitioner Study New England journal of medicine 1986;314 (13):823-828 [PubMed]
• Henny C. P., ten Cate H., ten Cate J. W., Prummel M. F., Peters M., Büller H. R. Thrombosis prophylaxis in an AT III deficient pregnant woman: application of a low molecular weight heparinoid Thrombosis and haemostasis 1986;55 (2):301 [PubMed]
• Lensing A. W., Levi M. M., ten Cate J. W., Huisman M. W., Büller H. R. Trombosediagnostiek in Noord-Holland anno 1985 Nederlands tijdschrift voor geneeskunde 1986;130 (32):1434-1436 [PubMed]
• Büller H., Peters M., Burger B., Nagelkerke N., ten Cate J. W., Breederveld C., Heymans H. Vitamin-K status beyond the neonatal period. A prospective study in normal breast-fed and formula-fed infants European journal of pediatrics 1986;145 (6):496-499 [PubMed]

1985

• Huisman M. V., Büller H. R., Basart D. C., ten Cate J. W. A comparison of impedance plethysmography and strain gauge plethysmography in the diagnosis of deep venous thrombosis in symptomatic outpatients Thrombosis research 1985;40 (4):533-541 [PubMed]
• ten Cate H., Henny C. P., ten Cate J. W., Büller H. R., Mooy M. C., Surachno S., Wilmink J. M. Anticoagulant effects of a low molecular weight heparinoid (Org 10172) in human volunteers and haemodialysis patients Thrombosis research 1985;39 (2):211-222 [PubMed]
• Henny C. P., ten Cate H., ten Cate J. W., Moulijn A. C., Sie T. H., Warren P., Büller H. R. A randomized blind study comparing standard heparin and a new low molecular weight heparinoid in cardiopulmonary bypass surgery in dogs Journal of laboratory and clinical medicine 1985;106 (2):187-196 [PubMed]
• Hull R. D., Hirsh J., Carter C. J., Jay R. M., Ockelford P. A., Buller H. R., Turpie A. G., Powers P., Kinch D., Dodd P. E. Diagnostic efficacy of impedance plethysmography for clinically suspected deep-vein thrombosis. A randomized trial Annals of internal medicine 1985;102 (1):21-28 [PubMed]
• Huisman M. V., ten Cate J. W., Büller H. R. Oral anticoagulants after calf-vein thrombosis Lancet 1985;2 (8462):1011 [PubMed]
• Henny C. P., ten Cate H., Surachno S., Stevens P., Büller H. R., den Hartog M., ten Cate J. W. The effectiveness of a low molecular weight heparinoid in chronic intermittent haemodialysis Thrombosis and haemostasis 1985;54 (2):460-462 [PubMed]
• Büller H. R., ten Cate J. W., Sturk A., Thomas L. L. Validity of the endotoxin assay in post surgical patients Progress in clinical and biological research 1985;189:405-417 [PubMed]

1984

• Thomas L. L., Sturk A., Büller H. R., ten Cate J. W., Spijker R. E., ten Cate H. Comparative investigation of a quantitative chromogenic endotoxin assay and blood cultures American journal of clinical pathology 1984;82 (2):203-206 [PubMed]
• Büller H. R., ten Cate J. W., Vreeken J. Diagnostiek van diep veneuze trombose. II. Strategie van onderzoek Nederlands tijdschrift voor geneeskunde 1984;128 (49):2312-2314 [PubMed]
• Büller H. R., ten Cate J. W., Vreeken J. Diagnostiek van diep veneuze trombose. I. Methoden van onderzoek Nederlands tijdschrift voor geneeskunde 1984;128 (49):2307-2312 [PubMed]
• Henny C. P., ten Cate H., Dabhoiwala N. F., Büller H. R., ten Cate J. W. Effect of hormonal manipulation on antithrombin III activity in patients with prostatic carcinoma European urology 1984;10 (3):202-206 [PubMed]
• Basart D. C., Huisman M. V., Büller H. R., Ockelford P. A., ten Cate J. W., Grasboer A., Marsman J. W., Vreeken J. Evaluation of impedance plethysmography as a single non-invasive test for the diagnosis of clinically suspected deep vein thrombosis Netherlands journal of medicine 1984;27 (6):197-201 [PubMed]
• ten Cate H., Henny C. P., Büller H. R., ten Cate J. W., Magnani H. N. Use of a heparinoid in patients with hemorrhagic stroke and thromboembolic disease Annals of neurology 1984;15 (3):268-270 [PubMed]

1983

• Büller H. R., ten Cate J. W. Antithrombin III infusion in patients undergoing peritoneovenous shunt operation: failure in the prevention of disseminated intravascular coagulation Thrombosis and haemostasis 1983;49 (2):128-131 [PubMed]
• Henny C. P., Lim A. E., Brummelkamp W. H., Buller H. R., ten Cate J. W. A review of the importance of acute multidisciplinary treatment following spontaneous rupture of the liver capsule during pregnancy Surgery, gynecology & obstetrics 1983;156 (5):593-598 [PubMed]
• Richard L. C., Büller H. R., Bovilland J., ten Cate J. W. Influence of anaesthesia on coagulation and fibrinolytic proteins British journal of anaesthesia 1983;55 (9):869-872 [PubMed]
• Hull R. D., Hirsh J., Carter C. J., Jay R. M., Dodd P. E., Ockelford P. A., Coates G., Gill G. J., Turpie A. G., Doyle D. J., Buller H. R., Raskob G. E. Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan Annals of internal medicine 1983;98 (6):891-899 [PubMed]
• Büller H. R., Ockelford P. A., Hull R. D. Strategies to diagnosis and screening of deep venous thrombosis and pulmonary embolism Netherlands journal of surgery 1983;35 (4):121-128 [PubMed]
• Büller H. R., Hobbelen P. M., Princen A. W., Moelker H. C., ten Cate J. W. The effects of antithrombin III, heparin and a novel heparinoid infusions on the bleeding tendency using an experimental model in the rat Thrombosis research 1983;31 (6):787-797 [PubMed]

1982

• Henny C. P., ten Cate H., Büller H. R., ten Cate J. W. Ambulatory heparin treatment Lancet 1982;1 (8272):615 [PubMed]
• Thomas L. L., Henny C. P., Büller H. R., Sturk A., Joop K., ten Cate J. W. Chromogenic endotoxin determination in blood--clinical relevance Klinische Wochenschrift 1982;60 (14):759-760 [PubMed]
• Büller H. R., Boon T. A., Henny C. P., Dabhoiwala N. F., ten Cate J. W. Estrogen-induced deficiency and decrease in antithrombin III activity in patients with prostatic cancer Journal of urology 1982;128 (1):72-74 [PubMed]
• Bolwerk C. J., Henny C. P., Büller H. R., ten Cate J. W. Hereditary AT III deficiency and heparin Thrombosis research 1982;28 (5):689-691 [PubMed]
• Büller H. R., Bolwerk C., ten Cate J., Roos J., Kahlé L. H., ten Cate J. W. Postoperative hemostatic profile in relation to gram-negative septicemia Critical care medicine 1982;10 (5):311-315 [PubMed]
• Henny C. P., Lim T. E., Brummelkamp W. H., Büller H. R., ten Cate J. W. Spontaneous rupture of Glisson's capsule during pregnancy. An acute surgical emergency Netherlands journal of surgery 1982;34 (2):72-75 [PubMed]

1981

• Büller H. R., ten Cate J. W. Zwangerschap en ontstolling Nederlands tijdschrift voor geneeskunde 1981;125 (18):710-713 [PubMed]

1980

• Büller H. R., Weenink A. H., Treffers P. E., Kahlé L. H., Otten H. A., ten Cate J. W. Severe antithrombin III deficiency in a patient with pre-eclampsia. Observations on the effect of human AT III concentrate transfusion Scandinavian journal of haematology 1980;25 (1):81-86 [PubMed]